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1 Introduction 
1.1 Metal-Catalyzed Direct C−H Bond Functionalizations 
1.1.1 Metal-Catalyzed Direct C−H Bond Functionalizations: An Overview 
The catalytic functionalization of unreactive C−H bonds represents one of the most powerful tools 
for sustainable syntheses and for opening new routes to pharmaceuticals and natural products.
1,2
 
These methods are economically attractive alternatives to conventional cross-coupling reactions 
(Scheme 1).
3,4
 For instance, the prefunctionalized organometallics or main-group element 
arylating reagents 2 (M = MgX, ZnX, BR2, SnR3, SiR3, etc.) are often sensitive to air or are 
relatively expensive, and their preparation from the corresponding arenes 1 usually involves a 
number of synthetic operations (Scheme 1a).
3a
 In contrast, direct C−H bond activations such as the 
direct arylation reactions represent an environmentally and economically more attractive strategy,  
 
Scheme 1 Conventional cross-coupling (a) versus direct arylation (b) 
                                                             
1  For recent reviews on C–H functionalizations in organic synthesis, see: (a) D. Y.-K. Chen, S. W. Youn, Chem. –
Eur. J. 2012, 18, 9452–9474; (b) W. R. Gutekunst, P. S. Baran, Chem. Soc. Rev. 2011, 40, 1976–1991; (c) L. 
McMurray, F. O’Hara, M. J. Gaunt, Chem. Soc. Rev. 2011, 40, 1885–1898. 
2  (a) J. Yamaguchi, A. D. Yamaguchi, K. Itami, Angew. Chem. Int. Ed. 2012, 51, 8960–9009; (c) Modern 
Heterocyclic Chemistry; J. Alvarez-Builla, J. J. Vaquero, J. Barluenga, Eds.; Wiley-VCH: Weinheim, Germany, 
2011. 
3  (a) Modern Arylation Methods; L. Ackermann, Ed.; Wiley-VCH: Weinheim, Germany, 2009; For recent 
reviews on conventional cross-coupling reactions, see: (b) C. C. C. Johansson Seechurn, M. O. Kitching, T. J. 
Colacot, V. Snieckus, Angew. Chem. Int. Ed. 2012, 51, 5062–5085; (c) Chem. Soc. Rev. 2011, 40, Special Issue 
10 "Cross coupling reactions in organic synthesis", pp 4877–5208; (d) B. M. Rosen, K. W. Quasdorf, D. A. 
Wilson, N. Zhang, A.-M. Resmerita, N. K. Garg, V. Percec, Chem. Rev. 2011, 111, 1346–1416; (e) G. Cahiez, A. 
Moyeux, A. Chem. Rev. 2010, 110, 1435–1462. 
4  For representative general reviews on C−H bond functionalizations, see: (a) K. M. Engle, J.-Q. Yu, J. Org. 
Chem. 2013, 78, 8927–8955; (b) J. J. Mousseau, A. B. Charrette, Acc. Chem. Res. 2013, 46, 412–424; (c) N. 
Kuhl, M. N. Hopkinson, J. Wencel-Delord, F. Glorius, Angew. Chem. Int. Ed. 2012, 51, 10236–10254; (d) C. S. 
Yeung, V. M. Dong, Chem. Rev. 2011, 111, 1215–1292; (e) D. A. Colby, R. G. Bergman, J. A. Ellman, Chem. 
Rev. 2010, 110, 624–655; (f) I. A. I. Mkhalid, J. H. Barnard, T. B. Marder, J. M. Murphy, J. F. Hartwig, Chem. 
Rev. 2010, 110, 890−931; (g) P. Sehnal, R. J. K. Taylor, I. J. S. Fairlamb, Chem. Rev. 2010, 110, 824–889; (h) 
M. C. Willis, Chem. Rev. 2010, 110, 725−748; (i) G. E. Dobereiner, R. H. Crabtree, Chem. Rev. 2010, 110, 
681−703; (j) P. Thansandote, M. Lautens, Chem. –Eur. J. 2009, 15, 5874–5883; (k) L. Ackermann, R. Vicente, 
A. R. Kapdi, Angew. Chem. Int. Ed. 2009, 48, 9792−9826; (l) L.-C. Campeau, D. R. Stuart, K. Fagnou, 
Aldrichim. Acta 2007, 40, 35−41; (m) D. Alberico, M. E. Scott, M. Lautens, Chem. Rev. 2007, 107, 174−238; 
(n) R. G. Bergman, Nature 2007, 446, 391−393; (o) K. Godula, D. Sames, Science 2006, 312, 67−72 and 
references cited therein. 
Introduction 
 
- 2 - 
 
which are not only advantageous with respect to the overall minimization of byproduct formation, 
but also allow for a streamlining of organic syntheses (Scheme 1b).
3a,4k,5
 
Early studies in the catalytic functionalization of unreactive C−H bonds were largely directed 
toward the challenging C–H bond activation of methane.
6
 However, during the past two decades, 
intensive research efforts have led to the development of C−H bond functionalizations
4
 with 
increasingly viable metal catalysts to improve the atom economy and more importantly the 
step-economy of organic syntheses.
5
 By far, a large variety of transition-metal catalysts have set 
the stage for efficient chemo-, site-, and enantioselective C−H bond functionalizations.
1,4
  
1.1.2 Mechanisms for Transition-Metal-Catalyzed C−H Bond Metalation 
Key to the success to the direct C–H bond functionalizations was generally a detailed mechanistic 
understanding of the elementary C–H bond metalation step. Traditionally, three different modes of 
action were primarily considered for C–H bond metalations,
7
 namely, (i) oxidative addition with 
electron-rich late transition metals, (ii) σ-bond metathesis with early transition metals, and (iii) 
electrophilic activation with electron-deficient late transition metals (Scheme 2). 
 
Scheme 2 Mechanisms for C−H bond metalation 
However, studies in the past years also indicated the existence of a continuum of electrophilic, 
ambiphilic, and nucleophilic interactions as well as base-assisted metalation reactions.
8
 As early 
as 1970s, the Shaw group
9a
 observed the beneficial effect exerted by NaOAc for stoichiometric 
                                                             
5  (a) P. A. Wender, V. A. Verma, T. J. Paxton, T, H. Pillow, Acc. Chem. Res. 2008, 41, 40–49; (b) B. M. Trost, Acc. 
Chem. Res. 2002, 35, 695–705; (c) B. M. Trost, Science 1991, 254, 1471–1477. 
6  (a) B. G. Hashiguchi, S. M. Bischof, M. M. Konnick, R. A. Periana, Acc. Chem. Res. 2012, 45, 885–898; (b) H. 
Schwarz, Angew. Chem. Int. Ed. 2011, 50, 10096–10115; (c) S. J. Blanksby, G. B. Ellison, Acc. Chem. Res. 
2003, 36, 255–263. 
7  For selected reviews on mechanistic aspects of C−H bond functionalizations, see: (a) D. Balcells, E. Clot, O. 
Eisenstein, Chem. Rev. 2010, 110, 749−823; (b) M. Lersch, M. Tilset, Chem. Rev. 2005, 105, 2471−2526; (c) 
V. Ritleng, C. Sirlin, M. Pfeffer, Chem. Rev. 2002, 102, 1731−1770 and references cited therein. 
8  L. Ackermann, Chem. Rev. 2011, 111, 1315–1345.  
9  (a) J. C. Gaunt, B. L. Shaw, J. Organomet. Chem. 1975, 102, 511–516; (b) V. I. Sokolov, L. L. Troitskaya, O. 
A. Reutov, J. Organomet. Chem. 1979, 182, 537–546. 
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cyclometalation reactions (Scheme 3). Thus, detailed experimental and computational analysis by 
Davies and coworkers
10
 provided strong evidence for this novel C–H bond metalation 
mechanisms relying on the assistance of a bifunctional ligand bearing an additional Lewis-basic 
heteroatom or most prominently carboxylates (Scheme 2, iv). 
 
Scheme 3 Stoichiometric acetate-mediated cyclometalation 
This novel insight into metalations has thus served as stimulus for the development of C–H bond 
transformations based on cocatalytic amounts of carboxylates.
8
 To differentiate this type of 
base-assisted metalations mechanistically, new concepts have recently been introduced (Scheme 
4). It has been proposed that a bidentate base is operating by the 
concerted-metalation-deprotonation pathway (CMD)
11
 or by the ambiphilic metal-ligand 
activation (AMLA) mechanism,
12
 both of which favor a six-membered transition state. 
Theoretical calculation
13
 disclose that the metal-acetate complexes have an ambiphilic character 
due to an intramolecular electrophilic activation of a C–H bond followed by deprotonation with an 
internal base. On the other hand, the mode of action of monodentate anionic ligands has been 
explored by the research groups of Oxgaard and Goddard as well as Gunnoe.
14
 DFT-studies favor 
an internal electrophilic substitution (IES) prior to traditional σ-bond metathesis.  
 
Scheme 4 Proposed transition states during C−H bond metalations 
1.1.3 Carboxylate-Assisted Ruthenium-Catalyzed Direct C–H Bond 
Functionalizations 
The contributions for C−H bond functionalization brought by palladium catalysts
1,4 
have 
motivated the search for less expensive, active ruthenium catalysts.
15
 Notably, the pioneering 
                                                             
10  D. L. Davies, O. Al-Duaij, J. Fawcett, M. Giardiello, S. T. Hilton, D. R. Russell, Dalton Trans. 2003, 4132–
4138 and references cited therein. 
11  D. Lapointe, K. Fagnou, Chem. Lett. 2010, 39, 1118–1126.  
12  (a) Y. Boutadla, D. L. Davies, S. A. Macgregor, A. I. Poblador-Bahamonde, Dalton Trans. 2009, 5820−5831; 
(b) Y. Boutadla, D. L. Davies, S. A. Macgregor, A. I. Poblador-Bahamonde, Dalton Trans. 2009, 5887−5893. 
13  D. H. Ess, S. M. Bischof, J. Oxgaard, R. A. Periana, W. A. Goddard, III, Organometallics 2008, 27, 6440–
6445. 
14  (a) J. Oxgaard, W. J. Trenn, III, R. J. Nielsen, R. A. Periana, W. A. Goddard, III, Organometallics 2007, 26, 
1565–1567; (b) D. Conner, K. N. Jayaprakash, T. R. Cundari, T. B. Gunnoe, Organometallics 2004, 23, 2724–
2733; (c) a review: J. R. Webb, T. BolaÇo, T. B. Gunnoe, ChemSusChem. 2011, 4, 37–49. 
15  February 2014, http://taxfreegold.co.uk/precious metalpricesusdollars.html: prices of gold, platinum, rhodium, 
iridium, palladium and ruthenium: $1244, $1377, $1053, $400, $705, and $56 US per troy ounce, respectively. 
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studies on ruthenium-catalyzed direct hydroarylations of alkenes by Lewis
16
 as well as Murai
17
 
highlighted the potential of efficient ruthenium catalysis for site-selective reactions of C–H bonds 
onto C–C and C−Het multiple bonds (see Chapter 1.4). 
The subsequent intensive search for easy-to-prepare and more stable ruthenium(II) catalysts 
during the following decades resulted in the discovery efficient ruthenium catalysts, milder 
reaction conditions and new ruthenium-catalyzed reactions, as was demonstrated by Oi and Inoue 
in 2001 (Scheme 5).
18
 However, essential progress in ruthenium-catalyzed direct arylations of 
arenes with aryl halides was achieved employing ruthenium complexes in situ derived from  
phosphine-
19
 or N-heterocyclic carbene
20
 (NHC) ligands. Notably, all of these reactions required 
the use of highly polar N-methylpyrrolidinone (NMP) as solvent, which led to catalytic systems 
with lower robustness,
21
 particularly when being applied to more challenging substrate 
combinations. 
 
Scheme 5 Ruthenium-catalyzed direct arylation with aryl halides by Oi and Inoue 
Until 2008, carboxylates have not been used as efficient cocatalytic additives in 
ruthenium-catalyzed C−H bond functionalizations. Primary studies from the Ackermann group 
highlighted a significant reaction rate acceleration applying bifunctional secondary phosphine 
oxides (SPO) preligand
22
 in ruthenium-catalyzed direct arylations with organic electrophiles.
23
 
Concerning the catalysis working mode,
23
 a base assistance with an intermediacy of the 
five-membered transition state 12 was proposed to be the decisive feature (Figure 1). Analogously, 
further studies from the same group showed that bifunctional ligands, especially carboxylates, 
were expected to give rise to six-membered transition state 13 (Figure 1).
8
 
                                                             
16  L. N. Lewis, J. F. Smith, J. Am. Chem. Soc. 1986, 108, 2728–2735. 
17  S. Murai, F. Kakiuchi, S. Sekine, Y. Tanaka, A. Kamatani, M. Sonoda, N. Chatani, Nature 1993, 366, 529–
531. 
18  (a) S. Oi, S. Fukita, N. Hirata, N. Watanuki, S. Miyano, Y. Inoue, Org. Lett. 2001, 3, 2579−2581; (b) S. Oi, Y. 
Ogino, S. Fukita, Y. Inoue, Org. Lett. 2002, 4, 1783−1785. 
19  L. Ackermann, R. Vicente, Top. Curr. Chem. 2010, 292, 211−229. 
20  (a) W. A. Herrmann, Angew. Chem. Int. Ed. 2002, 41, 1290−1309; (b) D. Bourissou, O. Guerret, F. P. Gabbaie, 
G. Bertrand, Chem. Rev. 2000, 100, 39−92; (c) N-Heterocyclic Carbenes in Synthesis; S. P. Nolan, Ed.; 
Wiley-VCH: Weinheim, Germany, 2006. 
21  S. G. Ouellet, A. Roy, C. Molinaro, R. Angelaud, J.-F., P. D. O’Shea, I. W. Davies, J. Org. Chem. 2011, 76, 
1436–1439. 
22  (a) L. Ackermann, Isr. J. Chem. 2010, 50, 652–663; (b) L. Ackermann, Synthesis 2006, 1557–1571. 
23  (a) L. Ackermann, Org. Lett. 2005, 7, 3123–3125; (b) L. Ackermann, A. Althammer, R. Born, Angew. Chem. 
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Figure 1 Proposed transition states for base-assisted ruthenations 
Hence, the Ackermann group investigated the order of efficacy for various cocatalytic additives in 
direct arylations using toluene as inert solvent and N-aryl-substitued 1,2,3-triazoles 14 as 
substrates (Scheme 6).
24
 Herein, complexes of previously used ligands, such as NHC precursors 
or tertiary phosphines, demonstrated only poor activity. On the contrary, bifunctional sterically 
hindered SPO preligand (1-Ad)2P(O)H enabled more efficient catalysis.
 
Further screening showed 
that acids were superior, with optimal results being obtained with sterically congested MesCO2H.  
 
Scheme 6 Cocatalytic additives in the ruthenium-catalyzed direct arylation 
The subsequent intensive mechanistic studies
24,25
 disclosed the ruthenium(II)-catalyzed direct 
arylations to involve initial C−H bond activations via carboxylate-assisted and thus deprotonative 
ruthenations via the transition state 19 (Scheme 7).  
                                                             
24  L. Ackermann, R. Vicente, A. Althammer, Org. Lett. 2008, 10, 2299−2302. 
25  L. Ackermann, R. Vicente, H. K. Potukuchi, V. Pirovano, Org. Lett. 2010, 12, 5032–5035. 
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Scheme 7 Proposed mechanism for direct arylations and alkylations by carboxylate assistance 
To address the mechanistic understanding, a ruthenium(II) biscarboxylate complex 23 was 
prepared (Scheme 8a).
25
 Notably, the well-defined complex 23 displayed a broad substrate scope 





Scheme 8 Direct arylations catalyzed by ruthenium(II) biscarboxylate 23 
On the basis of experimental findings in ruthenium-catalyzed direct arylations (Scheme 9, 27) as 
well as alkylations (28 and 29),
4k,8,19,22,26
 the Ackermann group intensively examined carboxylates 
as effective cocatalytic additives in ruthenium-catalyzed C−H bond functionalizations, such as 
                                                             
26  For selected reviews on ruthenium-catalyzed C–H bond functionalization, see also: (a) B. Li, P. H. Dixneuf, 
Chem. Soc. Rev. 2013, 42, 5744–5767; (b) P. B. Arockiam, C. Bruneau, P. H. Dixneuf, Chem. Rev. 2012, 112, 
5879–5918; (c) L. Ackermann, Pure Appl. Chem. 2010, 82, 1403–1413; (d) L. Ackermann, Chem. Commun. 
2010, 46, 4866–4877; (e) L. Ackermann, Synlett 2007, 507–526. 
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bond formations (Scheme 9). This thesis herein focuses on carboxylate-assisted 
ruthenium-catalyzed oxidative C−H bond functionalizations (32 and 33) and C(sp
3
)−H alkylations 
(31) with alkenes as well as direct ortho-C−Hal bond formations (36), which will be described in 
details in the following Chapters. 
 
Scheme 9 Carboxylate-assisted ruthenium-catalyzed direct C−H bond functionalizations 
1.2 Ruthenium-Catalyzed Alkyne Annulations by C−H/Het−H Bond 
Functionalizations 
Proceeding with the previously reported experimental results on direct arylations, the Ackermann 





 a research area that had thus far largely been dominated by the use of  
 
 
                                                             
27  Selected reviews: (a) J. R. Andreatta, B. A. McKeown, T. B. Gunnoe, J. Organomet. Chem. 2011, 696, 305–
315; (b) N. A. Foley, J. P. Lee, Z. Ke, T. B. Gunnoe, T. R. Cundari, Acc. Chem. Res. 2009, 42, 585–597; (c) F. 
Kakiuchi, Top. Organomet. Chem. 2007, 24, 1–33; (d) C. Nevado, A. M. Echavarren, Synthesis 2005, 167–182; 
(e) F. Kakiuchi, N. Chatani, Adv. Synth. Catal. 2003, 345, 1077–1101; (f) C. Jia, T. Kitamura, Y. Fujiwara, Acc. 
Chem. Res. 2001, 34, 633–639. 
28  L. Ackermann, Acc. Chem. Res. 2014, 47, 281–295. 
29  S. I. Kozhushkov, L. Ackermann, Chem. Sci. 2013, 4, 886−896. 
30  V. S. Thirunavukkarasu, S. I. Kozhushkov, L. Ackermann, Chem. Commun. 2014, 50, 29–39. 
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 or rhodium complexes.
32
  
Considering the importance for step-economical syntheses of bioactive heterocycles, Ackermann 
and coworkers hence set out to develop ruthenium-catalyzed oxidative annulations of alkynes 38 





 revealed [RuCl2(p-cymene)]2 (15) to be optimal among a variety of 
ruthenium complexes, while Cu(OAc)2·H2O was found to be the terminal oxidant of choice.
33a
 
The optimized ruthenium(II) catalyst 15 proved to be tolerant to valuable electrophilic functional 
groups, and was found to be applicable to benzamides 37 with different substituents on nitrogen 





Scheme 10 Ruthenium-catalyzed oxidative annulation via C−H/N−H bond cleavage 
Based on mechanistic studies, the ruthenium(II)-catalyzed oxidative annulation was proposed to 
proceed by an initial carboruthenation via acetate-assisted C−H bond cleavage,
8,28
 followed by 
migratory insertion, C−N bond-forming reductive elimination, and final reoxidation of the 
ruthenium(0) intermediate (Scheme 11).
33a
 Additional support for this proposed mechanism was 
recently provided through the independent synthesis and isolation of key intermediates by the 
groups of Li and Wang as well as Dixneuf.
34
 
                                                             
31  A review on palladium-catalyzed oxidative annulation of alkynes: C. Zhu, R. Wang, J. R. Falck, Chem. Asian 
J. 2012, 7, 1502–1514 and references cited therein. 
32  Selected reviews on rhodium-catalyzed oxidative annulation of alkynes: (a) G. Song, F. Wang, X. Li, Chem. 
Soc. Rev. 2012, 41, 3651–3678; (b) F. W. Patureau, J. Wencel-Delord, F. Glorius, Aldrichimica Acta 2012, 45, 
31-41; (c) T. Satoh, M. Miura, Chem.–Eur. J. 2010, 16, 11212–11222 and references cited therein. 
33  (a) L. Ackermann, A. V. Lygin, N. Hofmann, Angew. Chem. Int. Ed. 2011, 50, 6379–6382; (b) M. Deponti, S. 
I. Kozhushkov, D. S. Yufit, L. Ackermann, Org. Biomol. Chem. 2013, 11, 142–148. 
34  (a) B. Li, H. Feng, N. Wang, J. Ma, H. Song, S. Xu, B. Wang, Chem. –Eur. J. 2012, 18, 12873–12879; (b) B. 
Li, T. Roisnel, C. Darcel, P. H. Dixneuf, Dalton Trans. 2012, 41, 10934–10937. 
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Scheme 11 Catalytic cycle for ruthenium-catalyzed oxidative annulation of alkynes 
Subsequently, acrylamides 45 turned out to be competent substrates through alkenylic C−H bond 
activation with the same ruthenium(II) catalytic system (Scheme 12). Likewise, Cu(OAc)2·H2O as 




Scheme 12 Ruthenium-catalyzed synthesis of 2-pyridones 46 
Recently, Jeganmohan developed a route to isoquinolones 49 through ruthenium-catalyzed aerobic 
oxidative cyclization of (hetero)aromatic nitriles 47 with alkynes (Scheme 13).
36
 Mechanistic 
studies showed an acetamide intermediate 48 was generated with AcOH in the presence of 
Cu(OAc)2·H2O prior to oxidative annulation with alkynes. 
                                                             
35  L. Ackermann, A. V. Lygin, N. Hofmann, Org. Lett. 2011, 13, 3278–3281. 
36  M. C. Reddy, R. Manikandan, M. Jeganmohan, Chem. Commun., 2013, 49, 6060−6062. 
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Scheme 13 Ruthenium-catalyzed oxidative cyclization of aromatic nitriles 47 with alkynes 38 
The C−H/N−H bond functionalization strategy was not restricted to arenes bearing 
electron-withdrawing directing groups. Indeed, the cationic ruthenium(II) complexes derived from 
KPF6 facilitated oxidative C−H bond functionalizations with electron-rich anilines 50 through 
acetate assistance (Scheme 14).
37a
 A notable feature of this protocol was represented by the use of 
substrates bearing easily removable directing groups.
38
 The C−H/N−H bond cleavages occurred 
most efficiently in water as a green reaction medium and provided general access to indole 
derivatives 51. 
 
Scheme 14 Oxidative annulation with electron-rich anilines 50 bearing a removable directing group 
Furthermore, Ackermann and coworkers found the cationic ruthenium(II) complexes derived from 
AgSbF6 additives allowed for highly efficient oxidative annulations of aryl- and alkyl-substituted 




Scheme 15 Oxidative annulation of alkynes 38 by 5-aryl-1H-pyrazoles 52 
                                                             
37  (a) L. Ackermann, A. V. Lygin, Org. Lett. 2012, 14, 764–767; (b) for nickel-catalyzed alkyne annulation by 
anilines, see: W. Song, L. Ackermann, Chem. Commun. 2013, 49, 6638–6640. 
38  Representative reviews on removable directing groups: (a) C. Wang, Y. Huang, Synlett 2013, 24, 145–149; (b) 
G. Rousseau, B. Breit, Angew. Chem. Int. Ed. 2011, 50, 2450–2494. 
39  W. Ma, K. Graczyk, L. Ackermann, Org. Lett. 2012, 14, 6318–6321. 
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Very recently, the same group developed a ruthenium-catalyzed oxidative annulation of alkynes 
by ketimines 54 to furnish exo-methylene-1,2-dihydroisoquinolines 55. Particularly, 
carboxylate-assisted ruthenium(II) catalysis proved to be key to success for the synthesis of 




Scheme 16 Oxidative annulation of alkynes 38 by ketimines 54 
Besides this, oxidative annulations of alkynes 38 through C−H/O−H bond cleavages were 
independently achieved with ruthenium(II) complexes by the research groups of Ackermann and 
Jaganmohan (Scheme 17).
41,42
 Likewise, a cationic ruthenium(II) catalyst derived from KPF6 or 
AgSbF6 was employed for the synthesis of isocoumarins 57 through oxidative annulations of 
alkynes by (hetero)aromatic acids 56. Detailed optimization studies revealed acetates to be crucial 




Scheme 17 Synthesis of isocoumarins 57 by Ackermann 
Moreover, acetate assistance was found to be key to success for ruthenium(II)-catalyzed oxidative 
alkyne annulations with hydroxyl groups.
43
 Thus, hydroxyl-assisted C−H bond functionalizations 
provided step-economical access to diversely decorated fluorescent coumarins 59 and 
quinolin-2-ones 61, respectively (Scheme 18).  
 
Scheme 18 Hydroxyl-directed alkyne annulations 
                                                             
40  J. Li, L. Ackermann, Tetrahedron 2014, 70, doi: 10.1016/j.tet.2013.10.003. 
41  L. Ackermann, J. Pospech, K. Graczyk, K. Rauch, Org. Lett. 2012, 14, 930–933. 
42  R. K. Chinnagolla, M. Jeganmohan, Chem. Commun. 2012, 48, 2030–2032. 
43  V. S. Thirunavukkarasu, M. Donati, L. Ackermann, Org. Lett. 2012, 14, 3416–3419. 
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Along with the rapid development on C−H/N−H and C−H/O−H bond functionalizations, Lee 
developed the first ruthenium-catalyzed oxidative cyclization of phosphonic acid monoesters or 
phosphinic acids 62 with alkynes for the synthesis of phosphaisocoumarins 63 under aerobic 
conditions. A variety of arylphosphonic acid monoesters as well as arylphosphinic acids bearing 





Scheme 19 Ruthenium-catalyzed annulation of alkynes 38 with phosphonic acid derivatives 62 
Furthermore, Jeganmohan developed a highly regioselective ruthenium-catalyzed cyclization of 
aromatic ketones 64 with alkynes. This methodology offers a simple and mild method for the 
synthesis of indenols 65 and benzofulvenes 66 in a highly regioselective manner. Herein, the 
amount of silver salt determined the nature of the product: In the presence of 8 mol % of AgSbF6 
favored the formation of indenols 65 (Scheme 20, left), whereas with 20 mol % of AgSbF6 




Scheme 20 Ketone-directed alkyne annulations 
Lam recently reported a catalytic alkyne oxidative annulation by 2-aryl-1,3-dicarbonyl compounds 
67 involving the (formal) functionalization of C(sp
3
)−H bond and C(sp
2
−H) bond (Scheme 21a). 
Notably, this ruthenium-catalyzed process led to the synthesis of indenes 69 with the formation of 
an all-carbon quaternary center.
46a
 In analogy, Luan’s intermolecular annulation reactions of 
1-aryl-2-naphthols 70 with alkynes proceeded efficiently in the presence of the same ruthenium 
catalyst to generate spirocyclic compounds 71 by sequential cleavage of the C(sp
2
)–H bond, 
migratory insertion of the alkyne, and dearomatization of the naphthyl ring (Scheme 21b).
47
 
                                                             
44  Y. Park, I. Jeon, S. Shin, J. Min, P. H. Lee, J. Org. Chem. 2013, 78, 10209−10220. 
45  R. K. Chinnagolla, M. Jeganmohan, Eur. J. Org. Chem. 2012, 417−423. 
46  (a) S. R. Chidipudi, I. Khan, H. W. Lam, Angew. Chem. Int. Ed. 2012, 51, 12115–12119; (b) for similar 
research with palladium catalysis, see: J. D. Dooley, S. R. Chidipudi, H. W. Lam, J. Am. Chem. Soc. 2013, 135, 
10829−10836. 
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Scheme 21 Ruthenium-catalyzed carbocycles by (formal) C(sp3)−H/C(sp2)−H bond cleavage 
However, the success of the above-discussed ruthenium(II)-catalyzed annulations always relied on 
the use of an external oxidant in stoichiometric or cocatalytic amounts (vide supra). Thus, 
Cu(OAc)2·H2O proved to be essential for these transformations, since it not only acted as the 
(co)oxidant but also served as the source of acetate for the carboxylate-assisted C−H bond 
activation step. Conversely, an alternative strategy was viable through the use of substrates 
bearing N−O bonds as "internal"
48
 oxidants.  
Herein, N-methoxybenzamides and free hydroxamic acid 72 were utilized by Ackermann and 
Fenner for highly selective syntheses of isoquinolones 49 in the absence of an external oxidant 
under notably mild reaction conditions (Scheme 22).
49
 Remarkably, cocatalytic amounts of 
carboxylates were found to be indispensable for achieving efficient C−H bond functionalizations, 
with optimal results being accomplished with KO2CMes as the co-catalyst and H2O as the reaction 
medium.
49
 Meanwhile, an alternative protocol by Li and Wang employed NaOAc as the additive 
in MeOH as the solvent,
50
 which was also rationalized in terms of acetate-assisted C−H bond 
ruthenation. 
 
Scheme 22 Synthesis of isoquinolones 49 by C−H/N−O bond cleavages 
In analogy, this "internal" oxidant approach set the stage for an extension to the synthesis of 
isoquinolines 74 (Scheme 23).
51,52
 Thus, ketoximes 73 were selectively converted, with base 
                                                             
48  F. W. Patureau, F. Glorius, Angew. Chem., Int. Ed. 2011, 50, 1977–1979. 
49  L. Ackermann, S. Fenner, Org. Lett. 2011, 13, 6548–6551. 
50  B. Li, H. Feng, S. Xu, B. Wang, Chem. –Eur. J. 2011, 17, 12573–12577. 
51  C. Kornhaaß, J. Li, L. Ackermann, J. Org. Chem. 2012, 77, 9190–9198. 
52  (a) R. K. Chinnagolla, S. Pimparkar, M. Jeganmohan, Org. Lett. 2012, 14, 3032–3035; (b) see also: K. 
Parthasarathy, N. Senthilkumar, J. Jayakumar, C.-H. Cheng, Org. Lett. 2012, 14, 3478–3481; (c) P. Villuendas, 
E. P. Urriobeitia, J. Org. Chem. 2013, 78, 5254–5263. 
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Scheme 23 Synthesis of isoquinolines 74 by dehydrative alkyne annulations 
1.3 Ruthenium-Catalyzed Direct Oxidative Alkenylation of Arenes  
Styrene derivatives are useful intermediates in synthetic organic chemistry and represent key 
structural motifs in natural products as well as in medicinal chemistry.
53





 such as the Mizoroki–Heck reaction,
54
 have matured to 
being reliable tools for the preparation of styrene derivatives (Scheme 24a). Besides, alkenylation 
via transmetallation employing stoichiometric amounts of palladium chloride and organomercury, 
-tin, or -lead arenes in lieu of aryl halides were also reported (Scheme 24b).
3,54
 However, the 
Mizoroki–Heck reaction is accompanied by the formation of a stoichiometric amount of 
potentially hazardous halide salt and transmetallation reactions always require organometallic 
nucleophilic reagents, which are, however, often not commercially available or are relatively 
expensive.  
In contrast, the catalytic oxidative dehydrogenative alkenylation via a twofold C–H bond 
activation approach, as initially demonstrated by Fujiwara and Moritani,
55
 presents a powerful 
tool for the synthesis of styrene derivatives (Scheme 24c).
56
 Importantly, this approach is not only 
advantageous with respect to the overall minimization of byproduct formation (atom-economy),
5b,c 
but also allows for significantly reducing the number of required reaction steps (step-economy).
5a
 
Subsequently, a variety of synthetically useful protocols for palladium-catalyzed direct oxidative 
couplings between arenes and alkenes have been achieved by inter alia Miura and Satoh, as well 
as Yu.
56
 Efficient and selective rhodium catalysts have also been developed in recent years.
32
 
                                                             
53  (a) M. Sova, Mini-Rev. Med. Chem. 2012, 12, 749–767; (b) B. S. Siddiqui, H. Aslan, S. Begus, S. T. Ali, Nat. 
Prod. Res. 2007, 21, 736–741.  
54  The Mizoroki–Heck Reaction, M. Oestreich, ed.; Wiley, Chichester, 2009. 
55  (a) I. Moritani, Y. Fujiwara, Tetrahedron Lett. 1967, 8, 1119–1122; (b) Y. Fujiwara, I. Moritani, M. Matsuda, 
Tetrahedron 1968, 24, 4819–4824. 
56  Reviews: (a) L. Zhou, W. Lu, Chem. –Eur. J. 2014, 20, 634–642; (b) J. Le Bras, J. Muzart, Chem. Rev. 2011, 
111, 1170–1214; (c) B. Karimi, H. Behzadnia, D. Elhamifar, P. F. Akhavan, F. K. Esfahani, Synthesis 2010, 
1399–1427; (d) M. Wasa, K. M. Engle, J.-Q. Yu, Isr. J. Chem. 2010, 50, 605–616. 
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Scheme 24 Strategies for streamlining of styrene synthesis 
However, less expensive ruthenium complexes have only recently been exploited as catalysts for 
oxidative C–H bond alkenylations on arenes, starting from the work by Milstein and coworkers in 
2001 (Scheme 25).
57
 According to this protocol, styrene derivatives 77 were obtained from 
substituted arenes 75. Unfortunately, major limitations of this protocol were represented by the 
low reactivity of unactivated alkenes as well as the poor site-selectivities with substituted arenes.  
 
Scheme 25 Ruthenium-catalyzed direct alkenylations with simple arenes 75 
The low selectivities observed in reactions of simple arenes were successfully addressed with the 
aid of Lewis-basic functional groups. Thus, a cationic ruthenium hydride complex
 
80 enabled 
highly site-selective oxidative C–H bond alkenylations of benzamides 78 (Scheme 26), as 
described by Yi and coworkers.
58a
 Since an external oxidant was not employed, an excess of the 
alkene 79 as well as the newly formed alkenylated benzamide 81 served as the hydrogen 
scavenger. Therefore, the products 81 were unfortunately contaminated with hydrogenated 
benzamides 82. 
                                                             
57  H. Weissman, X. Song, D. Milstein, J. Am. Chem. Soc. 2001, 123, 337–338. 
58  (a) K.-H. Kwon, D. W. Lee, C. S. Yi, Organometallics 2010, 29, 5748–5750; (b) C. S. Yi, D. W. Lee, 
Organometallics 2009, 28, 4266−4268. 
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Scheme 26 Direct oxidative alkenylation of benzamides 78 with unactivated alkenes 79 
The major breakthrough on the ruthenium-catalyzed oxidative alkenylaltions with directing groups 
was achieved by inter alia Ackermann as well as Miura and Satoh in recent years.
29
  
In 2011, Ackermann and Pospech disclosed the ruthenium(II)-catalyzed oxidative C–H bond 
alkenylation of benzoic acids 56 to smoothly proceed in water with Cu(OAc)2·H2O as the oxidant 
(Scheme 27).
59
 Yet, the expected alkenylated benzoic acids 84 were not isolated, but the 
alkenylation products 84 immediately underwent a subsequent intramolecular oxa-Michael 
reaction, affording isobenzofuran-1(3H)-ones 85 in high yields. Experimental studies with 
isotopically labelled substrates suggested a kinetically relevant C–H bond ruthenation through 




Scheme 27 Ruthenium-catalyzed oxidative alkenylation of benzoic acids 56 in water 
Satoh and Miura reported on the use of a cationic ruthenium catalyst, in situ generated from 
[RuCl2(p-cymene)]2 and AgSbF6, for oxidative alkenylations of benzamides 78 (Scheme 28).
60a
 
Notably, the reaction did not proceed in the absence of AgSbF6. Besides, Loh developed a 
ruthenium catalytic system with KPF6 as the efficient additive for the direct cross-coupling of 




Scheme 28 Ruthenium-catalyzed oxidative alkenylation of benzamides 78 with AgSbF6 as the additive 
Alternatively, ruthenium-catalyzed C–H bond alkenylations can also be realized with 
                                                             
59  L. Ackermann, J. Pospech, Org. Lett. 2011, 13, 4153–4155. 
60  (a) Y. Hashimoto, T. Ortloff, K. Hirano, T. Satoh, C. Bolm, M. Miura, Chem. Lett. 2012, 41, 151–153; (b) J. 
Zhang, T.-P. Loh, Chem. Commun. 2012, 48, 11232–11234; (c) for a ruthenium-catalyzed amide directed 
ortho-C−H alkylation, see: J. Qi, L. Huang, Z. Wang, H. Jiang, Org. Biomol. Chem. 2013, 11, 8009–8013. 
Introduction 
 
- 17 - 
 
pre-functionalized starting materials bearing an "internal" oxidizing directing group.
48
 Notably, 
the reactions with acrylates 76 resulted in C–H bond alkenylations of methoxybenzamides 72, 




Scheme 29 Ruthenium-catalyzed C−H bond alkenylation with an "internal" oxidazing directing group 
With the success of chelation-assisted alkenylations on benzamides, analogous 
ruthenium-catalyzed oxidative functionalizations of weakly coordinating esters has until recently 




 disclosed reaction 
conditions for the versatile oxidative direct functionalization of aromatic esters 88 (Scheme 30). 
Thus, a catalytic system comprising [RuCl2(p-cymene)]2, AgSbF6 and cocatalytic amounts of 
Cu(OAc)2·H2O utilizing air as the ideal terminal oxidant allowed for efficient aerobic C–H bond 




Scheme 30 Ruthenium-catalyzed oxidative alkenylations of weakly coordinating aromatic esters 88 
This catalytic system was also found to be effective for alkenylations of aromatic ketones and 
benzaldehydes 90 (Scheme 31).
64,65
 Thus, the ruthenium-catalyzed C–H bond functionalization 
provided alkenylated products 91 in moderate to good yields with acrylates and styrenes. 
 
Scheme 31 Ruthenium-catalyzed oxidative alkenylation of phenones and benzaldhydes 90 
Moreover, the ruthenium catalytic system enabled oxidative alkenylations of electron-rich aryl 
carbamates 92 with weakly coordinating and removable directing groups
38
 in a chemo- and  
 
 
                                                             
61  B. Li, J. Ma, N. Wang, H. Feng, S. Xu, B. Wang, Org. Lett. 2012, 14, 736–739. 
62  K. Graczyk, W. Ma, L. Ackermann, Org. Lett. 2012, 14, 4110–4113. 
63  K. Padala, S. Pimparkar, P. Madasamy, M. Jeganmohan, Chem. Commun. 2012, 48, 7140–7142. 
64  K. Padala, M. Jeganmohan, Org. Lett. 2011, 13, 6144–6147. 
65  K. Padala, M. Jeganmohan, Org. Lett. 2012, 14, 1134–1137. 
Introduction 
 
- 18 - 
 




Scheme 32 Ruthenium-catalyzed oxidative alkenylation of aryl carbamates 92 
Recently, the ruthenium(II)-promoted oxidative alkenylations of phenols 94 bearing easily 
cleavable directing groups
38
 was reported (Scheme 33).
67
 The double C−H functionalization 
process proceeded with excellent chemo-, site-, and diastereoselectivities in an aerobic fashion.  
 
Scheme 33 Ruthenium(II)-catalyzed C−H alkenylations of arenes 94 with removable directing groups 
Besides, Dixneuf and Bruneau reported on ruthenium-catalyzed oxidative alkenylation of 
N-phenylpyrazole (96) with acrylates and acrylamides (Scheme 34).
68
 Unfortunately, in many 
cases the products 97 were contaminated with by-products 98 generated through dehydrogenative 
homocoupling of substrates 96.  
 
Scheme 34 Ruthenium-catalyzed oxidative alkenylation of N-phenylpyrazole 96 
However, employing [RuCl2(p-cymene)]2 complex instead of the above mentioned 
[Ru(OAc)2(p-cymene)] analog, along with a higher loading of Cu(OAc)2·H2O, efficiently 
suppressed the competitive homocoupling reaction.
69
 Hence, alkenylations of 2-phenylazoles 100 




                                                             
66  (a) J. Li, C. Kornhaaß, L. Ackermann, Chem. Commun. 2012, 48, 11343–11345; (b) for subsequent report: M. 
C. Reddy, M. Jeganmohan, Eur. J. Org. Chem. 2013, 1150−1157; (c) B. Li, J. Ma, Y. Liang, N. Wang, S. Xu, 
H. Song, B. Wang, Eur. J. Org. Chem. 2013, 1950–1962; (d) for hydroalkenylation of alkynes, see: M. C. 
Reddy, M. Jeganmohan, Chem. Commun. 2013, 49, 481−483. 
67  W. Ma, L. Ackermann, Chem.−Eur. J. 2013, 19, 13925–13928. 
68  P. B. Arockiam, C. Fischmeister, C. Bruneau, P. H. Dixneuf, Green Chem. 2011, 13, 3075–3078. 
69  Y. Hashimoto, T. Ueyama, T. Fukutani, K. Hirano, T. Satoh, M. Miura, Chem. Lett. 2011, 40, 1165–1166. 
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Scheme 35 Ruthenium-catalyzed oxidative alkenylation of 2-phenylazoles 100 
Furthermore, monoalkenylations of aromatic C–H bonds directed by an oxazoline group were 
found by the same group to take place efficiently using [RuCl2(p-cymene)]2 along with 




Scheme 36 Ruthenium-catalyzed oxidative alkenylation of 2-phenyloxazolines 102 
Essentially, ruthenium-catalyzed alkenylations of heteroarenes 105 with various directing groups 
were achieved with the catalytic systems described above, albeit with different catalytic 
efficacies.
71,72 
The experimental results are summarized in Scheme 37 and highlight various esters, 
benzamides, aldehydes and carbamates could be employed for chemo- and site-selective 
ruthenium-catalyzed twofold C–H bond functionalizations.  
                                                             
70  B. Li, K. Devaraj, C. Darcel, P. Dixneuf, Green Chem. 2012, 14, 2706–2709. 
71  T. Ueyama, S. Mochida, T. Fukutani, K. Hirano, T. Satoh, M. Miura, Org. Lett. 2011, 13, 706–708. 
72  (a) B. Li, J. Ma, W. Xie, H. Song, S. Xu, B. Wang, J. Org. Chem. 2013, 78, 9345−9353; (b) L.-Q. Zhang, S. 
Yang, X. Huang, J. You, F. Sodirectng, Chem. Commun. 2013, 49, 8830−8832. 
Introduction 
 
- 20 - 
 
 
Scheme 37 Ruthenium-catalyzed oxidative alkenylation of substituted heteroarenes 
1.4 Ruthenium-Catalyzed Direct Hydroarylations 
1.4.1 Ruthenium-Catalyzed Direct Hydroarylations 
As discussed above, the oxidative direct functionalization with unreactive C−H bonds is a 
powerful tool for the construction of C−C bonds in a step-economical fashion. On the other hand, 
the prospects to develop metal-catalyzed hydroarylation reactions are alternatively attractive due 




As early as 1986, Lewis reported the first ortho-selective hydroarylation of phenol (107) with 




Scheme 38 Ruthenium-catalyzed direct C−H alkylation by Lewis 
However, a major breakthrough in the ruthenium-catalyzed directed hydroarylations was achieved 
by Murai in 1993 (Scheme 39).
17
 According to this protocol, chelation-assistance resulted in 
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highly site-selective C−H bond cleavage, leading to addition of aromatic ketone 90 to alkenes 111 




Scheme 39 Ruthenium-catalyzed direct C−H alkylation by Murai 
Intensive mechanistic studies
73,74
 on the Murai reaction showed that the initial formation of 
intermediate 117 via transition state 116, subsequent coordination of alkene 111 and migratory 
insertion to the Ru–H bond are reversible (Scheme 40). Finally, reductive elimination of complex 
119 delivers the target product 113 and regenerates the active ruthenium species 114. Besides, 
isotopically labelled experiment with substrates suggested that a branched species 119' is also 
probably formed, which, however, seems not to undergo reductive elimination, since no 




showed that the C−C bond 
formation is the rate determining step. 
 
Scheme 40 Catalytic cycle for the Murai reaction 
                                                             
73  F. Kakiuchi, H. Ohtaki, M. Sonoda, N. Chatani, S. Murai, Chem. Lett. 2001, 918–919. 
74  F. Kakiuchi, T. Kochi, E. Mizushima, S. Murai, J. Am. Chem. Soc. 2010, 132, 17741–17750. 
75  (a) F. Kakiuchi, T. Sato, T. Tsujimoto, M. Yamauchi, N. Chatani, S. Murai, Chem. Lett. 1998, 1053–1054; (b) 
T. Matsubara, N. Koga, D. G. Musaev, K. Morokuma, J. Am. Chem. Soc. 1998, 120, 12692–12693; (c) T. 
Matsubara, N. Koga, D. G. Musaev, K. Morokuma, Organometallics 2000, 19, 2318–2329. 
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In the following years,
76
 Murai and coworkers extended the application of hydroarylations 
including replacement of the terminal alkenes 111 by acetylenes
 77









 as efficient directing groups. Coinciding with Murai’s 
alkylations of cyclic and acyclic α,β-enones, 82  Trost successfully applied the precatalyst 
[RuH2(CO)(PPh3)3] (114) to the alkylation of acrylic acid esters.
83
 
However, a major disadvantage of Murai’s protocol is the air sensitivity of catalyst 
[RuH2(CO)(PPh3)3] (114). This promoted Darses and Genet to develop a new hydroarylating 
system through the elegant in situ formation of catalyst [RuH2(PPh3)4] (121) from 
[RuCl2(p-cymene)]2 (15) and sodium formate, in association with a phosphine ligand (Scheme 
41).
84
 This novel system showed high activity in the ortho-hydroarylations of tetralone and 





Scheme 41 Ruthenium-catalyzed direct C−H alkylation by Genet and Darses 
Besides, Ackermann and coworkers achieved the hydroarylation of highly strained 
methylenecyclopropanes 124 by the combination of [RuCl2(cod)]n (125) and XPhos, which 




                                                             
76  (a) F. Kakiuchi, T. Kochi, Synthesis 2008, 3013−3039; (b) F. Kakiuchi, S. Murai, Acc. Chem. Res. 2002, 35, 
826–834; (c) S. Murai, F. Kakiuchi, S. Sekine, Y. Tanaka, A. Kamatani, M. Sonoda, N. Chatani, Pure Appl. 
Chem. 1994, 66, 1527–1534; (d) S. Murai, N. Chatani, F. Kakiuchi, Pure Appl. Chem. 1997, 69, 589–594; (e) 
M. Sonoda, F. Kakiuchi, N. Chatani, S. Murai, Bull. Chem. Soc. Jpn. 1997, 70, 3117–3128. 
77  F. Kakiuchi, Y. Yamamoto, N. Chatani, S. Murai, Chem. Lett. 1995, 681–682.  
78  M. Sonoda, F. Kakiuchi, A. Kamatani, N. Chatani, S. Murai, Chem. Lett. 1996, 109–110. 
79  F. Kakiuchi, M. Yamauchi, N. Chatani, S. Murai, Chem. Lett. 1996, 111–112.  
80  F. Kakiuchi, T. Sato, M. Yamauchi, N. Chatani, S. Murai, Chem. Lett. 1999, 19–20.  
81  F. Kakiuchi, T. Sato, K. Igi, N. Chatani, S. Murai, Chem. Lett. 2001, 386–387.  
82  (a) F. Kakiuchi, Y. Tanaka, T. Sato, N. Chatani, S. Murai, Chem. Lett. 1995, 679–680; (b) T. Sato, F. Kakiuchi, 
N. Chatani, S. Murai, Chem. Lett. 1998, 893–894. 
83  B. M. Trost, K. Imi, I. W. Davies, J. Am. Chem. Soc. 1995, 117, 5371–5372. 
84  (a) R. Martinez, R. Chevalier, S. Darses, J.-P. Genet, Angew. Chem. Int. Ed. 2006, 45, 8232–8235; (b) R. 
Martinez, M.-O. Simon, R. Chevalier, C. Pautigny, J.-P. Genet, S. Darses, J. Am. Chem. Soc. 2009, 131, 7887–
7895. 
85  (a) R. Martinez, J.-P. Genet, S. Darses, Chem. Commun. 2008, 3855–3857; (b) M.-O. Simon, R. Martinez, J.-P. 
Genet, S. Darses, Adv. Synth. Catal. 2009, 351, 153–157; (c) M.-O. Simon, R. Martinez, J.-P. Genet, S. Darses, 
J. Org. Chem. 2009, 75, 208–210; (d) M.-O. Simon, J.-P. Genet, S. Darses, Org. Lett. 2010, 12, 3038–3041; (e) 
M.-O. Simon, G. Ung, S. Darses, Adv. Synth. Catal. 2011, 353, 1045–1048; (c) M.-O. Simon, S. Darses, J. Org. 
Chem. 2013, 78, 9981–9985. 
86  (a) S. I. Kozhushkov, D. S. Yufit, L. Ackermann, Org. Lett. 2008, 10, 3409–3412; (b) L. Ackermann, S. I. 
Kozhushkov, D. S. Yufit, Chem. –Eur. J. 2012, 18, 12068–12077. 
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Scheme 42 Ruthenium-catalyzed hydroarylation of methylenecyclopropanes 





as of yet not exploited as cocatalytic additives for ruthenium-catalyzed hydroarylations. Very 
recently, Ackermann and co-workers reported on highly efficient carboxylate-assisted 
ruthenium-catalyzed hydroarylations of unactivated alkenes 111 and of methylenecyclopropanes 




Scheme 43 Carboxylate-assisted ruthenium-catalyzed hydroarylations  
Ruthenium-catalyzed hydroarylations of aromatic amides 129 with various α,β-unsaturated 
ketones 130 using a removable 8-aminoquinoline bidentate directing group
38,88
 has been recently 
developed by Chatani (Scheme 44).
89
 This methodology represented the first efficient utilization 
of active enones in the ortho-directed ruthenium-catalyzed addition of C–H bonds to C–C double 
bonds. 
 
Scheme 44 Ruthenium-catalyzed ortho-hydroarylation with α,β-unsaturated ketones 
Along with the obvious progress in the ruthenium-catalyzed chelation-assisted hydroarylations, 
Nakamura and Yoshikai independently reported on the first examples of cobalt-catalyzed  
 
 
                                                             
87  (a) M. Schinkel, I. Marek, L. Ackermann, Angew. Chem. Int. Ed. 2013, 52, 3977–3980; (b) M. Schinkel, J. 
Wallbaum, S. I. Kozhushkov, I. Marek, L. Ackermann, Org. Lett. 2013, 15, 4482–4484. 
88  A recent review on catalytic functionalization of C(sp2)−H and C(sp3)−H bonds by using bidentate directing 
groups: G. Rouquet, N. Chatani, Angew. Chem. Int. Ed. 2013, 52, 11726–11743. 
89  (a) G. Rouquet, N. Chatani, Chem. Sci. 2013, 4, 2201–2208; selected examples of Rh(I) catalysis: (b) L. Yang, 
B. Qian, H. Huang, Chem. –Eur. J. 2012, 18, 9511−9515; (b) L. Yang, C. A. Correia, C.-J. Li, Org. Biomol. 
Chem. 2011, 9, 7176−7179; (c) S.-G. Lim, J.-A. Ahn, C.-H. Jun, Org. Lett. 2004, 6, 4687−4690. 
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hydroarylation of terminal alkenes
90,91
 and internal alkynes
92 
using ketimines, N-methyl amide 
and pyridine as directing groups. However, the employment of this catalytic system was limited 
by low tolerance of many important functional groups. Besides, the first manganese-catalyzed 
hydroarylation of terminal alkynes was recently reported.
93
  
1.4.2 Ruthenium-Catalyzed Direct C(sp
3
)−H Alkylations 
In contrast to the direct transformations of C(sp
2
)–H bonds, catalytic alkylations with alkenes 




 have unfortunately thus far met with limited 
success. In 1998, Jun achieved the first chelation-assisted C(sp
3
)−H alkylation on benzylamines 
133 employing Ru3(CO)12 (132). However, only benzylic C−H bonds enabled addition to alkenes 




Scheme 45 Ruthenium-catalyzed hydroalkylation of benzylamines 133 with alkenes 134 
Promoted by the success of rhodium-catalyzed α-carbonylation of C(sp
3
)−H bonds to cyclic amino 
and amido groups,
96
 Murai, Kakiuchi and Chatani observed that Ru3(CO)12 (132) enabled the 
addition of C(sp
3
)−H bond across the alkene bond to give the corresponding alkylated products 
137 (Scheme 46).
97
 Intensive studies showed that the reactivity was improved using iso-propanol 
as the solvent. Various alkenes, including terminal, internal and cyclic alkenes, proved to be 
suitable applying this protocol, and the substrates were successfully extended to five-, six- and 
seven-membered rings.  
 
                                                             
90  L. Ilies, Q. Chen, X. Zeng, E. Nakamura, J. Am. Chem. Soc. 2011, 133, 5219–5223. 
91  (a) K. Gao, N. Yoshikai, Angew. Chem. Int. Ed. 2011, 50, 6888–6892; (b) K. Gao, N. Yoshikai, J. Am. Chem. 
Soc. 2011, 133, 400–402. See also: (c) W. Song, L. Ackermann, Angew. Chem. Int. Ed. 2012, 51, 8251−8254.  
92  K. Gao, P.-S. Lee, T. Fujita, N. Yoshikai, J. Am. Chem. Soc. 2010, 132, 12249–12251. 
93  B. Zhou, H. Chen, C. Wang, J. Am. Chem. Soc. 2013, 135, 1264–1267. 
94  For selected reviews on C(sp3)−H bond transformations, see: (a) S. A. Girard, T. Knauber, C.-J. Li, Angew. 
Chem. Int. Ed. 2014, 53, 74–100; (b) H. Li, B.-J. Li, Z.-J. Shi, Catal. Sci. Technol. 2011, 1, 191; (c) O. Baudoin, 
Chem. Soc. Rev. 2011, 40, 4902; (d) M. Wasa, K. M. Engle, J.-Q. Yu, Isr. J. Chem. 2010, 50, 605; (e) R. Jazzar, 
J. Hitce, A. Renaudat, J. Sofack-Kreutzer, O. Baudoin, Chem. –Eur. J. 2010, 16, 2654. 
95  C.-H. Jun, D.-C. Hwang, S.-J. Na, Chem. Commun. 1998, 1405–1406. 
96  (a) N. Chatani, T. Asaumi, T. Ikeda, S. Yorimitsu, Y. Ishii, F. Kakiuchi, S. Murai, J. Am. Chem. Soc. 2000, 122, 
12882–12883; (b) Y. Ishii, N. Chatani, F. Kakiuchi, S. Murai, Organometallics 1997, 16, 3615–3622; (c) Y. 
Ishii, N. Chatani, F. Kakiuchi, S. Murai, Tetrahedron Lett. 1997, 38, 7565–7568.  
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Scheme 46 Ruthenium-catalyzed alkylation of cyclic amines 136 with alkenes 134 
The reaction mechanism proposed for Murai’s C(sp
3
)−H alkylation was similar to the mechanisms 
of C(sp
2
)−H bond functionalizations discussed above (Scheme 47).
73–75,98
 First, coordination of 
substrate 136 to ruthenium provides complex 140, in which the C−H bond undergoes cleavage to 
give a Ru–H complex 141. Subsequently, coordination of alkene 134 and its migratory insertion 
furnishes the Ru–alkyl complex 143, from which reductive elimination affords the final product 
137, with the active ruthenium complex being regenerate. 
 
Scheme 47 Proposed mechanism for the ruthenium-catalyzed hydroalkylation 
Very recently, Maes reported a ruthenium(0)-catalyzed α-alkylation and -arylation of piperidines 
144 with terminal alkenes 111a.
99
 Control experiments showed the carboxylic acid can efficiently 
increase the catalyst activation and longevity, along with that the alcohol reduces the side 
reactions (Scheme 48).
99a 
                                                             
98  Analogous mechanism with Iridium catalysis: (a) E. Clot, J. Chen, D.-H. Lee, S. Y. Sung, L. N. Appelhans, J. 
W. Faller, R. H. Crabtree, O. Eisenstein, J. Am. Chem. Soc. 2004, 126, 8795–8804; (b) D.-H. Lee, J. Chen, J. 
W. Faller, R. H. Crabtree, Chem. Commun. 2001, 213–214.  
99  (a) S. D. Bergman, T. E. Storr, H. Prokopcová, K. Aelvoet, G. Diels, L. Meerpoel, B. U. W. Maes, Chem. –Eur. 
J. 2012, 18, 10393–10398; (b) A. Peschiulli, V. Smout, T. E. Storr, E. A. Mitchell, Z. Eliáš, W. Herrebout, D. 
Berthelot, L. Meerpoel, B. U. W. Maes, Chem.– Eur. J. 2013, 19, 10378–10387. 
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Scheme 48 Ruthenium-catalyzed alkylation of amines in the presence of carboxylate acid  
Besides, using the ruthenium-hydride complex 150, Yi showed that the alkylation of cyclic amines 
149 without additional directing group can be achieved by invoking the dehydrogenation of amine 




Scheme 49 Ruthenium-catalyzed alkylation of unprotected cyclic amines with alkenes 
1.5 Metal-Catalyzed ortho-C−H Halogenations  
Aromatic halides are key intermediates in organic synthesis, and have been broadly utilized for 
natural products synthesis, material sciences and medicinal chemistry.
101
 As a consequence, the 
development of efficient and selective methods for their syntheses continues to be of prime 
importance. Conventionally, the most useful strategies for their synthesis rely on the electrophilic 
aromatic substitution (SE
Ar
), the Sandmeyer reaction or the directed ortho-lithiation approach  
(Scheme 50a–c).
102
 Unfortunately, these methods face considerable limitations, including tedious 
and/or hazardous reaction procedures, poor site selectivities, and harsh reaction conditions, 
resulting in low chemo-selectivities. In recent years, metal-catalyzed C−H activation has emerged 
as an increasingly viable tool for C−X bond formations (Scheme 50d).
4
 In this context, methods 
for the palladium-catalyzed chelation-assisted direct C−H bond functionalization with 
                                                             
100  C. S. Yi, S. Y. Yun, I. A. Guzei, Organometallics 2004, 23, 5392–5395. 
101 Selected reviews: (a) S. Johansson, C. C. Carin, M. O. Kitching, T. J. Colacot, V. Snieckus, Angew. Chem. Int. 
Ed. 2012, 51, 5062−5085; (b) G. Evano, N. Blanchard, M. Toumi, Chem. Rev. 2008, 108, 3054−3131; (c) K. C. 
Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4442−4489; (d) P. Knochel, W. Dohle, N. 
Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A. Vu, Angew. Chem. Int. Ed. 2003, 42, 
4302−4320 and cited references. 
102 (a) Y. L. Janin, Chem. Rev. 2012, 112, 3924−3958; (b) S. D. Roughley, A. M. Jordan, J. Med. Chem. 2011, 54, 
3451−3479; (c) A. Podgorsek, M. Zupan, J. Iskra, Angew. Chem. Int. Ed. 2009, 48, 8424−8450; (d) E. B. 
Merkushev, Synthesis 1988, 923−937; (e) E. J.-G. Anctil, V. Snieckus, in Metal-Catalyzed Cross-Coupling 
Reactions; A. de Meijere, F. Diederich, eds.; Wiley-VCH: Weinheim, Germany, 2004, pp761−814. 
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Scheme 50 Conventional approaches for halogenation reactions 
An early report on palladium catalysis involved the ortho-halogenation of azobenzene 161 with X2 
(Scheme 51),
104
 which afforded a mixture of mono-, di-, tri-, and tetra-halogenated products. 
While this work elegantly demonstrated the viability of such transformations, the requirement for 
X2 as the oxidant limited its widespread application in organic synthesis.  
 
Scheme 51 Pd-catalyzed direct ortho-halogenation of azobenzene 161 
In 2005, Yu and coworkers reported an auxiliary approach for the chemo- and stereo- selective 
ambient-temperature iodination of methyl groups with oxazoline as directing group (Table 1, entry 
1). This protocol has also been successfully applied to the activation of cyclopropanes (C−H bond 
β to the carboxy group) and arenes (C−H bond γ to the carboxy group).
105a,b
 Furthermore, they 
developed ortho-iodination and bromination of arene carboxylic acids 56 with Suárez reagents 
                                                             
103 Reviews: (a) T. W. Lyons, M. S. Sanford, Chem. Rev. 2010, 110, 1147–1169; (b) S. R. Neufeldt, M. S. Sanford, 
Acc. Chem. Res. 2012, 45, 936−946. 
104 D. R. Fahey, J. Organomet. Chem. 1971, 27, 283−292. 
105 (a) R. Giri, X. Chen, J.-Q. Yu, Angew. Chem. Int. Ed. 2005, 44, 2112−2115; (b) R. Giri, X. Chen, X.-S. Hao, 
J.-J. Li, J. Liang, Z.-P. Fan, J.-Q. Yu, Tetrahedron Asym. 2005, 16, 3502−3505; (c) T.-S. Mei, R. Giri, N. 
Maugel, J.-Q. Yu, Angew. Chem. Int. Ed. 2008, 47, 5215−5219; (d) T.-S. Mei, D.-H. Wang, J.-Q. Yu, Org. Lett. 
2010, 12, 3140−3143; (e) J.-J. Li, T.-S. Mei, J.-Q. Yu, Angew. Chem. Int. Ed. 2008, 47, 6452−6455; (f) X.-C. 
Wang, Y. Hu, S. Bonacorsi, Y. Hong, R. Burrell, J.-Q. Yu, J. Am. Chem. Soc. 2013, 135, 10326−10329; (g) L. 
Chu, X.-C. Wang, C. E. Moore, A. L. Rheingold, J.-Q. Yu, J. Am. Chem. Soc. 2013, 135, 16344–16347. 
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(XOAc) as the halogen source as well as the terminal oxidant (entries 2–3).
105c
 In this case, 
mechanistic study shows that employment of the large tetraalkylammonium cation can efficiently 
prevent the formation of dihalogenated product.
105c
 In 2010, this group extended this protocol to 
phenylacetic acid 167 (entry 4)
105d
 as well as triflamide (NHTf) directing groups (entry 5).
105e
 
Very recently, palladium-catalyzed ortho-C−H iodination directed by a weakly coordinating amide 
auxiliary (171) using I2 as the sole oxidant was developed (entry 6).
105f
 This reaction is compatible 
with a wide range of heterocycles including pyridines, imidazoles, oxazoles, thiazoles, isoxazoles, 
and pyrazoles. Furthermore, a similar protocol realized the enantioselective C−H iodination 
reaction using a mono-N-benzoyl-protected amino acid for the synthesis of chiral 
diarylmethylamines 174 (entry 7).
105g
 
Table 1 Palladium-catalyzed direct C−H halogenations reported by the Yu group 






I2 (1.0 equiv), Pd(OAc)2 (10 mol %), 







IOAc (2.0 equiv), Pd(OAc)2 (5.0 mol %), 






IOAc (4.0 equiv), Pd(OAc)2 (5.0 mol %), 






I2 (0.75 equiv), Pd(OAc)2 (10 mol %), 








I2 (2.0 equiv), Pd(OAc)2 (10 mol %),  
PhI(OAc)2 (2.0 equiv), NaHCO3 (2.0 equiv), 







I2 (2.5 equiv), Pd(OAc)2 (2.0 mol%), CsOAc 
(1.2 equiv), NaHCO3 (1.0 equiv), 4 Å 
molecular sieves, t-AmOH/DMF (1:1)  







I2 (2.5 equiv), Pd(OAc)2 (10 mol %), 
Bz-Leu-OH (40 mol %), CsOAc 
(3.0 equiv), Na2CO3 (3.0 equiv), DMSO  
(15 equiv), t-AmOH, 30 °C, air, 48 h. 
105g 
Meanwhile, distinct contributions arose also from the Sanford group. In 2004, Sanford and 
coworkers disclosed a highly regio- and chemo-selective palladium-catalyzed ortho-halogenation 
on benzo[h]quinolone (175), using NCS or NBS in place of PhI(OAc)2 as the stoichiometric 
Introduction 
 




 These transformations have been subsequently applied to a wide array of substrates 





 Further studies showed that the nature of the directing 
group and the substitution pattern on the arene ring of the substrate both led to different reactivity 
profiles, and often different and complementary products in the presence and absence of the 
catalyst (Scheme 52).
106c
 In other words, arene C−H functionalization with an electrophilic 
oxidant can occurred by either a palladium-catalyzed pathway or an uncatalyzed electrophilic 
aromatic substitution (SE
Ar
). In certain cases, these two pathways afforded different and 
complementary site selectivity. For example, the halogenation of electron-rich oxime ether 176 
(which selectively affords 178 in the absence of Pd and 177 under Pd catalysis), pyrazole 96 





Scheme 52 Complementary site selectivity of halogenation in the presence and absence of palladium catalyst 
Along with Yu’s and Sanford’s independent work, Shi reported a highly regioselective C−H 
functionalization/halogenation of acetanilides 184 catalyzed by Pd(OAc)2 and Cu(OAc) 2 with 




Scheme 53 Palladium-catalyzed C−H halogenation of acetanilides 184 with CuX2 as the halogen source 
                                                             
106 (a) A. R. Dick, K. L. Hull, M. S. Sanford, J. Am. Chem. Soc. 2004, 126, 2300−2301; (b) D. Kalyani, A. R. Dick, 
W. Q. Anani, M. S. Sanford, Org. Lett. 2006, 8, 2523−2526; (c) D. Kalyani, A. R. Dick, W. Q. Anani, M. S. 
Sanford, Tetrahedron 2006, 62,11483−11498; (d) S. R. Whitfield, M. S. Sanford, J. Am. Chem. Soc. 2007, 129, 
15142−15143. 
107 (a) X. Wan, Z. Ma, B. Li, K. Zhang, S. Cao, S. Zhang, Z. Shi, J. Am. Chem. Soc. 2006, 128, 7416−7417; for 
similar research, see: (b) R. B. Bedford, J. U. Engelhart, M. F. Haddow, C. J. Mitchell, R. L. Webster, Dalton 
Trans. 2010, 39, 10464−10472; (c) B. Song, X. Zheng, J. Mo, B. Xu, Adv. Synth. Catal. 2010, 352, 329–335; 
(d) X. Zheng, B. Song, G. Li, B. Liu, H. Deng, B. Xu, Tetrahedron Lett. 2010, 52, 6641–6645; (e) X. Zhao, E. 
Dimitrijević, V. M. Dong, J. Am. Chem. Soc. 2009, 131, 3466−3467. 
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In 2011, Bedford achieved a facile palladium-catalyzed ortho-selective bromination and 
chlorination of anilides 186 under aerobic conditions at ambient temperature 
with N-halosuccinimides (NXS) as the halogen source (Scheme 54a).
108a
 Mechanistic studies 
showed that p-toluenesulfonic acid (PTSA) plays a key role in the catalytic process. Following 
this report, analogous work was achieved with varieties of directing groups in the presence of 
PTSA as efficient additive.
109
 Likewise, Rao very recently reported a palladium-catalyzed regio- 
and chemoselective chlorination for the facile synthesis of aromatic chlorides 189. The reaction 
demonstrates excellent reactivity, good functional-group tolerance, and high yields. Control 
experiment showed that TfOH could accelerate the halogenation efficiently and that a co-oxidant 




Scheme 54 Palladium-catalyzed C−H halogenation in the presence of acid additives 
Meanwhile, Gevorgyan developed an efficient strategy for the synthesis of 1,2-ambiphilic 
aromatic and heteroannulated aromatic synthons (Scheme 55).
110
 This method featured 
installation of the removable/modifiable PyDipSi directing group on haloarenes and subsequent 
palladium-catalyzed directed ortho-halogenation reaction to give the ortho-halogenated 
PyDipSi-arene derivatives 191. The synthetic usefulness of these 1,2-ambiphilic building blocks 
was demonstrated in a variety of transformations, involving reactions on both nucleophilic aryl 
silane and electrophilic aryl iodide moieties. 
                                                             
108 (a) R. B. Bedford, M. F. Haddow, C. J. Mitchell, R. L. Webster, Angew. Chem. Int. Ed. 2011, 50, 5524−5527; 
(b) X. Sun, G. Shan, Y. Sun, Y. Rao, Angew. Chem. Int. Ed. 2013, 52, 4440−4444; (c) X. Sun, Y. Sun, C. 
Zhang, Y. Rao, Chem. Commun. 2014, 50, 1262−1264. 
109 (a) B. Du, X. Jiang, P. Sun, J. Org. Chem. 2013, 78, 2786−2791; (b) P. Sadhu, S. K. Alla, T. Punniyamurthy, J. 
Org. Chem. 2013, 78, 6104−6111; (c) A. John, K. M. Nicholas, J. Org. Chem. 2012, 77, 5600−5605; (d) X.-T. 
Ma, S.-K. Tian, Adv. Synth. Catal. 2013, 355, 337−340; (e) E. Dubost, C. Fossey, T. Cailly, S. Rault, F. Fabis, J. 
Org. Chem. 2011, 76, 6414−6420. 
110 (a) A. S. Dudnik, N. Chernyak, C. Huang, V. Gevorgyan, Angew. Chem. Int. Ed. 2010, 49, 8729–8732; (b) D. 
Sarkar, F. S. Melkonyan, A. V. Gulevich, V. Gevorgyan, Angew. Chem. Int. Ed. 2013, 52, 10800–10804. 
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Scheme 55 Palladium-catalyzed ortho-halogenation of aryl silanes 190 
Distinguished from the above protocols, Kakiuchi described a new strategy for catalytic 
halogenation of C−H bonds by means of electrochemical oxidation. Herein, combination of 
palladium-catalyzed aromatic C−H bond cleavage and halogenation with electrochemically 
generated halonium ions enables highly efficient, selective halogenations of aromatic compounds 




Scheme 56 Palladium-catalyzed regioselective halogenantion via electrochemical oxidation 
In addition to palladium-catalyzed halogenation protocols, versatile copper-catalyzed/promoted 
ortho-halogenation strategies have also been applied to arenes. These reactions were usually 
directed by pyridyl or related heteroaryl directing groups along with employment of a proper 













                                                             
111 F. Kakiuchi, T. Kochi, H. Mutsutani, N. Kobayashi, S. Urano, M. Sato, S. Nishiyama, T. Tanabe, J. Am. Chem. 
Soc. 2009, 131, 11310−11311. 
112 (a) X. Chen, X. S. Hao, C. E. Goodhue, J.-Q. Yu, J. Am. Chem. Soc. 2006, 128, 6790–6791; (b) W. Wang, C. 
Pan, F. Chen, J. Chen, Chem. Commun. 2011, 47, 3978−3980; (c) S. Mo, Y. Zhu, Z. Shen, Org. Biomol. Chem. 
2013, 11, 2756−2760; (d) B. Urones, Á. M. Martínez, N. Rodríguez, R. G. Arrayás, J. C. Carretero, Chem. 
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Table 2 Copper-catalyzed direct C−H halogenations 





197      198 
CuCl2 (20 mol %), Cl2CHCHCl2, O2 (1 atm), 






197       198 
X = Br: Cu(OAc)2 (1.0 equiv), air, Br2CHCHBr2, 
130 °C, 24 h. 
X = I: Cu(OAc)2 (1.0 equiv), I2 (1.0 equiv), air, 







Cu(OAc)2 (20 mol %), benzoyl chloride (3.0 







197      198 
Cu(NO3)2·3H2O (20 mol %), LiCl (3.0 equiv), 







CuX2 (10 mol %), NXS (1.2 equiv), MeCN, O2 (1 







CuX (1.0 equiv, NXS (2.0 equiv), HOAc (0.5 




 was very recently demonstrated to be a competent catalyst for 
the halogenation of aromatic C−H bonds in arenes 202, as reported by Glorius (Scheme 57).
113a
 In 
addition, this protocol was realized for the iodination and bromination of vinylic C−H bonds 




Scheme 57 Rh(III)-catalyzed ortho-halogenations 
 
                                                             
113 (a) N. Schröder, J. Wencel-Delord, F. Glorius, J. Am. Chem. Soc. 2012, 134, 8298−8301; (b) N. Kuhl, N. 
Schröder, F. Glorius, Org. Lett. 2013, 15, 3860−3863. 
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Recently, Jeganmohan reported an intramolecular halogenation of O-methylbenzohydroximoyl 
halides 204 in the presence of the widely used ruthenium complex [RuCl2(p-cymene)]2 (15)
26–30
  
along with diphenylacetylene (38a) as the ligand, yielding substituted halo aromatic nitriles under 























                                                             
114 R. K. Chinnagolla, S. Pimparkar, M. Jeganmohan, Chem. Commun. 2013, 49, 3146−3148. 
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2 Objectives 
During the past decade, remarkable progress in organometallic chemistry has set the stage for the 
development of increasingly viable metal catalysts for C−H bond activation reactions. Among 
these methods, oxidative C−H bond functionalizations are particularly attractive because they 
avoid the use of prefunctionalized starting materials.
4
 Among such protocols, oxidative 
annulations that involve sequential C−H and heteroatom−H bond cleavages allow for the modular 
assembly of regioselectively decorated heterocycles.
28–32 





 complexes for oxidative alkyne annulations, our group has focused on 




Carboxylate-assisted oxidative annulations of alkynes by benzamides employing ruthenium 
catalysts were only disclosed in 2011.
33
 Unfortunately, these ruthenium-catalyzed transformations 
were as of yet restricted to the use of superstoichiometric amounts of copper(II) or silver(I) salts as 
the sacrificial oxidants, thereby leading to the formation of stoichiometric amounts of undesired 
heavy metal by-products.
115
 During our studies on ruthenium-catalyzed oxidative C–H bond 
functionalizations with substituted pyrroles, we focused on developing carboxylate-assisted 
ruthenium-catalyzed oxidative annulations with air as an ideal oxidant (Scheme 59). Thereby, we 
established a novel access to pyrrolo[2,1-a]isoquinolines 209, which are indispensable structural 
motifs of inter alia bioactive lamellarine alkaloid.
116
 An additional asset of our 
ruthenium-catalyzed process is represented by its complementary scope and chemoselectivity as 





Scheme 59 Ruthenium-catalyzed aerobic oxidative annulation with substituted pyrroles 
The recent years witnessed a rapid development of the ruthenium-catalyzed oxidative C−H/N−H 
bond functionalizations.
28
 However, these C−H/N−H bond functionalizations were hitherto 
restricted to electron-deficient Michael acceptors decorated with electron-withdrawing carbonyl 
groups. Herein, we wanted to devise a new protocol that could achieve the ruthenium-catalyzed 
oxidative alkyne annulations with challenging electron-rich alkenes 210 for an expedient pyrrole 
synthesis, which was also accomplished in an aerobic manner with air as the ideal terminal 
oxidant (Scheme 60). 
                                                             
115 Notably, ruthenium-catalyzed oxidative alkyne annulations with air as ideal oxidant were also achieved during 
the preparation of this thesis, see ref. 36, 39, 40 and 44. 
116 T. Fukuda, F. Ishibashi, M. Iwao, Heterocycles 2011, 83, 491–529. 
117 K. Morimoto, K. Hirano, T. Satoh, M. Miura, Org. Lett. 2010, 12, 2068–2071. 
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Scheme 60 Ruthenium(II)-catalyzed oxidative pyrrole synthesis 
Along with the rapidly developing oxidative annulation with alkynes, significant progress has 
been accomplished in direct alkenylations through twofold C–H bond functionalization of arenes 
and heteroarenes employing ruthenium catalysts.
29
 Herein, we were interested in the use of 
[RuCl2(p-cymene)]2 and KPF6 for efficient oxidative alkenylations of electron-rich anilides 212 in 
water as a green solvent (Scheme 61). Notably, this reaction also proved to be applicable to 
electron-deficient (hetero)aromatic amides 214. Mechanistic studies showed that the 
transformations of these two types of substrates displayed different rate-limiting steps, with an 
irreversible C−H bond metalation in the case of oxidative alkenylations with benzamides 214. 
 
Scheme 61 Ruthenium-catalyzed oxidative C−H alkenylations of anilides 212 and benzamides 214 in water 
Despite the progress in the ruthenium-catalyzed C(sp
3
)−H alkylations with unactivated alkenes in 
the past years, all protocols were restricted to Ru3(CO)12 catalyst under relatively harsh reaction 
conditions and with high catalyst loadings. Thus, we became attached by developing a general 
procedure for ruthenium-catalyzed C(sp
3
)−H alkylations of unactivated alkenes 111 with 
pyrrolidines 216 employing ruthenium(II) catalyst. Complementing to the above-discussed 
oxidative protocols, this procedure would be a new powerful tool to construct C−C bonds. 
Furthermore, the pyridyl directing group can easily be removed to furnish the corresponding 
(NH)-free cyclic amines 218 (Scheme 62). 
Scheme 62 Ruthenium(II)-catalyzed direct C(sp3)−H bond alkylations with alkenes 111 
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In addition to the C−C bond formations, ruthenium complexes have been identified as powerful 




 In strict contrast, ruthenium-catalyzed intermolecular
114
 C−Hal bond forming processes 
were unfortunately thus far not available. As a consequence, we became intrigued by a catalytic 
system comprising of [Ru3(CO)12] and AgO2CAd for first ruthenium-catalyzed intermolecular 
brominations and iodinations of electron-rich and electron-deficient benzamides 219 using 
N-halosuccinimides as halogen source (Scheme 63).  
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3 Ruthenium-Catalyzed Oxidative Annulation of Alkynes 
Through C−H/N−H Bond Functionalizations 
3.1 Ruthenium-Catalyzed Aerobic Oxidative Annulation of Alkynes with 
2-Aryl-Substituted Indoles and Pyrroles 
As indicated in Chapter 1.2, transition metal-catalyzed oxidative annulations that involve 
sequential C−H and heteroatom−H bond cleavages allow for the modular assembly of 
regioselectively decorated heterocycles.
31,32
 Publications on carboxylate-assisted oxidative 
annulations of alkynes employing less expensive, yet highly selective ruthenium catalysts,
26,28−30
 
appeared only since the pionnering work in 2011.
33a
 Unfortunately, these transformations were as 
of yet restricted to the use of superstoichiometric amounts of copper(II) or silver(I) salts as the 
sacrificial oxidants. We established a novel access to pyrrolo[2,1-a]isoquinolines 207 through 
ruthenium-catalyzed oxidative C–H bond functionalizations with cocatalytic amounts of 
Cu(OAc)2·H2O under an atmosphere of ambient air.
118
 
3.1.1 Optimization Studies 
At the outset of our studies, we explored representative oxidants and additives for the envisioned 
ruthenium-catalyzed annulation of tolane (38a) by indole 206a (Table 3). Thus, the C–H/N–H 
bond functionalization was achieved with [RuCl2(p-cymene)]2 and stoichiometric amounts of 
Cu(OAc)2·H2O as the terminal oxidant (entries 1–3). Interestingly, catalytic amounts of 
Cu(OAc)2·H2O were found to be sufficient, provided that reactions were conducted under an 
atmosphere of air (entry 4). Furthermore, the use of cocatalytic additive KPF6 that forms cationic 
ruthenium(II) catalyst did not improve the catalytic activity (entry 5).
119
 While reactions with 
CuBr2 as the co-oxidant did not furnish the desired product (entry 6), cocatalytic amounts of metal 













                                                             
118 L. Ackermann, L. Wang, A. V. Lygin, Chem. Sci. 2012, 3, 177–180. 
119 (a) S. Fernández, M. Pfeffer, V. Ritleng, C. Sirlin, Organometallics 1999, 18, 2390–2394; (b) M. A. Bennett, 
A. K. Smith, J. Chem. Soc., Dalton Trans. 1974, 233–241. 
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Table 3 Optimization of oxidative annulation with indole 206aa 
 
Entry Co-catalyst (mol %) Additive (mol %) 207aa (%) 
1 — — <5b 
2 Cu(OAc)2·H2O (200) — 84
c 
3 Cu(OAc)2·H2O (10) — 21
c 
4 Cu(OAc)2·H2O (10) — 82 
5 Cu(OAc)2·H2O (10) KPF6 (20) 84 
6 CuBr2 (10) — <5
b 
7 CuBr2 (10) KPF6 (20) <5
b 
8 CuBr2 (10) LiOAc·H2O (20) 16
b 
9 CuBr2 (10) NaOAc (20) 51 
10 CuBr2 (10) CsOAc (20) 50 
a Reaction conditions: 206a (0.5 mmol), 38a (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), cocatalyst, t-AmOH 
(2.0 mL), 100 °C, 22 h, under air (1 atm); isolated yields. b GC-conversion. c Under N2. 
3.1.2 Scope of the Annulation with 2-Aryl-Substituted Indoles 
With an optimized catalytic system in hand, we explored the scope of this ruthenium-catalyzed 
aerobic oxidative annulation of alkynes 38 by indoles 206 (Table 4). Notably, the aerobic 
annulation proved to be broadly applicable, and occurred chemoselectively at the N–H 
functionality of indoles 206. Valuable functional groups, such as fluoro, bromo, nitro or ester 
substituents, were well tolerated by the catalytic system. Electron-deficient heteroarenes 206 were 
efficiently converted, generally furnishing moderate to high isolated yields (entries 1–3 and 5–8). 
Unfortunately, electron-rich heteroarenes 206e and 206k (entries 4 and 10) as well as substrates 
206j and 206m (entries 9 and 12) gave low conversion. However, improved yields were obtained 
when switching to stoichiometric amounts of the terminal oxidant Cu(OAc)2·H2O. On the other 
hand, the aerobic annulation tolerated decorated tolane derivatives 38 as well (entries 13–14).
118
 
Likewise, dichlorotolane 38c delivered the desired annulated product 207 in good yield with 
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Table 4 Aerobic oxidative annulation of alkynes 38 with indoles 206a 
 
Entry  Indole 206 Alkyne 38 Product 207 Yield (%) 
1 
206b−d 





2 R = Br (206c) 207ca 32 















6 R = CF3 (206g) 207ga 72 
7 R = NO2 (206h) 207ha 44 
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Table 4 (continued) 












a Reaction conditions: 206 (0.5 mmol), 38 (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), Cu(OAc)2·H2O (10 
mol %), t-AmOH (2.0 mL), 100 °C, 22 h, under air (1 atm); isolated yields. b Cu(OAc)2·H2O (1.0 mmol), under 
N2. 
3.1.3 Scope of the Annulation with 2-Aryl-Substituted Pyrroles 
Importantly, the ruthenium catalysis was not restricted to the use of 2-aryl-substituted indoles 206, 
but also allowed for the first metal-catalyzed oxidative annulations with pyrroles 208 (Table 5). 
The remarkable chemoselectivity of the catalytic system enabled the preparation of substituted 
pyrrolo[2,1-a]isoquinolines 209 in a highly regioselective fashion (entries 1−4), a structural motif 
found among others in the biologically active lamellarine alkaloids.
115
 Likewise, the ruthenium 
system proved tolerant of various electrophilic functional groups, such as esters, cyano or 
enolizable ketones (entries 1–4), although 5-methylpyrrole derivative 208e failed to deliver the 
desired product (entry 5). Electron-rich as well as electron-deficient tolanes 38 were efficiently 
converted, with the latter furnishing higher isolated yields (entry 6).
118
 
Table 5 Aerobic oxidative annulation with pyrroles 208a 
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Table 5 (continued) 








































a Reaction conditions: 208 (0.5 mmol), 38 (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), Cu(OAc)2·H2O (10 
mol %), t-AmOH (2.0 mL), 100 °C, 22 h, under air (1 atm); isolated yields. 
Further, the aerobic ruthenium-catalyzed annulation displayed an improved chemoselectivity as 
compared to the reported rhodium-catalyzed process.
117
 For instance, alkyl-substituted alkynes 38 
gave access to the desired products without the formation of structural isomers (Table 6). Hence, 
the annulated heteroarenes 209 were isolated in high yields with slightly increased loadings of 
Cu(OAc)2·H2O (entry 1 vs entry 2), while the related rhodium catalysis was shown to deliver a 
mixture of products.
117
 The selective transformation of n-alkyl-substituted alkynes 38 also enabled 
aerobic oxidative annulations with unsymmetrically-substituted alkynes 38g and 38h, which 
proceeded with synthetically useful regiocontrol (entries 6−8). 
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Table 6 Aerobic oxidative annulation with pyrroles 208a 
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Table 6 (continued) 







a Reaction conditions: 208 (0.5 mmol), 38 (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), Cu(OAc)2·H2O (30 
mol %), t-AmOH (2.0 mL), 100 °C, 22 h, under air (1 atm); isolated yields. b Cu(OAc)2·H2O (10 mol %). 
c The 
ratio of isomers was determined by 1H-NMR spectroscopy. 
3.1.4 Mechanistic Studies 
3.1.4.1 Inter- and Intramolercular Competition Experiments 
Considering the unique selectivity and outstanding efficacy of our ruthenium catalyst, we became 
interested in understanding its mode of action. For this purpose, intermolecular competition 
experiments with indoles 206b and 206o were performed and selectively yielded 
fluoro-substituted indole 207ba as the sole product (Scheme 64a). Furthermore, electron-deficient 
alkyne 38b was preferentially reacted with indole 206a under the optimized reaction conditions 
(Scheme 64b). 
 
Scheme 64 Intermolecular competition experiments 
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Additionally, an intramolecular competition experiment with meta-fluoro-substituted indole 206p 





Scheme 65 Annulation with meta-fluorophenyl-substituted indole 206p 
3.1.4.2 Reactions in Isotopically Labelled Solvents 
Furthermore, no significant H/D scrambling was observed in the oxidative annulations with indole 
substrate 206d in [D]4-MeOH under otherwise identical reaction conditions (Scheme 66). These 
results can be rationalized in terms of an irreversible carboxylate-assisted C−H bond metalation 
step with the ruthenium complex (Scheme 67).  
 
Scheme 66 Aerobic oxidative annulation in [D]4-MeOH 
3.1.5 Proposed Catalytic Cycle  
Based on our experimental mechanistic studies, the following catalytic cycle for the 
ruthenium(II)-catalyzed aerobic oxidative annulation is proposed (Scheme 67).
28
 Initially, the 
ruthenium-dimer is expected to form an acetate complex 222, similar to those observed in the 
ruthenium-catalyzed carboxylate-assisted direct arylation.
8
 Subsequently, N–H bond ruthenation 
of free N−H group followed by irreversible C–H bond metalation via a key transition state 223 
with a loss of two molecules of acetic acid affords ruthenacycle 224. Coordination of alkyne 38 
and regioselective migratory insertion delivers seven-membered ruthenacycle 225 as a key 
intermediate. Finally, the intermediate 225 releases the desired product 207 or 209 through 
                                                             
120 2-Aryl-substituted indoles bearing electron-donating groups on the aryl moiety led to low conversion. 
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reductive elimination, which is followed by reoxidation of the resulting ruthenium(0) species core 
226 by the copper (II)-acetate.  
 
Scheme 67 Proposed catalytic cycle for the aerobic oxidative alkyne annulations 
3.2 Ruthenium-Catalyzed Oxidative Annulation of Alkynes with Enamines 
for Pyrrole Synthesis 
Pyrroles are among the most abundant heterocycles and represent indispensable structural motifs 
in bioactive natural products or material sciences.
121a,b
 Therefore, there is a continued strong 
demand for methods that give broad access to this important heteroaromatic scaffold after the 
pioneering Knorr-pyrrole synthesis.
121c,d
 Among these methods, transition-metal-catalyzed C–H 
bond functionalization strategy for the pyrrole synthesis provides a more atom-economical 
approach and thus receives much recent attention.
2
 
The seminal work by the research groups of Glorius
122
 as well as Stuart and Fagnou
123
 have 
revealed novel syntheses of polysubstituted pyrroles through rhodium(III)-catalyzed C−H 
activation of enamines followed by the cyclization with an internal alkyne. Unfortunately, the high 
costs of the required rhodium(III) catalyst were identified as a limitation of this approach.
15
 The 
past three years witness a rapid development of the ruthenium-catalyzed oxidative C−H/N−H 
bond functionalizations.
28
 However, these protocols were restricted to alkenes activated with  
electron-withdrawing carbonyl groups. To overcome these restrictions, we hence became intrigued 
                                                             
121 (a) V. Estevés, M. Villacampa, J. C. Menendéz, Chem. Soc. Rev. 2010, 39, 4402–4421, and references cited 
therein; (b) D. S. Bhakuni, D. S. Rawat, Bioactive Marine Natural Products, Springer: New York, 2005; (c) C. 
Paal, Ber. Dtsch. Chem. Ges. 1885, 18, 367–371; (d) A. Hantzch, Ber. Dtsch. Chem. Ges. 1890, 23, 1474–
1476.  
122 S. Rakshit, F. W. Patureau, F. Glorius, J. Am. Chem. Soc. 2010, 132, 9585−9587. 
123 (a) M. P. Huestis, L. Chan, D. R. Stuart, K. Fagnou, Angew. Chem. Int. Ed. 2011, 50, 1338−1341; (b) D. R. 
Stuart, P. Alsabeh, M. Kuhn, K. Fagnou, J. Am. Chem. Soc. 2010, 132, 18326−18339. 
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by developing a new ruthenium(II)-catalyzed oxidative alkyne annulations with challenging 
electron-rich alkenes for the pyrrole synthesis.
124,125 
3.2.1 Optimization Studies 
We commenced our studies by probing oxidative annulations with differently N-substituted 
enamines 210 (Scheme 68). Among starting materials 210 bearing a variety of functional 
substituents, such as Boc, Ts, acetyl, solely the N-acetylated substrate delivered the product 211aa 
in a satisfactory yield of 70%, while the corresponding trifluoroacetylated starting material led to 
the NH-free product 212aa, albeit in low yield (15%). 
Scheme 68 Ruthenium(II)-catalyzed oxidative pyrrole synthesis 
Thereafter, we tested the influence of reaction conditions on the activaty of the ruthenium(II) 
catalyst (Table 7). In the absence of either the ruthenium complex or the copper oxidant, the 
desired product 211aa was not formed (entries 1 and 2). Likewise, the use of cocatalytic additive 
KPF6 that forms cationic ruthenium(II) catalyst did not improve the catalytic activity (entries 
3−5),
118
 whereas the replacement with AgSbF6 led to 211aa in 39% yield, along with the 
formation of NH-free product 212aa in 19% yield (entry 6). Further, a series of solvents, including 
DCE, H2O, DMF, NMP, PhMe, DMA and t-AmOH (entries 3−11), were tested and disclosed the 
latter to be the most efficient one. Moreover, the use of CuBr2 instead of Cu(OAc)2·H2O
8
 as the 
sacrificial oxidant did not deliver the desired product 211aa (entries 12–14). Besides, the complex 
RuCl3·xH2O applied instead of [RuCl2(p-cymene)]2 displayed no catalytic activity in the pyrrole 







                                                             
124 L. Wang, L. Ackermann, Org. Lett. 2013, 15, 176–179. 
125 For similar subsequent reports on ruthenium(II)-catalyzed pyrrole synthesis, see: (a) B. Li, N. Wang, Y. Liang, 
S. Xu, B. Wang, Org. Lett. 2013, 15, 136–139; (b) K. Murugan, S.-T. Liu, Tetrahedron Lett. 2013, 54, 2608–
2611; for recent palladium-catalyzed oxidative substituted pyrrole synthesis, see: (c) M.-N. Zhao, Z.-H. Ren, 
Y.-Y. Wang, Z.-H. Guan, Org. Lett. 2014, 16, 608–611. 
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Table 7 Optimization study for the oxidative pyrrole synthesisa 
 
Entry Oxidant Additive Solvent T (°C) 211aa (%) 
1 — — t-AmOH 100 0 
2 Cu(OAc)2·H2O — t-AmOH 100 0
b 
3 Cu(OAc)2·H2O — t-AmOH 100 70 
4 Cu(OAc)2·H2O — t-AmOH 120 68 
5 Cu(OAc)2·H2O KPF6 t-AmOH 120 68 
6 Cu(OAc)2·H2O AgSbF6 DCE 100 39
c 
7 Cu(OAc)2·H2O — H2O 100 35 
8 Cu(OAc)2·H2O — DMF 100 55 
9 Cu(OAc)2·H2O — NMP 100 53 
10 Cu(OAc)2·H2O — PhMe 100 38 
11 Cu(OAc)2·H2O — DMA 100 63 
12 CuBr2 — t-AmOH 100 0 
13 CuBr2 NaOAc t-AmOH 100 0 
14 CuBr2 CsOAc t-AmOH 100 0 
15 Cu(OAc)2·H2O — t-AmOH 100 0
d 
a Reaction conditions: 210a (0.5 mmol), 38a (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), oxidant (0.5 mmol), 
solvent (2.0 mL), 22 h; isolated yields. b In the absence of [RuCl2(p-cymene)]2. 
c 212aa (19%) was also isolated. d 
RuCl3·xH2O (10 mol %) was used instead of [RuCl2(p-cymene)]2. 
3.2.2 Scope of the Oxidative Pyrrole Synthesis  
To evaluate the scope of the optimized ruthenium(II) catalyst, we tested its versatility in oxidative 
annulations of tolane (38a) utilizing representative enamines 210 (Table 8). We were delighted to 
observe that numerous useful electrophilic functional groups were well tolerated, including ester, 
vinyl, bromo, cyano, and nitro substituents. Substrates 210d and 210e with a ketone moiety or 
without an additional substituent, respectively, provided only low conversion under the optimized 
reaction conditions (entries 3 and 4). Transformations of 1-aryl-substituted enamines (entries 6–15) 
proceeded very smoothly in most cases. However, electron-rich methyl and methoxy (entries 12, 
13) as well as cyclopropyl groups only delivered the target product in low yields, while more 
sterically congested substrate 210p was efficiently converted to product 211pa (entry 15). 
Moreover, 1-heteroaryl-substituted substrates 210q and 210r furnished the desired pyrroles 211q 
and 211ra as well (entries 16 and 17), albeit in lower yields. In the latter case, the NH-free pyrrole 
212ra was formed in a comparable yield, and the substrate 210s afforded analogous compound 
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Table 8 Oxidative annulation of tolane (38a) by enamides 210a 
 








2 R = CO2i-Pr (210c) 211ca 66 
3 R = COMe (210d) 211da 7 














7 R = CF3 (210h) 211ha 68 
8 R = F (210i) 211ia 53 
9 R = Br (210j) 211ja 58 
10 R = CN (210k) 211ka 74 
11 R = NO2 (210l) 211la 71 
12 R = Me (210m) 211ma 18 






















X = Ac 
(211ra) 
33 
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Table 8 (continued) 







a Reaction conditions: 210 (0.5 mmol), 38a (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), Cu(OAc)2·H2O (0.5 
mmol), t-AmOH (2.0 mL), 22 h; isolated yields. 
Thereafter, we probed different tolane derivatives 38 in the oxidative pyrrole synthesis (Table 9). 
The optimized ruthenium catalyst proved to be tolerant of functional groups in the para-, meta- 
and ortho-position of tolane (entries 1–8), but was not restricted to aryl alkynes 38. 
Dialkyl-substituted substrates 38e and 38f delivered the desired products 211ae and 211af, 
respectively, in high yields (entries 9 and 10). Notably, oxidative annulations of unsymmetrical 
alkynes 38h and 38o occurred with synthetically useful levels of regiocontrol, furnishing 
exclusively the products 211lh, 211ah and 211ao (entries 11–13). This selectivity pattern is in 
good agreement with the previously observed one for a related indole synthesis.
37
 
Table 9 Oxidative annulation of alkynes 38 by enamines 210a 
 






R = Me (38i) 
211li−211ll 
211li 63 
2 R = OMe (38j) 211lj 52 
3 R = CF3 (38b) 211b 67 
4 R = F (38k) 211lk 67 
5 R = Cl (38c) 211lc 68 
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Table 9 (continued) 























R = Me (38h) 
211ah−211ao 
211ah 66 
13 R = Et (38o) 211ao 54 
a Reaction conditions: 210 (0.5 mmol), 38 (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), Cu(OAc)2·H2O (0.5 
mmol), t-AmOH (2.0 mL), 22 h; isolated yields. 
3.2.3 Ruthenium(II)-Catalyzed Aerobic Oxidative Pyrrole Synthesis  
We were pleased that the C–H/N–H bond functionalization was also achieved in an aerobic 
fashion employing cocatalytic amounts of Cu(OAc)2·H2O under an ambient atmosphere of air as 
the ideal oxidant (Scheme 69). 
 
Scheme 69 Aerobic oxidative C–H/N–H bond functionalization under ambient air 
3.2.4 Mechanistic Studies 
3.2.4.1 Intermolecular Competition Experiments 
Given the remarkable catalytic activity of the ruthenium(II) catalyst, we became interested in 
elucidating the mechanistic aspects of this transformation. We conducted intermolecular 
competition experiments with alkynes 38, which revealed more electron-rich alkyne 38j to react 
preferentially (Scheme 70). 
Ruthenium-Catalyzed Oxidative Annulations with Alkynes 
 
- 51 - 
 
 
Scheme 70 Intermolecular competition between alkynes 38 
Additionally, competition experiments with differently 2-aryl-substituted enamines 210 
highlighted electron-donating substituents on the aryl moiety to be beneficial (Scheme 71). 
 
Scheme 71 Intermolecular competition between enamines 210 
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3.2.4.2 Reactions in Isotopically Labelled Solvents 
Oxidative annulations in isotopically labeled solvent [D]4-MeOH unraveled the C–H bond 
activation on enamines 210 to be reversible in nature (Scheme 72a). Yet, the H/D scrambling was 
not observed in the presence of alkyne 38e under otherwise identical reaction conditions (Scheme 
72b). These results can be rationalized in terms of an alkyne-coordinated ruthenium complex 
undergoing an irreversible C–H bond metalation step. 
 
Scheme 72 Oxidative annulations in [D]4-MeOH 
3.2.5 Proposed Catalytic Cycle  
Based on the above discussed experiments and on the known mechanisms of transiti-
on-metal-catalyzed oxidative annulation reactions,
28 
a plausible catalytic cycle for the 
ruthenium(II)-catalyzed pyrrole synthesis is proposed (Scheme 73). Initially, the ruthenium-dimer 
reacts with Cu(OAc)2·H2O to form an acetate-ligated species 227, which is subsequently 
coordinated by 210 via the amide oxygen to generate complex 228. Then an alkyne-coordinate 
ruthenium complex undergoes an irreversible C–H bond metalation step to deliver a 
six-membered ruthenacycle 230 with concomitant formation of acetic acid via an acetate-assisted 
transition state 229.
 
Regioselectively migratory insertion into the Ru–C bond and cleavage of N–H 
bond furnish a six-membered ruthenacycle intermediate 231. Subsequently, the oxidative coupling 
of the C–N bond takes place to form the pyrrole product 211 with the reduction of the ruthenium 
core from ruthenium(II) to ruthenium(0). Finally, the ruthenium(0) species 232 undergoes 
oxidation to regenerate the active ruthenium(II) complex with the aid of the copper oxidant. 
Ruthenium-Catalyzed Oxidative Annulations with Alkynes 
 
- 53 - 
 
 















Ruthenium-Catalyzed Oxidative C–H Alkenylations 
 
- 54 - 
 
4 Ruthenium-Catalyzed Oxidative C–H Alkenylations  
4.1 Ruthenium-Catalyzed Oxidative C–H Alkenylations of Anilides 
Along with the rapid developing oxidative annulations of alkynes,
28
 significant progress has been 
accomplished in direct oxidative alkenylations of (hetero)arenes via twofold C–H bond cleavages 
employing ruthenium catalysts.
29
 However, ruthenium-catalyzed direct oxidative alkenylations 
continue to be limited to (hetero)arenes bearing electron-withdrawing directing groups.
126
 Given 
the importance of anilines as key intermediates for the preparation of bioactive compounds and 
functional materials,
127




4.1.1 Optimization Studies 
At the outset of our studies, we optimized reaction conditions for the oxidative alkenylation of 
acetanilide 212a with alkene 76a in water (Table 10). In the absence of an additive, only trace 
amounts of the desired product 213aa were formed (entries 1 and 2). However, high catalytic 
efficiency was ensured by a complex generated in situ from [RuCl2(p-cymene)]2 and cocatalytic 
amounts of KPF6 (entries 3–9), reaction conditions previously established for the generation of 
cationic ruthenium(II) complexes.
119 
An aerobic oxidative alkenylation with cocatalytic amounts 
of Cu(OAc)2·H2O was viable, albeit with reduced efficacy (entry 10). Further, the use of silver(I) 
salts as terminal oxidants provided less satisfactory results but indicated a strong dependence of 
the catalyst’s performance on the presence of acetates (entries 11 and 12).
8
 
Table 10 Optimization of alkenylation with acetanilide 212aa 
 
Entry [RuCl2(p-cymene)]2 (mol %) Oxidant (equiv) Additive (mol %) 213aa (%) 
1 — Cu(OAc)2·H2O (1.0) KPF6 (10) 0 
2 2.5  Cu(OAc)2·H2O (1.0) — 2
b 
3 1.0 Cu(OAc)2·H2O (1.0) KPF6 (5) 43
b 
4 2.5 Cu(OAc)2·H2O (1.0) AgSbF6 (10) 54 
5 2.5 Cu(OAc)2·H2O (1.0) KPF6 (10) 87 
6 2.5 Cu(OAc)2·H2O (1.0) KPF6 (5) 76 
7 2.5 Cu(OAc)2·H2O (2.0) KPF6 (10) 84 
8 5.0 Cu(OAc)2·H2O (1.0) KPF6 (20) 86 
(continued) 
                                                             
126 For the recent reports on ruthenium-catalyzed oxidative olefinations with electron-rich arenes appeared during 
the preparation of this thesis, see ref. 66 and 67. 
127 Amino Group Chemistry; A. Ricci, Ed.; Wiley-VCH: Weinheim, 2008. 
128 L. Ackermann, L. Wang, R. Wolfram, A. V. Lygin, Org. Lett. 2012, 14, 728–731. 
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Table 10 (continued) 
Entry [RuCl2(p-cymene)]2 (mol %) Oxidant (equiv) Additive (mol %) 213aa (%) 
9 2.5 Cu(OAc)2·H2O (1.0) KPF6 (10) 77
c 
10 2.5 Cu(OAc)2·H2O (0.05) KPF6 (10) 48
b,c,d 
11 2.5 Ag2CO3 (1.0) KPF6 (10) 0 
12 2.5 AgOAc (1.0) KPF6 (10) 40
b 
a Reaction conditions: 212a (0.50 mmol), 76a (0.75 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), additive (10 mol %), 
oxidant (0.5 mmol), H2O (2.0 mL), 120 °C, 20 h, under N2; isolated yields. 
b GC conversion. c100 °C. d Under air 
(1 atm). 
Notably, the replacement of water by organic solvents, such as t-AmOH and DMF, led to 
lower-yielding reactions (Table 11, entries 2−6). Hence, the reaction mixture was biphasic, which 
suggested that the reaction occured "on" water, rather than "in water".
129
 However, addition of 
surfactants, such as Triton X-100, surprisingly delivered the alkenylated product in similar yield in 
H2O (entry 7 vs entry 1). 
Table 11 Influence of solvent on the alkenylation with acetanilide 212aa 
 
Entry Solvent Surfactant  213aa (%) 
1 H2O — 87 
2 t-AmOH — 54 
3 DMF — 55 
4 H2O/DMF (9:1) — 75 
5 H2O/DMF (1:1) — 10
b 
6 H2O/DMF (1:9) — 11
b 
7 H2O Triton X-100 (10 mol %) 81 
a Reaction conditions: 212a (0.50 mmol), 76a (0.75 mmol), [RuCl2(p-cymene)]2 (2.5 mol %), KPF6 (10 mol %), 
Cu(OAc)2·H2O (0.5 mmol), solvent (2.0 mL), 120 °C, 20 h, under N2; isolated yields. 
b GC conversion. 
4.1.2 Effect of Directing Groups  
Furthermore, we probed the ruthenium-catalyzed oxidative alkenylation with differently 
N-substituted substrates 212 (Scheme 74). Among a variety of starting materials 212, 
N-phenylacetamide (212d) delivered the product 213da in best yield in H2O (68%), while the 
corresponding N,N-disubstituted substrate 212f led to the target product 213fa with a low 
conversion (15%). 
                                                             
129 For recent reviews on transition-metal-catalyzed coupling reactions in or on water, see: (a) M.-O. Simon, C.-J. 
Li, Chem. Soc. Rev. 2012, 41, 1415–1427; (b) C.-J. Li, Acc. Chem. Res. 2010, 43, 581–590; (c) B. H. Lipshutz, 
A. R. Abela, Z. V. Boskovic, T. Nishikata, C. Duplais, A. Krasovskiy, Top. Catal. 2010, 53, 985–990; (d) R. N. 
Butler, A. G. Coyne, Chem. Rev. 2010, 110, 6302–6337. 
Ruthenium-Catalyzed Oxidative C–H Alkenylations 
 
- 56 - 
 
 
Scheme 74 Ruthenium(II)-catalyzed oxidative alkenylations 
4.1.3 Scope and Limitations  
With the optimized catalytic system in hand, we explored the scope in the ruthenium-catalyzed 
oxidative alkenylation of anilides 212 (Table 12). Thus, the catalytic C–H bond functionalization 
in water allowed for the efficient conversion of para-substituted substrates 212g−i via 
chemoselective monoalkenylations (entries 1–5). Intramolecular competition experiments with 
meta-substituted anilides 212 site selectively delivered the products 213 through alkenylation in 
position C-6, likely due to steric interactions (entries 6−10). Notably, this reactivity pattern was 
not observed when using meta-fluoro-substituted anilide 212m (entry 11), as was previously noted 
for ruthenium-catalyzed C–H bond functionalization with organic electrophiles.
24
 Unfortunately, 
ortho-substituted substrate 212n delivered the alkenylated product 213na in only 41% conversion 
(entry 13). However, hydroarylation of alkenes surprisingly occurred with methy vinyl ketone 
(76c), yielding the corresponding alkylated product 213ac in 31% yield (entry 12).
130
 
Table 12 Oxidative alkenylations with anilides 212a
 
 












R = Bu (213gb) 55 
(continued) 
                                                             
130 For a similar subsequent example, see: L. Huang, Q. Wang, J. Qi, X. Wu, K. Huang, H. Jiang, Chem. Sci. 2013, 
4, 2665−2669. 
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Table 12 (continued)  







R = Et (213ha) 74 




















R = Et (213ja) 58 (10:1)b 
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Table 12 (continued)  








a Reaction conditions: 212 (0.50 mmol), 76 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), KPF6 (10 mol %), 
Cu(OAc)2·H2O (0.5 mmol), H2O (2.0 mL), 120 °C, 20 h, under N2; isolated yields (of the major isomers). 
b Ratio 
of the regioisomers determined by GC. c GC conversion. 
Furthermore, we were pleased to observe that this ruthenium-catalyzed oxidative C–H 
alkenylation proceeded smoothly even on a large scale (0.5g–5.0 g).
131
 Herein, 5 mmol scale 
anilide loadings delivered the target product 213aa in 73% yield (Scheme 75). 
 
Scheme 75 Ruthenium(II)-catalyzed oxidative alkenylations of anilide 212a in 5 mmol scale 
The cationic ruthenium(II) system unfortunately led to low conversions with acrylonitrile (76d), 
styrene (76e), tert-butyl acrylate (76f), acrolein (76g) and α- or β-substituted alkenes (76h−k) 
(Table 13), even when switching H2O to the organic solvent t-AmOH (entry 3). 
Table 13 Oxidative alkenylations with alkene derivatives 76a 
 
Entry Alkene 76 213 (%) 






4  (76f) 0 
5  (76g) 0 





                                                             
131 L. Wang, K. Rauch, A. V. Lygin, S. I. Kozhushkov, L. Ackermann, Org. Synth. submitted. 
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Table 13 (continued)  
Entry Alkene 76 213 (%) 
8  (76j) 3 
9  (76k) 0 
a Reaction conditions: 212a (0.50 mmol), 76 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), KPF6 (20 mol %), 
Cu(OAc)2·H2O (0.5 mmol), H2O (2.0 mL), 120 °C, 20 h, under N2; GC conversion. 
b t-AmOH as solvent. 
4.1.4 Mechanistic Studies 
4.1.4.1 Intermolercular Competition Experiments 
Considering the unique features of our ruthenium catalyst, we became interested in understanding 
its mode of action. Thus, intermolecular competition experiments revealed electron-rich anilides 
212 to be preferentially functionalized (Scheme 76), which is in good agreement with an 
electrophilic activation manifold. 
 
Scheme 76 Intermolecular Competition Experiments 
4.1.4.2 Reactions in Isotopically Labelled Solvents 
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Oxidative alkenylation in D2O unraveled the C–H bond activation in anilide 212d to be reversible 
in nature (Scheme 77a).
128
 Consistence with this result, an obvious H/D scrambling on both the 
recycled starting material [D]n-212a and target product [D]n-213aa were observed in the presence 
of alkene 76a under identical reaction conditions in D2O (Scheme 77b). These findings can be 
rationalized in that the ruthenium-catalyzed alkenylation proceeds by a reversible C–H bond 
metalation step. 
 
Scheme 77 Ruthenium-Catalyzed H/D Exchange in D2O 
4.1.5 Proposed Catalytic Cycle  
Based on our mechanistic studies, we propose the catalytic cycle to involve an initial reversible 
acetate-assisted
8
 cycloruthenation of the cationic species 233 with anilide 212 to form complex 
235 through a transition state 234 (Scheme 78), which subsequently undergoes a migratory 
insertion with alkene 76 to furnish the six-membered intermediate 236. Finally, β-hydride 
elimination yields the desired product 213, and oxidation of [RuH] species with Cu(OAc)2 
regenerates the catalytically active cationic catalyst 233. 
 
Scheme 78 Proposed mechanism for the ruthenium-catalyzed oxidative alkenylation 
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4.2 Ruthenium-Catalyzed Oxidative C–H Alkenylations of Benzamides 
Notably, the efficient catalysis achieved with the cationic ruthenium(II) complex in water allowed 
for efficient oxidative alkenylations of benzamides.
128
 Thus, direct C−H bond functionalization of 
heteroaromatic amides 214 occurred with high catalytic efficacy and excellent site selectivity 
(Table 14). However, the alkenylation of NH-free indole 214c did not proceed under the identical 
reaction conditions (entry 3). 
Table 14 Oxidative alkenylation of heteroaromatic amides 214a 
 


































R = Et (215ea) 76 
6 76b R = Bu (215eb) 72 
a Reaction conditions: 214 (0.50 mmol), 76 (0.75 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), KPF6 (20 mol %), 
Cu(OAc)2·H2O (0.5 mmol), H2O (2.0 mL), 120 °C, 20 h, under N2; isolated yield. 
b t-AmOH as solvent. 
Furthermore, the site selectivity within intramolecular competition experiments with 
heteroaromatic amides was largely governed by electrophilic effects. Hence, substrate 214f was 
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preferentially functionalized at its C-2 position (Scheme 79). 
 




















Ruthenium(II)-Catalyzed C(sp3)–H α-Alkylation with Alkenes 
 




)−H α-Alkylation of 
Pyrrolidines with Alkenes 
In spite of the progress on ruthenium-catalyzed C(sp
3
)−H alkylations with alkenes in the past 
years, these protocols were largely restricted to Ru3(CO)12 catalysis under harsh conditions, i.e. 
relatively high pressure and reaction temperature.
95,97,99
 Taking into consideration our group’s 
recent report on ruthenium-catalyzed hydroarylations with unactivated alkenes through 
carboxylate-assistance,
87
 we hence set out to develop a novel directed C(sp
3
)−H alkylations of 
alkenes on pyrrolidines by ruthenium(II) catalyst. 
5.1 Optimization Studies 
Based on recently obtained results from our group,
132
 we were interested in exploring 
representative cocatalytic additives for the envisioned hydroalkylation of unactivated alkenes 111a 
(Table 15). Not surprisingly, test reactions clearly illustrated the importance of [RuCl2(PPh3)3] as 
well as of rac-BINAP. Indeed, simple [RuCl2(PPh3)3] did not affect the desired C–H bond 
functionalization in the absence of ligands and additives (entry 1). Likewise, in the absence of 
rac-BINAP satisfactory results were not obtained (entries 2–4). Notably, more promising results 
were achieved utilizing metal triflate as additives, and AgOTf was identified as being optimal 
(entries 5–7). 
Table 15 Further screenings of the ruthenium(II)-catalyzed C(sp3)−H alkylation of pyrrolidine 216aa 
 
Entry Additive 217aa (%) 
1 — 4b 
2 — 8 
3 AgOTf 0c 
4 AgOTf <1b 
5 AgOTf 73d 
6 AgOAc 7 
7 NaOTf 70d 
a Reaction conditions: 216a (1.5 mmol), 111a (0.5 mmol), [RuCl2(PPh3)3] (5.0 mol %), rac-BINAP (6.0 mol %), 
additive (12 mol %), 120 ˚C, 18 h; GC analysis with n-tridecane as an internal standard. b Without rac-BINAP. c 
Without [RuCl2(PPh3)3] 
d Isolated yield. 
5.2 Scope and Limitations  
With a highly selective catalytic system in hand (Table 15, entry 5), we next examined the 
influence exerted by substituents at the heteroaromatic moiety (Table 16). Thus, the optimized 
                                                             
132 Ph.D Dissertation, M. Schinkel, University of Göttingen, Göttingen, Germany, 2013. 
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ruthenium catalyst proved applicable to high-yielding transformations of pyrrolidines with 3-, 4- 
or 5-substituents on the pyridyl group, thereby selectively delivering the monoalkylated products 
217ba–217ea (entries 1−4). Notably, the optimized catalyst system was not restricted to pyridine 
moieties, but also enabled the C–H activation using an isoquinoline (entry 6). Contrarily, methyl 
groups either on the pyridine (216f) or on the pyrrolidine (216h) had a detrimental effect (entries 5 
and 7). 
Table 16 Ruthenium(II)-catalyzed C(sp3)−H alkylation with pyrrolidine 216a 
 






R = Me (217ba) 94 
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Table 16 (continued) 







a Reaction conditions: 216 (1.5 mmol), 111a (0.5 mmol), [RuCl2(PPh3)3] (5.0 mol %), rac-BINAP (6.0 mol %), 
AgOTf (12 mol %), 120 ˚C, 18 h; isolated yield. b GC analysis with n-tridecane as the internal standard. 
Thereafter, we explored the versatility of this method by testing a representative set of unactivated 
alkenes 111 (Table 17). Different alkenes 111b–h furnished the corresponding products 217bb–
bh in high yields even at a significantly reduced temperature of 80 ˚C (entries 1−7). Notably, the 
catalytic system tolerated functional groups, such as silanes (111i and 111j) or ethers (111k) 
(entries 8−10). Intriguingly, competition experiments with haloalkenes 111l and 111m highlighted 
the excellent chemoselectivity of the C(sp
3
)−H alkylations with substrates 111l–n (entries 11−12), 
in that products stemming from direct C–H bond alkylations with the alkyl halide moieties were 
not observed.
26, 133
 Likewise, styrene derivatives 111o–s proved to be suitable substrates, 
delivering the corresponding alkylated products 217bo−217bs in good yields   (entries 13−18).  
Table 17 Ruthenium(II)-catalyzed C(sp3)−H alkylation with alkene 111a 
 

















                                                             
133 Selected examples on ruthenium-catalyzed direct alkylations with alkyl halides: ortho-Alkylations: (a) L. 
Ackermann, P. Novák, R. Vicente, N. Hofmann, Angew. Chem. Int. Ed. 2009, 48, 6045–6048; (b) L. 
Ackermann, N. Hofmann, R. Vicente, Org. Lett. 2011, 13, 1875–1877; meta-Alkylations: (c) N. Hofmann, L. 
Ackermann, J. Am. Chem. Soc. 2013, 135, 5877–5884; Highlight article: (d) F. Juliá-Hernández, M. Simonetti, 
I. Larrosa, Angew. Chem. Int. Ed. 2013, 52, 11458–11460. 
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 Table 17 (continued)  
























































R = H (217bo) 73 
15 R = OMe (217bp) 70 
16 R = Br (217bq) 65 
17 R = F (217br) 64 
(continued) 
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Table 17 (continued) 







a Reaction conditions: 216b (1.5 mmol), 111 (0.5 mmol), [RuCl2(PPh3)3] (5.0 mol %), rac-BINAP (6.0 mol %), 
AgOTf (12 mol %), 120 ˚C, 18 h; Isolated yield. b 80 °C. c 216b (0.5 mmol), 111h (1.5 mmol). d DCE as solvent. 
However, nucleophilic substitution occurred upon alkylation of the substrate 111t in the protic 
solvent i-BuOH, affording product 219'bt (Scheme 80a). Fortunately, simply switching the 
solvent to aprotic DCE delivered the target product 219bt in good yield applying the optimized 
ruthenium catalyst. Besides, alkene 111u with a ketone moiety was well tolerated, while 
alkylation along with unexpected hydrogen transfer generated the reduced product 217bv in a 
moderate yield (Scheme 80b).  
 
Scheme 80 Ruthenium(II)-catalyzed C(sp3)−H alkylation with alkenes 111t–v 
Unfortunately, substrates with six- or seven-membered rings fused to a pyrrolidine moiety, and 
among others compounds 237a–b gave unsatisfactory results under the identical conditions 
(Scheme 81).
134
 Furthermore, substrates 237c–g bearing oxazole, pyrrole, imine, acetyl or cyano 
directing groups proved inefficient. On the other hand, products of reduction were obtained in low 
yield from activated alkenes 76a, 76c and 238a–c. Terminal, internal and cyclic alkenes 238d–g 
and diene 238h as well as alkynes 238i–j and 38a were inactive under the standard reaction 
conditions. 
                                                             
134 For details, see also: B.Sc. Thesis, K. Bielefeld, University of Göttingen, Göttingen, Germany, 2012. 
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Scheme 81 Limitations of substrate scope under the identical conditions 
5.3 Mechanistic Studies 
5.3.1 Reactions in the Presence of Radical Scavengers 
Given the unique reactivity profile of the novel ruthenium(II) catalyst, we subsequently performed 
mechanistic studies to rationalize its mode of action. Thus, SET-type processes could be ruled out 
by successfully performing the C(sp
3
)−H alkylation in the presence of stoichiometric amounts of 
the radical scavenger TEMPO (Scheme 82). 
 
Scheme 82 Mechanistic studies with TEMPO 
5.3.2 Reactions in Isotopically Labelled Reagents 
Next, the H/D exchange reaction was undertaken to obtain information concerning the reaction 
mechanism. In the present case, ruthenium(II)-catalyzed C(sp
3
)−H alkylation in [D]4-MeOH 
(Schemes 83a–b) or with isotopically enriched substrate [D]n-216b (Scheme 84) indicated the C–
H bond metalation step to be reversible. Surprisingly, the treatment of 216b under catalytic 
reaction conditions (either in the absence or presence of 111a) in [D]4-MeOH showed significant 
deuterium incorporation at the β-positions of the pyrrolidine (Scheme 83a–b). However, this result 
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Scheme 83 Studies in isotopically labelled solvents 
Scheme 84 Studies in isotopically labelled compounds 
5.4 Proposed Catalytic Cycle 
Based on our experimental mechanistic studies, the following catalytic cycle for the 
ruthenium(II)-catalyzed C(sp
3
)−H alkylation of pyrrolidines 216 is postulated (Scheme 85). 
Initially, the active species 239 is in situ formed from ruthenium precursor. Subsequently, 
reversible C–H bond metalation via transition state 240 forms ruthenacycle 241, which is similar 
to those observed in the carboxylate-assisted ruthenium-catalyzed oxidative direct C–H 
activations.
8 
Coordination of alkene 111 followed by its regioselective migratory insertion deliver 
a key intermediate 243. Finally, reductive elimination of 243 affords complex 244, which 
subsequently releases the desired product 217 and regenerates the active species 239. However, it 
should be noted that a precise investigation of the exact intermediate structures in terms of the 
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ligand sphere is required. Due to the important role of rac-BINAP in the process (Table15, entry 
1), it remains questionable as to whether exchange of rac-BINAP with PPh3 as a ligand occurs.
84 
 
Scheme 85 Proposed reaction mechanism 
5.5 Removal of the Directing Groups 
The pyridyl directing group was efficiently removed according to Maes’ recent "one-pot" 
protocols, namely, hydrogenation/hydride reduction and quaternization/hydride reduction 
strategies (Scheme 86).
135
 Thus, the hydrogenation/hydride reduction protocol was successfully 
applied to substrate 217ba and 217bj, delivering the desired (NH)-free pyrrolidines under 
comparably mild conditions (Scheme 86a). Although the pyridine directing group in substrate 
217bo was removed under the hydrogenation/hydride reduction strategy as well, the arene ring of 
the phenethyl moiety was simultaneously reduced. Further switching to the quaternization/hydride 
reduction strategy led to unsatisfactory result (Scheme 86b). 
                                                             
135 V. Smout, A. Peschiulli, S. Verbeeck, E. A. Mitchell, W. Herrebout, P. Bultinck, C. M. L. Vande Velde, D. 
Berthelot, L. Meerpoel, B. U. W. Maes, J. Org. Chem. 2013, 78, 9803−9814. 
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6 Ruthenium-Catalyzed ortho-C−H Halogenations 
In addition to the C−C bond formations, ruthenium complexes have been identified as powerful 
catalysts for the oxidative transformation of otherwise unreactive C−H bonds into C−O and C−N 
bonds.
30
 In strict contrast, ruthenium-catalyzed intermolecular
114
 C−Hal bond forming processes 
are unfortunately not available. Herein, we established a ruthenium catalytic system which 
enabled the first ruthenium-catalyzed intermolecular brominations and iodinations of benzamides 
using N-halosuccinimides as halogen sources.
136
 
6.1 Preliminary Studies with Ruthenium(II)-Catalysis 
6.1.1 ortho-Halogenations of Electron-Rich Arenes 
At the outset of our studies, we explored the widely used [RuCl2(p-cymene)]2 complex for the 
halogenation of electron-rich anilide 184a with CuBr2 or NBS as a halogen source (Table 18). To 
our disappointment, only classical electrophilic aromatic substitution (SE
Ar
) occurred delivering 
the corresponding para-brominated product 245a both in the absence and presence of the catalyst. 
Further efforts to probe parameters, including oxidant, additive and solvent, unfortunately did not 
offer the target ortho-brominated product even at the lower reaction temperature (entries 2, 10 and 
11). In addition, no conversion was observed with CuCl2 as a halogenating reagent (entries 7 and 
8). 
Table 18 Screenings of the ruthenium(II)-catalyzed C–H halogenations of acetanilide 184aa 
 
Entry [X] (equiv) Oxidant (equiv) Additive (equiv) Solvent  T (°C) 245a (%) 
1 CuBr2 (2.0) — PivOH (1.1) MeCN  100 76
b 
2 CuBr2 (2.0) — — DCE 60 10 
3 CuBr2 (2.0) Cu(OAc)2 (2.0) — DCE 100 49 
4 CuBr2 (2.0) — PTSA·H2O (1.1) DCE 100 7 
5 CuBr2 (2.0) Cu(OAc)2 (2.0) PivOH (1.1) AcOH 100 11 
6 CuBr2 (2.0) Cu(OAc)2 (2.0) PivOH (1.1) MeCN 100 63 
7 CuCl2 (2.0) — — DCE 60 0 
8 CuCl2 (2.0) Cu(OAc)2 (2.0) — DCE 90 0 
9 NBS (1.1) Cu(OAc)2 (2.0) — DCE 120 100
b 
10 NBS (1.1) — — DCE 60 71 
11 NBS (1.1) — PTSA·H2O (0.5) DCE 60 100 
a Reaction conditions: 187a (0.5 mmol), halogen source [X], [RuCl2(p-cymene)]2 (5.0 mol %), AgSbF6 (20 
mol %), additive, solvent (2.0 mL), 60−120 °C, 16 h; GC conversion. b Without [RuCl2(p-cymene)]2. 
                                                             
136 L. Wang, L. Ackermann, Chem. Commun. 2014, 50, 1083–1085. 
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Further screenings of directing groups (DG) with [RuCl2(p-cymene)]2 as the catalyst gave 
unsatisfactory results as well (Scheme 87). For instance, the use of 184b and 184c delivered 
para-brominated products in low yields, whereas no conversion was observed for electron-rich 
substrates 184d–g. 
 
Scheme 87 Ruthenium(II)-catalyzed C–H halogenations of electron-rich arenes 184 
6.1.2 ortho-Halogenations of Electron-Deficient Arenes 
As the bromination of electron-rich substrates always led to significant formation of para 
electrophilic substitution products, we subsequently turned to more challenging electron-deficient 
arenes (Table 19). Herein, ortho-bromination on benzamide 219a was observed employing CuBr2 
as the halogen source, yet with low conversion (6%). However, further screenings proved 
N-bromosuccinimide (NBS) to be more efficient for ruthenium(II)-catalyzed ortho-C−H 
halogenations under otherwise identical reaction conditions (entry 2). In spite of acids are known 





halogenations, to our disappointment, no better results were obtained with acidic additives in our 
ruthenium(II) system. The reason for this is obviously a competitive ortho-C–O bond formation 
(246a) (entries 3−14), and addition of an external oxidant did not improve the situation (entries 8 
and 12). However, we were pleased to observe that switching to a catalytic amount of the 
corresponding silver(I) carboxylate salt significantly improved the efficacy (entries 15−20), and 
the target product 220a was obtained in 43% isolated yield with AgO2CCF3 (entry 16). In addition, 
base additives did shut down the reaction almost completely (entries 21−22).  
Table 19 Screenings of the ruthenium(II)-catalyzed C–H brominations of benzamide 219aa 
 
Entry Additive (equiv) Solvent Yield of 220a (%) 246a (%) 
1b — DCE 0 0 
2 — DCE 27 0 
3 PTSA·H2O (1.1) DCE 0 0 
4 TfOH (1.1) DCE 11 0 
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Table 19 (continued) 
Entry Additive (equiv) Solvent Yield of 220a (%) 246a (%) 
5 MesCO2H (1.1) DCE 9 9 
6 (1-Ad)CO2H (1.1) DCE 0 0 
7 PivOH (1.1) DCE 20 39 
8c PivOH (1.1) DCE 12 33 
9 TFA (1.1) DCE 21 32 
10 TFA (1.1) MeCN 1 4 
11 TFA (1.1) AcOH 7 3 
12d TFA (1.1) DCE 2 0 
13 TFAA (1.1) DCE 31 22 
14e TFA (1.1) DCE 0 0 
15b AgO2CCF3 (0.2) DCE 0
 0 
16 AgO2CCF3 (0.2) DCE 51 (43
f) 18 
17 AgO2CCF3 (0.5) DCE 13 32 
18g AgO2CCF3 (0.2) DCE 32
 16 
19 Ag2O (0.2) DCE 5 0 
20 AgOTf (0.2) DCE 11 2 
21 KO2CCF3 (0.2) DCE 5 2 
22 CsOPiv (1.1) DCE 0 7 
a Reaction conditions: 219a (0.5 mmol), NBS (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), AgSbF6 (20 mol %), 
additive, solvent (2.0 mL), 100−120 °C, 16 h; GC-yield. b Without [RuCl2(p-cymene)]2. 
c Cu(OAc)2 (1.0 mmol). 
d 
CuBr2 (0.1 mmol). 
e KPF6 was used instead of AgSbF6. 
f Isolated yield. g 100 °C. 
Functional directing groups, such as amide, ester, ketone and pyridine (Scheme 88), were also 
examined under the optimal reaction conditions (Table 19, entry 16). Unfortunately, only low 
conversions to the ortho-brominated products were observed. Moreover, significant side reactions 
such as bromination of the methyl group and ortho-oxygenation occurred in acetophenone (247e) 
and 2-phenylpyridine (247f), respectively. 
 
Scheme 88 Ruthenium(II)-catalyzed ortho-C–H halogenations of electron-deficient arenes 247 
6.2 Ruthenium(0)-Catalyzed ortho-C−H Halogenations of Benzamides 
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6.2.1 Optimization Studies  
To our delight, simply switching the catalyst to Ru3(CO)12 for the ortho-C−H halogenations of 
benzamide 219a successfully delivered the desired product 220a in 27% yield (Table 20, entry 1). 
Notably, control experiment showed that no conversion of the starting material 219a was detected 
in the absence of Ru3(CO)12, highlighting the efficiency of the ruthenium(0)-catalyzed pathway 
(entries 2 and 14). Further investigations indicated that stoichiometric quantities of carboxylate 
acid not only promoted the ortho-halogenation, but also provoked ortho-oxygenation affording 
small amounts of the by-product 246a (entries 3−13). Maes has recently reported that alcohol 





alcohol additives herein completely inhibited the halogenation process (entry 16). It is noteworthy 
that the use of additional oxidants, such as copper(II) salts, did not improve the yield (entries 5 
and 15). Furthermore, switching the solvent to AcOH, MeCN, or even neat reaction did not 
improve the reaction efficacy (entries 17−19). 
Table 20 Screenings of the ruthenium(0)-catalyzed ortho-C–H halogenations with acids as additivesa 
 
Entry Additive A (equiv) Additive B (equiv) Solvent Yield of 220a (%) 246a (%) 
1 — — DCE 27 0 
2b — — DCE <2 0 
3 PTSA·H2O (2.0) — DCE 5 0 
4 TFA (2.0) — DCE 39 0 
5 TFA (2.0) Cu(OAc)2 (2.0) DCE 43 7 
6 AcOH (1.0) — DCE 56 7 
7 Ac2O (1.0) — DCE 55 5 
8 AcOH (1.0) + Ac2O (1.0) — DCE 54 5 
9 MesCO2H (2.0) — DCE 9 0 
10 PhCO2H (2.0) — DCE 24 0 
11 (1-Ad)CO2H (2.0) — DCE 57 <3 
12 PivOH (2.0) — DCE 57 11 
13 PivOH (0.2) — DCE 19 0 
14b PivOH (0.2) — DCE <2 0 
15 PivOH (2.0) CuBr2 (2.0) DCE 16 0 
16 PivOH (2.0) i-PrCHOH (5.0) DCE 0 0 
17 PivOH (0.2) — AcOH 41 4 
18 PivOH (0.2) — MeCN 14 0 
19 PivOH (0.2) — neat 43 10 
20c — — DCE 0 0 
a Reaction conditions: 219a (0.5 mmol), NBS (1.0 mmol), [Ru3(CO)12] (3.3 mol %), additives, solvent (2.0 mL), 
120 °C, 16 h; 1H-NMR yield with 1,3,5-trimethoxybenzene (0.1 mmol) as an internal standard. b without 
[Ru3(CO)12]. 
c RuCl3 (10 mol %) was used instead of [Ru3(CO)12]. 
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Further investigations revealed that, as in the case of the above-discussed catalytic system from 
[RuCl2(p-cymene)]2 (Table 19), base additives did not accelerate the halogenation process 
catalyzed with Ru3(CO)12 (Table 21, entry 1). On the other hand, replacing carboxylic acid with a 
catalytic amount of silver(I) carboxylate salt significantly improved the desired formation of target 
product 220a (entries 3−20). To our delight, AgO2C(1-Ad) delivered the best isolated yield, and 
meanwhile no C−O bond formation was detected due to the steric effect of the adamantyl moiety 
(entry 19). It is noteworthy to mention that 0.05 equivalent amount of phosphine ligand slightly 
accelerated the transformation, while increasing the loadings to 0.2 equivalent completely 
inhibited the process (entry 11 vs entry 12). Further screenings proved 1,2-dichloroethane (DCE) 
to be superior to other solvents with this ruthenium(0) catalyst (entries 14−17).  
Table 21 Screenings of the ruthenium(0)-catalyzed ortho-C–H halogenations with metal salts as additivesa 
 
Entry Additive A (equiv) Additive B (equiv) Solvent Yield of 220a (%) 246a (%) 
1 CsOAc (0.2) — DCE 24 0 
2 KPF6 (0.2) — DCE 0 0 
3 AgSbF6 (0.2) — DCE 18 0 
4 AgCl (0.2) — DCE 20 0 
5 Ag2CO3 (0.2) — DCE 34 0 
6 AgO2CCF3 (0.2) — DCE 41 4 
7 AgOAc (0.2) — DCE 58 7 
8 AgOAc (0.05) — DCE 21 0 
9 AgOAc (0.5) — DCE 48 5 
10 — PPh3 (0.05) DCE 9 0 
11 AgOAc (0.2) PPh3 (0.05) DCE 53 0 
12 AgOAc (0.2) PPh3 (0.2) DCE 2 0 
13 AgOAc (0.2) PivOH (1.1) DCE 51 10 
14 AgOAc (0.2) — t-BuOH 10 0 
15 AgOAc (0.2) — PhMe 2 0 
16 AgOAc (0.2) — Pinacolone 35 0 
17 AgOAc (0.2) — NMP <1 0 
18 AgOPiv (0.2) — DCE 60 6 
19 AgO2C(1-Ad) (0.2) — DCE 64 (60
b) 0 
20c AgO2C(1-Ad) (0.2) — DCE <2
 0 
a Reaction conditions: 219a (0.5 mmol), NBS (1.0 mmol), [Ru3(CO)12] (3.3 mol %), additives, solvent (2.0 mL), 
120 °C, 16 h; 1H-NMR yield with 1,3,5-trimethoxybenzene (0.1 mmol) as an internal standard. b Isolated yield. c 
without [Ru3(CO)12]. 
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6.2.2 Scope of the Ruthenium(0)-Catalyzed ortho-C−H halogenations  
With the optimized conditions in hand (Table 21, entry 19), we initially examined the influence of 
different amide N-substituents on the efficacy of the corresponding brominations as well as 
iodinations (Table 22).
137
 Thus, a variety of benzamides 219 provided the desired halogenated 
products 220 and 221 in good yields. Herein, electron-donating amide group gave a slightly better 
performance and bulky substituent such as N,N-diisopropylamide efficiently directed the 
bromination as well. In contrast to brominations, successive addition of N-iodosuccinimide (NIS) 
in two equal portions was required to deliver the iodinated products 221 in best yield. Besides, 
control experiments demonstrated that omission of the ruthenium(0) catalyst proved to be 
detrimental.  
Table 22 Effect of N-substituents on C−H halogenationsa 
 




Cond. (B)   
Yield (%) 






X = Br (220b) 68 —b 8 






X = Br (220c) 56 — b 0 






X = Br (220d) 89 — b 0 





X = Br (220e) 36 36 2 






X = Br (220f) 62 — b 25 
10 X = I (221f) 62 76 0 
(continued) 
                                                             
137 Primary and secondary benzamides provided thus far only unsatisfactory results (<15% conversion). 
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Table 22 (continued)  




Cond. (B)   
Yield (%) 





X = Br (220g) 52 — b 25 
12 X = I (221g) 54 72 1 
a Reaction conditions A: 219 (1.0 mmol), NXS (2.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 mol %), 
DCE (3.0 mL), 120 °C, 16 h; B: 219 (1.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 mol %), DCE (3.0 
mL), 120 °C, NXS (1.0 equiv) was added and stirred for 8 h, then the second equiv of NXS was added and the 
stirring was continued for 14 h; C: 219 (0.5 mmol), NXS (1.0 mmol), DCE (2.0 mL), 120 °C, 16 h; GC analysis. b 
Not tested. c 80 °C.  
Thereafter, we probed the scope of the C–H bromination with differently decorated benzamides 
219 (Table 23). Intramolecular competition experiments with meta-methyl arene 219h bearing two 
chemically inequivalent ortho C–H bonds showed the less hindered C–H bond to be 
predominantly brominated (entry 1). In contrast, the electron-deficient benzamide 219i afforded 
mainly isomer 220i, most probably because of the secondary directing group effect (entry 2).
7a
 
The C–H functionalizations of substrates bearing additional (hetero)aromatic moieties proceeded 
with excellent site-selectivities in the ortho-position to the amide (entries 3−10). Thereby, 
synthetically useful heterocycles (220q) and functional groups, such as acetyl (220n and 220o) or 
ester (220p), were well tolerated by the catalyst.
138
  
Table 23 Ruthenium(0)-catalyzed ortho-C–H bromination on benzamides 219a 
 

















                                                             
138 Under the optimized reaction conditions, the mass balance accounted for the unreacted starting materials as 
well as the second regioisomers in case of meta-substituted substrates 219. 
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Table 23 (continued)  












R = H (220k) B 65
c 
5 R = Me (220l) B 47
c 
6 R = F (220m) B 54
c 
7 




















a Reaction conditions A: 219 (0.5–1.0 mmol), NBS (1.0–2.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 
mol %), DCE (3.0 mL), 120 °C, 16 h; B: 219 (0.5–1.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 
mol %), DCE (2.0 mL), 120 °C, NBS (1.0 equiv) was added and stirred for 8 h, then the second equiv of NBS was 
added and the stirring was continued for 14 h; Isolated yield. b Isolated yields of the major isomer; ratio of 
regioisomers (major: minor) in the crude reaction mixture, as determined by GC analysis in parenthesis. c Only one 
isomer was observed by GC analysis. 
However, ortho-substitution turned out to be detrimental for this transformation, due to the 
sterically demanding tertiary benzamide directing group: The brominated product 220r was 
detected in 13% conversion by GC analysis of the crude reaction mixture (Scheme 89).
139
 Besides, 
electron-withdrawing groups at the para-position, such as F (219s) and CF3 (219t), only led to low 
conversions. para-Methoxyl benzamide 219u proceeded in high reactivity, however, poor 
regioselectivities were obtained. 
                                                             
139 Similar result was obtained applying rhodium(I) catalyst, see ref. 113. 
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Scheme 89 Limitations of benzamide scope 
Furthermore, the versatile ruthenium(0) catalyst displayed a broad substrate scope and allowed for 
C−H iodinations of differently substituted arenes 219 (Table 24). Thus, benzamide 219a provided 
the mono-halogenated products 221a in moderate yield (entry 1). Importantly, meta-substituted 
arenes 219 gave the desired products 221 with useful site-selectivities (entries 2–8). As was 
observed for the bromination (vide supra), the C−H iodination herein was neither viable in the 
absence of the ruthenium(0) catalyst nor of the additive AgO2C(1-Ad) for all benzamides 219. 
Table 24 Ruthenium(0)-catalyzed ortho-C–H iodination on benzamides 219a 
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Table 24 (continued)  












R = H (221k) 64c 







a Reaction conditions: 219 (0.5–1.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 mol %), DCE (2.0 mL), 
120 °C, NIS (1.0 equiv) was added and stirred for 8 h, then the second equiv of NIS was added and the stirring was 
continued for 14 h; Isolated yield. b Isolated yields of the major isomer; ratio of regioisomers (major: minor) in the 
crude reaction mixture, as determined by GC analysis in parenthesis. c Only one isomer was observed by GC 
analysis. 
6.2.3 Mechanistic Studies 
6.2.3.1 Reactions in the Presence of Radical Scavengers 
In consideration of the unique reactivity profile of the novel ruthenium(0) catalyst, we performed 
mechanistic studies to delineate its mode of action. To this end, (co)catalysis with a Brønsted acid 
could be ruled out by successfully performing the C−H bromination in the presence of 
stoichiometric amounts of 2,6-di-tert-butylpyridine (249a)
140
 (Table 25, entry 1). Furthermore, a 
radical inhibition test was next carried out in order to get insight into whether the reaction 
proceeds via radical intermediates. When such known effective radical scavengers as 
2,2,6,6-tetramethylpiperidin-1-yloxy (TEMPO, 249b), 2,2-diphenyl-1-picrylhydrazyl (DPPH, 
249c), 2,6-di-tert-butyl-4-methylphenol (BHT, 249d), trans-stilbene (249e) or 
1,1-diphenylethylene (249f) were added to the reaction mixture under otherwise identical 
conditions, the reaction process was significantly suppressed (Table 25, entries 2−7). The latter 
could be rationalized in terms of SET-type processes
141





                                                             
140 T. C. Wabnitz, J.-Q. Yu, J. B. Spencer, Chem.–Eur. J. 2004, 10, 484–493. 
141 (a) E. C. Ashby, Acc. Chem. Res. 1988, 21, 414–421; (b) A. Pross, Acc. Chem. Res. 1985, 18, 212–219. 
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Table 25 Effect of additives on the ortho-C–H bromination of benzamide 219aa 
 
Entry Additive 249 (equiv) 220a (%) 
1 2,6-di-tert-Butylpyridine (249a) (1.0) 61 
2 TEMPO (249b) (0.2) 9 
3 TEMPO (249b) (2.0) 0 
4 DPPH (249c) (2.0) 0 
5 BHT (249d) (2.0) 0 
6 trans-Stilbene (249e) (2.0) 16 
7 1,1-Diphenylethene (249f) (2.0) 0 
a Reaction conditions: 219a (0.5 mmol), NBS (1.0 mmol), [Ru3(CO)12] (3.3 mol %), AgO2C(1-Ad) (20 mol %), 
additive 249 (0.5−1.0 mmol), DCE (2.0 mL), 120 °C, 16 h; 1H-NMR yield with 1,3,5-trimethoxybenzene (0.1 
mmol) as an internal standard. 
6.2.3.2 Reactions in Isotopically Labelled Reagents 
Furthermore, the catalytic C−H functionalization in the presence of isotopically labelled additive 
[D]1-250 highlighted a reversible C−H ruthenation event (Scheme 90). 
 
Scheme 90 C−H Functionalization with isotopically labelled reagents 
In good agreement with these observations were the results of kinetic isotope effect (KIE)
142
  
measurements. The independent experiments with substrates 219a and [D]5-219a disclosed a KIE 
of kH/kD ≈ 1.0, hence indicating the C−H cleavage step not to be kinetically relevant (Scheme 91). 
                                                             
142 E. M. Simmons, J. F. Hartwig, Angew. Chem. Int. Ed. 2012, 51, 3066–3072. 
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Scheme 91 Kinetic isotope effect studies 
6.2.4 Proposed Catalytic Cycle 
Based on our experimental mechanistic studies and independent kinetic isotope effect 
measurements, the following catalytic cycle for the ruthenium(0)-catalyzed C–H halogenation is 
proposed (Scheme 92). Analogously to the general mechanism of the carboxylate-assisted 
ruthenium-catalyzed oxidative direct C–H activations,
8
 after chelation with amide substituent, the 
ruthenium species is expected to form initially a ruthenacycle 254 through reversible C–H bond 
metalation via transition state 253. Subsequently, migratory insertion of N-halosuccinimide (NXS) 
through a SET sequence delivers intermediate 255. Finally, reductive elimination of intermediate 
255 releases the desired product 220 or 221 and regenerates ruthenium (0) species 251.  
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7 Summary and Outlook 
Ruthenium-catalyzed direct C–H bond functionalizations was shown to be an attractive approach 
for the development of sustainable chemical processes. The significant rate acceleration of 
cycloruthenations by carboxylates has provided the bases for various catalyzed C–H bond 
functionalizations.  
In a first project, ruthenium(II)-catalyzed oxidative annulations were realized in an aerobic fashion 
with cocatalytic amounts of Cu(OAc)2·H2O under an atmosphere of ambient air. Pleasingly, the 
C–H/N–H bond functionalization occurred with unparalleled selectivities and ample scope to 
deliver indole 207 and pyrrole derivatives 209 (Scheme 93). While reactions with CuBr2 as the 
co-oxidant did not furnish the desired products, cocatalytic amounts of metal acetates restored the 
catalytic efficacy, thus providing strong evidence for carboxylate-assisted aerobic oxidations. 
Furthermore, the highly selective conversion of unsymmetrical alkynes 38 constituted a strong 
testament to the unique features of chemoselective ruthenium catalysts. 
 
Scheme 93 Ruthenium(II)-catalyzed aerobic oxidative annulation 
This efficient ruthenium(II) catalyst also enabled broadly applicable oxidative alkyne annulations 
with electron-rich enamines 210 to provide diversely decorated pyrroles 211, even with air as the 
ideal oxidant (Scheme 94). We were delighted to observe that numerous useful electrophilic 
functional groups were well tolerated, including ester, vinyl, bromo, cyano, and nitro substituents. 
Notably, oxidative annulations of unsymmetrical alkynes 38 occurred with synthetically useful 
levels of regiocontrol.  
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Scheme 94 Ruthenium(II)-catalyzed oxidative pyrrole synthesis by C−H activation 
Along with the rapid development of the oxidative annulations, challenging oxidative olefinations 
with electron-rich anilides 212 as well as electron-deficient benzamides 214 were elaborated with 
[RuCl2(p-cymene)]2, KPF6 and Cu(OAc)2·H2O as the catalytic system (Scheme 95). Remarkably, 
this protocol proved to be most effective with water as the reaction medium and provided an 
expedient access to differently decorated arenes 213 and 215. Furthermore, we were pleased to 
observe that this ruthenium-catalyzed oxidative C–H alkenylations proceeded smoothly even on a 
large scale. 
 
Scheme 95 Ruthenium-catalyzed oxidative alkenylation 
A catalytic system comprising of [RuCl2(PPh3)3], AgOTf and rac-BINAP enabled 
step-economical additions of C(sp
3
)–H bonds (216) onto unactivated alkenes 111 with ample 
scope under comparably mild reaction conditions (Scheme 96). Furthermore, the pyridyl directing 
group was efficiently removed to furnish (NH)-free pyrrolidines 218. 
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Scheme 96 Ruthenium(II)-catalyzed direct C(sp3)−H alkylations with alkenes 
Finally, [Ru3(CO)12] and AgO2C(1-Ad) enabled the first ruthenium-catalyzed intermolecular 
ortho-selective halogenations of benzamides 219 via C−H activation (Scheme 97). Thereby, 
brominations and iodinations of electron-rich and electron-deficient benzamides were achieved in 
a highly selective fashion as well as with excellent functional group tolerance. Preliminary 
mechanistic studies provided evidence for a reversible C−H metalation event in this process. 
 
Scheme 97 Ruthenium-catalyzed direct ortho-halogenations 
In summary, recent years have witnessed significant progress in transition-metal-catalyzed C−H 





challenging oxidative C−C, C−O, C−N
 
and C−Hal bond formations have 
proven viable with ruthenium complexes with considerable progress being accomplished in the 
past several years. Notable features of the most user-friendly ruthenium catalysts include the 
remarkably broad substrate scope and the extraordinarily high chemo- and site-selectivity. 
Particularly, the significant rate acceleration of stoichiometric cyclometalations by carboxylates 
along with recent detailed experimental and computational studies has provided strong evidence 
for various C−H bond ruthenations to proceed by base-assisted deprotonations. Considering the 
highly sustainable nature of ruthenium-catalyzed direct C−H bond functionalizations, along with 
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the improved mechanistic understanding of base-assisted metalations, further exciting 
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8 Experimental Section 
8.1 General Remarks  
Unless otherwise noticed, all reactions were performed under a N2 atmosphere using pre-dried 
glassware and standard Schlenk techniques.  
Solvents  
All solvents for reactions involving moisture-sensitive reagents were dried, distilled and stored 
under inert atmosphere (argon or nitrogen) according to the following standard procedures. 
tert-Amylalcohol (t-AmOH) was used as supplied by Merck or stirred over sodium chips for 5 h at 
120 °C and distilled under ambient pressure; water (H2O) was degassed before its use applying 
repeated Freeze-Pump-Thaw degassing procedure; 1,2-dichloroethane (DCE), i-BuOH, 
N,N-dimethylformamide (DMF), acetonitrile (MeCN) and dimethylacetamide (DMA) were dried 
over CaH2 for 8 h, degassed and distilled under reduced pressure; dichloromethane (DCM) and 
tetrahydrofuran (THF) were purified using a solvent purification system (SPS) from MBRAUN; 
N-methyl-2-pyrrolidone (NMP) was stirred over CaH2 for 4 h at 150 °C and subsequently distilled 
under reduced pressure; methanol (MeOH) was distilled from magnesium methanolate; toluene 
(PhMe) was either pre-dried over KH followed by distillation from sodium benzophenone ketyl; 
1,4-dioxane was dried by distillation from sodium benzophenone ketyl.  
Vacuum  
The following pressures were measured on the used vacuum pump and were not corrected: 
membrane pump vacuum (MPV): 0.5 mbar, oil pump vacuum (OPV): 0.1 mbar.  
Melting Points (M. p.) 
Melting points were measured using a Stuart
®
 Melting Point Apparatus SMP3 from 
BARLOWORLD SCIENTIFIC. Reported values are uncorrected.  
Chromatography  
Analytical thin layer chromatography (TLC) was performed on 0.25 mm silica gel 60F-plates 
(MACHEREY-NAGEL) with 254 nm fluorescent indicator from MERCK. Plates were visualized 
under UV-light or developed by treatment with a KMnO4 solution followed by careful applying a 
heat gun. Chromatographic purification of products was accomplished by flash column 
chromatography on MERCK silica gel, grade 60 (0.040–0.063 mm and 0.063–0.200 mm).  
Gas Chromatograpgy (GC) 
The conversion of the reactions was monitored applying coupled gas chromatography/mass 
spectrometry using G1760C GCDplus with mass detector HP 5971, 5890 Series II with mass 
detector HP 5972 from HEWLETT-PACKARD and 7890A GC-System with mass detector 5975C 
(Triplex-Axis-Detector) from AGILENT TECHNOLOGIES equipped with HP-5MS columns 
(30 m × 0.25 mm × 0.25 m) were used.  
High Performance Liquid Chromatography (HPLC) 
Preparative and analytical separations were performed on an HPLC-System from KNAUER 
(Smartline Pump 100, Dynamic Mixing Chamber, Injection- and Control-Valve, Smartline UV 
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Detector 2500). Separation normal phase column (250 × 10 mm) from MACHEREY-NAGEL 
(MN) was used. Organic solvents of HPLC grade were employed. All samples were filtered 
through Polytetrafluorethylen Filter from ROTH (Ø 25 mm, 0.2 μm) or VWR (Ø 13 mm, 0.2 μm) 
prior to separation.  
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear magnetic resonance (NMR) spectroscopy was performed at 300 or 600 MHz (
1
H-NMR), 
75 or 125 MHz (
13
C-NMR, APT) and 283 MHz (
19
F-NMR) on BRUKER AM 250, VARIAN 
Unity-300 and Inova 500 instruments. Chemical shifts are reported as δ-values in ppm relative to 
the residual proton peak of the deuterated solvent or its carbon atom, respectively, or the standard 
trimethylsilyl (TMS) peak. For characterization of the observed resonance multiplicities the 
following abbrevations were applied: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), 
dd (doublet of doublet), dt (doublet of triplet), or analogue representations. The coupling constants 
J are reported in Hertz (Hz).  
Infrared Spectroscopy (IR) 
Infrared spectra were recorded on a BRUKER Alpha-P ATR-spectrometer. Liquid probes have 
been measured as film and solid probes neat. Analysis of the spectral data has been done by using 
the OPUS 3.1 software from BRUKER, respectively OPUS 6. Absorption (ṽ) is given in wave 
numbers (cm
–1
). Spectra were recorded in the range of 4000 to 400 cm
–1
.  
Mass Spectrometry (MS) 
MS (EI) and HR-MS (EI) were measured on a Time-of-Flight mass spectrometer AccuTOF from 
JOEL. ESI-mass spectra were recorded on an Ion-Trap mass spectrometer LCQ from FINNIGAN 
or on a Time-of-Flight mass spectrometer microTOF from BRUKER. ESI-HR-MS spectra were 
recorded on a BRUKER APEX IV or a BRUKER DALTONIC {7T, Fourier Transform Ion 
Cyclotron Resonance (FTICR)} mass spectrometer. The ratios of mass to charge (m/z) are 
indicated, intensities relative to the base peak (I = 100) are written in parentheses.  
Reagents  
Chemicals obtained from commercial sources with purity above 95% were used without further 
purification.  
8.2 Synthesis of Starting Materials 
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The following compounds were obtained by the generous courtesy of the persons named below:  




Karsten Rauch: [RuCl2(p-cymene)]2. 
8.3 General Procedures 
General procedure A for ruthenium-catalyzed aerobic coupling of substituted indoles 206 
and pyrroles 208 with alkynes 38:  
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A mixture of 2-aryl indole 206 or pyrrole 208 (0.50 mmol), alkyne 38 (1.00 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (10 mg, 10.0 mol % or 30 mg, 
30.0 mol %) in t-AmOH (2.0 mL) was stirred at 100 °C under air (1 atm) for 22 h. At ambient 
temperature, the reaction mixture was diluted with H2O (75 mL) and extracted with EtOAc (3  
75 mL). The combined organic phase was washed with brine (50 mL) and dried over anhydrous 
Na2SO4. After filtration and evaporation of the solvents under reduced pressure, the crude product 
was purified by column chromatography on silica gel (n-hexane/EtOAc or n-hexane/CH2Cl2) to 
yield compound 207 and 209. 
General procedure B for ruthenium-catalyzed oxidative coupling of substituted indoles 206 
and pyrroles 208 with alkynes 38:  
A mixture of 2-aryl indole 206 or pyrrole 208 (0.50 mmol), alkyne 38 (1.00 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (200 mg, 1.00 mmol) in t-AmOH 
(2.0 mL) was stirred at 100 °C under N2 for 22 h. At ambient temperature, the reaction mixture 
was diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic 
phase was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and 
evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc or n-hexane/CH2Cl2) to yield compound 207 and 
209. 
General procedure C for ruthenium-catalyzed oxidative annulation of alkynes 38 with 
enamines 210:  
A mixture of enamine 210 (0.50 mmol), alkyne 38 (1.00 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 
5.0 mol %) and Cu(OAc)2·H2O (200 mg, 1.00 mmol) in t-AmOH (2.0 mL) was stirred at 120 °C 
under N2 for 22 h. At ambient temperature, the reaction mixture was diluted with sat. aq. 
NH4Cl/NH3 (1:1, 75 mL) and extracted with EtOAc (3  75 mL). The combined organic phase 
was washed with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and dried over anhydrous Na2SO4. After 
filtration and evaporation of the solvents under reduced pressure, the crude product was purified 
by column chromatography on silica gel (n-hexane/EtOAc) to yield compound 211. 
General procedure D for ruthenium-catalyzed oxidative alkenylation of anilides 212 and 
heteroamides 214: 
A mixture of anilide 212 or heteroarylamide 214 (0.50 mmol), acrylate 76 (0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), KPF6 (18.4 mg, 20 mol %) and Cu(OAc)2·H2O 
(99.5 mg, 1.00 mmol) in H2O (2.0 mL) (sealed tube) was stirred at 120 °C under N2 for 20 h. At 
ambient temperature, the mixture was diluted with H2O (75 mL) and extracted with EtOAc 
(3  75 mL). The combined organic phase was washed with brine (50 mL) and dried over 
anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced pressure, the 
crude product was purified by column chromatography on silica gel (n-hexane/EtOAc) to yield 
compound 213 and 215. 
General procedure E for ruthenium-catalyzed C(sp
3
)−H α-alkylation of pyrrolidine 216 with 
alkene 111: 
A suspension of [RuCl2(PPh3)3] (24.0 mg, 5.0 mol %), rac-BINAP (18.7 mg, 6.0 mol %), AgOTf 
(15.4 mg, 12 mol %), pyrrolidine 216 (1.5 mmol) and alkene 111 (0.5 mmol) in i-BuOH (1.0 mL) 
Experimental Section 
 
- 92 - 
 
was stirred at 120 °C under N2 for 18 h. At ambient temperature, CuCl (50 mg), tridecane (25 µL) 
and EtOAc (5 mL) were added to the reaction mixture. After GC analysis, the solvents were 
evaporated in reduced pressure. Purification by column chromatography on silica gel 
(n-hexane/EtOAc) yielded compound 217. 
General procedure F for the removal of 2-pyrridyl directing groups (217):
135
 
Step 1: A 25 mL Schlenk flask was charged with compound 217 (0.5 mmol) and Pt/C (5% Pt, 
195 mg, 10 mol %). Under N2, EtOH (4.5 mL) was added. To the resulting black suspension was 
added 1.25 M HCl in EtOH (0.5 mL, 0.6 mmol), and the reaction mixture was subsequently 
flushed twice with H2. The reaction mixture was then stirred under H2 (1 atm) at 23 °C for 24 h. 
The solids were removed by filtration through a short pad of celite, the pad was washed with 
CH2Cl2 (3 × 10 mL), and the combined filtrate was evaporated to dryness.  
Step 2: The residue was dissolved in MeOH (5 mL), and the resulting solution was cooled to 0 °C 
using an ice/water bath. NaBH4 (76 mg, 2.0 mmol) was added portionwise to the cooled solution 
under magnetic stirring at 0 °C. After complete addition of NaBH4, the reaction mixture was 
stirred further at 0 °C for 15 min. The volatiles were removed in reduced pressure. Purification by 
column chromatography on silica gel (CH2Cl2/MeOH) yielded compound 218. 
General procedure G for ruthenium-catalyzed ortho-C−H halogenation of benzamide 219: 
To a seal tube equipped with a magnetic stir bar were added Ru3(CO)12 (10.5 mg, 3.3 mol %), 
AgO2C(1-Ad) (28.7 mg, 20 mol %) and DCE (2.0 mL) under N2. Benzamide substrate 219 
(0.5 mmol) and N-halosuccinimide (1.0 mmol) were added. After being stirred at ambient 
temperature for 10 min, the tube was placed in a pre-heated oil-bath and stirred at 120 °C for 16 h. 
The reaction mixture was then allowed to cool to ambient temperature, diluted with EtOAc (5 mL) 
and filtered through a short pad of silica gel and eluted with EtOAc (50 mL). After removing the 
solvent under reduced pressure, purification by column chromatography on silica gel 
(n-hexane/EtOAc) yielded the corresponding compound 220. 
General procedure H for ruthenium-catalyzed ortho-C−H halogenation of benzamides 219: 
To a seal tube equipped with a magnetic stir bar were added Ru3(CO)12 (10.5 mg, 3.3 mol %), 
AgO2C(1-Ad) (28.7 mg, 20 mol %) and DCE (2.0 mL) under N2. Benzamide substrate 219 
(0.5 mmol) and the first portion of N-halosuccinimide (0.5 mmol) were added. After being stirred 
at ambient temperature for 10 min, the tube was placed in a pre-heated oil-bath and stirred at 
120 °C for 8 h. The mixture was then allowed to cool to ambient temperature, the second portion 
of N-halosuccinimide (0.5 mmol) was added under N2 and the stirring was continued for further 
14 h at 120 °C. The mixture was then allowed to cool to ambient temperature, diluted with EtOAc 
(5 mL) and filtered through a short pad of silica gel and eluted with EtOAc (50 mL). After 
removing the solvent under reduced pressure, purification by column chromatography on silica gel 
(n-hexane/EtOAc) yielded the corresponding compound 220 and 221. 
8.4 Analytical Data 
8.4.1 Analytical Data for the Products of Ruthenium-Catalyzed Aerobic 
Coupling of Substituted Indoles 206 or Pyrroles 208 with Alkynes 38 
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Synthesis of 5,6-diphenylindolo[2,1-a]isoquinoline (207aa) 
The general procedure A was followed using 2-phenylindole (206a) (96.5 mg, 
0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O 
(10 mg, 10.0 mol %). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1) yielded 207aa (151 mg, 82%) as a white 
solid. 
M. p. = 205−206 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.31 (d, J = 6.7 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.51 (ddd, J = 
7.7, 7.2, 1.3 Hz, 1H), 7.38 (s, 1H), 7.38−7.14 (m, 13H), 6.82 (ddd, J = 7.8, 7.0, 1.3 Hz, 1H), 6.01 




C-NMR (75 MHz, CDCl3): δ = 136.7 (Cq), 136.0 (Cq), 135.9 (Cq), 135.3 (Cq), 132.7 (Cq), 131.8 
(CH), 130.8 (CH), 130.2 (Cq), 129.7 (Cq), 128.7 (CH), 128.6 (CH), 127.8 (CH), 127.3 (CH), 127.0 
(CH), 126.7 (CH), 126.2 (CH), 125.4 (Cq), 123.3 (CH), 121.6 (CH), 121.4 (Cq), 120.2 (CH), 120.1 
(CH), 114.6 (CH), 94.2 (CH).  
IR (ATR): ṽ = 1543, 1484, 1443, 1377, 1338, 1245, 1030, 756, 736, 696 cm–1.  
MS (EI) m/z (relative intensity): 369 (100) [M
+
], 291 (13).  
HR-MS (EI) m/z calcd for C28H19NO
+
 369.1517, found 369.1518.  
The spectral data were in accordance with those reported in the literature.
117
 
Synthesis of 10-fluoro-5,6-diphenylindolo[2,1-a]isoquinoline (207ba) 
The general procedure A was followed using 5-fluoro-2-phenyl-1H-indole 
(206b) (106 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 50/1) yielded 207ba (102 mg, 
54%) as a yellow solid.  
M. p. = 227−228 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.26 (d, J = 7.8 Hz, 1H), 7.49 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 
7.39−7.11 (m, 14H), 6.52 (ddd, J = 9.2, 9.1, 2.6 Hz. 1H), 5.86 (dd, J = 9.4, 4.6 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 158.6 (d, 
1
JC–F = 238 Hz, Cq), 137.4 (Cq), 136.5 (Cq), 135.7 (Cq), 
135.0 (Cq), 131.7 (CH), 130.8 (CH), 130.3 (d, 
3
JC–F = 10 Hz, Cq), 130.2 (Cq), 129.4 (Cq), 128.8 
(CH), 128.7 (CH), 127.8 (CH), 127.6 (CH), 127.1 (CH), 126.8 (CH), 126.2 (CH), 124.9 (Cq), 
123.4 (CH), 121.6 (Cq), 111.6 (d, 
3
JC–F = 9 Hz, CH), 108.5 (d, 
2
JC–F = 26 Hz, CH), 104.3 (d, 
2
JC–F 
= 23 Hz, CH), 94.0 (d, 
4
JC–F = 4 Hz, CH). 
19
F-NMR (283 MHz, CDCl3): δ = −(121.7–121.8) (m).  
IR (ATR): ṽ = 3054, 1610, 1539, 1485, 1441, 1117, 855, 787, 753, 696 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 309 (30).  
HR-MS (EI) m/z calcd for C28H18FN
+
 387.1383, found 387.1382. 
Synthesis of 10-bromo-5,6-diphenylindolo[2,1-a]isoquinoline (207ca) 
The general procedure A was followed using 5-bromo-2-phenyl-1H-indole 
(206c) (136 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 5/1) yielded 207ca (72 mg, 
32%) as a yellow solid.  
M. p. = 213−214 °C.  
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1
H-NMR (300 MHz, CDCl3): δ = 8.29 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 2.0 Hz, 1H), 7.53 (dd, J = 
7.6, 7.2 Hz, 1H), 7.38−7.12 (m, 13H), 6.87 (dd, J = 9.0, 2.0 Hz, 1H), 5.81 (d, J = 9.0 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3): δ = 136.9 (Cq), 136.4 (Cq), 135.6 (Cq), 134.9 (Cq), 131.7 (CH), 131.3 
(Cq), 131.2 (Cq),130.7 (CH), 130.3 (Cq), 128.9 (CH), 128.8 (CH), 127.9 (CH), 127.7 (CH), 127.2 
(CH), 126.9 (CH), 126.3 (CH), 125.0 (Cq), 123.4 (CH), 122.8 (CH), 122.4 (CH), 122.0 (Cq), 111.9 
(CH), 111.2 (Cq), 93.5 (CH).  
IR (ATR): ṽ = 3056, 1620, 1487, 1377, 1030, 725, 696 cm–1.  








Br), 367 (44), 291 (37).  
HR-MS (ESI) m/z calcd for C28H18BrN
+
 447.0623, found 447.0634. 
Synthesis of 10-nitro-5,6-diphenylindolo[2,1-a]isoquinoline (207da) 
The general procedure A was followed using 5-nitro-2-phenyl-1H-indole 
(206d) (119 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 25/1) yielded 207da (141 
mg, 71%) as a yellow solid.  
M. p. = 281−282 °C.   
1
H-NMR (300 MHz, CDCl3): δ = 8.66 (s, 1H), 8.28 (d, J = 7.8 Hz, 1H), 7.63 (dd, J = 9.4, 2.3 Hz, 
1H), 7.58−7.45 (m, 2H), 7.44−7.30 (m, 4H), 7.30−7.08 (m, 8H), 5.96 (d, J = 9.4 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3): δ = 138.5 (Cq), 138.8 (CH), 135.9 (Cq), 135.3 (Cq), 134.9 (Cq), 134.5 
(CH), 131.4 (CH), 130.7 (Cq), 130.2 (CH), 129.2 (CH), 128.9 (CH), 128.8 (CH), 128.4 (CH), 
128.0 (CH), 127.7 (CH), 127.1 (CH), 126.6 (Cq), 124.7 (Cq), 123.6 (CH), 123.6 (Cq), 116.7 (Cq), 
114.8 (Cq), 114.6 (CH), 95.9 (CH).  
IR (ATR): ṽ = 3060, 1600, 1545, 1505, 1487, 1336, 1073, 759, 731, 696 cm–1.  
MS (EI) m/z (relative intensity): 414 (100) [M
+
], 384 (27), 368 (30), 291 (13).  
HR-MS (EI) m/z calcd for C28H18N2O2
+
 414.1368, found 414.1384. 
Synthesis of 10-methyl-5,6-diphenylindolo[2,1-a]isoquinoline (207ea) 
The general procedure A was followed using 5-methyl-2-phenyl-1H-indole 
(206e) (103 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 4/1) yielded 207ea (14 mg, 
7%) as a yellow solid.  
The general procedure B was followed using 5-methyl-2-phenyl-1H-indole (206e) (103 mg, 
0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 4/1) yielded 207ea (126 mg, 65%) as a yellow 
solid.  
M. p. = 236−237 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.29 (d, J = 8.0 Hz, 1H), 7.57 (s, 1H), 7.51 (dd, J = 8.0, 7.2 Hz, 
1H), 7.40−7.29 (m, 7H), 7.27−7.12 (m, 6H), 6.66 (dd, J = 8.8, 2.7 Hz, 1H), 5.87 (d, J = 8.8 Hz, 
1H), 2.44 (s, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 136.8 (Cq), 136.0 (Cq), 135.4 (Cq), 135.2 (Cq), 131.8 (CH), 131.1 
(Cq), 130.9 (CH), 130.8 (CH), 130.2 (Cq), 130.0 (Cq), 128.6 (CH), 128.5 (CH), 127.8 (CH), 127.1 
(CH), 126.9 (CH), 126.7 (CH), 126.1 (CH), 125.5 (Cq), 123.2 (Cq), 121.9 (CH), 121.0 (Cq), 119.7 
(CH), 114.2 (CH), 93.7 (CH), 21.3 (CH3).  
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IR (ATR): ṽ = 3047, 1614, 1574, 1443, 1376, 745, 697, 650 cm–1.  
MS (EI) m/z (relative intensity): 383 (100) [M
+
], 367 (25), 306 (10).  
HR-MS (EI) m/z calcd for C29H21N
+
 383.1674, found 399.1676.  
Synthesis of 3-fluoro-5,6-diphenylindolo[2,1-a]isoquinoline (207fa) 
The general procedure A was followed using 2-(4-fluorophenyl)-1H-indole 
(206f) (106 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 207fa (164 mg, 84%) as a yellow 
solid.  
M. p. = 178−179 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.26 (dd, J = 8.7, 5.5 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 
7.40−7.28 (m, 6H), 7.28−7.11 (m, 7H), 6.87−6.76 (m, 2H), 6.00 (d, J = 8.7 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 162.0 (d, 
1
JC–F = 246 Hz, Cq), 137.1 (Cq), 136.1 (Cq), 135.4 (Cq), 
135.0 (Cq), 132.6 (Cq), 132.3 (d, 
3
JC–F = 9 Hz, Cq), 131.6 (CH), 130.6 (CH), 129.7 (Cq), 128.8 
(CH), 128.6 (CH), 128.0 (CH), 127.0 (CH), 125.4 (d, 
3
JC–F = 9 Hz, CH), 121.9 (Cq), 121.9 (CH), 
121.8 (CH), 120.8 (d, 
4
JC–F = 3 Hz, Cq), 120.1 (CH), 111.2 (d, 
2
JC–F = 23 Hz, CH), 114.6 (CH), 
111.6 (d, 
2
JC–F = 23 Hz, CH), 93.9 (CH).  
19
F-NMR (283 MHz, CDCl3): δ = −(112.6−112.7) (m).  
IR (ATR): ṽ = 3055, 1609, 1546, 1481, 1438, 1273, 775, 738, 724, 693 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 309 (37).  
HR-MS (EI) m/z calcd for C28H18FN
+ 
387.1383, found 387.1412. 
Synthesis of 5,6-diphenyl-3-(trifluoromethyl)indolo[2,1-a]isoquinoline (207ga) 
The general procedure A was followed using 
2-{4-(trifluoromethyl)phenyl}-1H-indole (207g) (131 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 
10.0 mol %). After 22 h, purification by column chromatography on silica gel (n-hexane/CH2Cl2: 
5/1) yielded 207ga (158 mg, 72%) as a yellow solid.  
M. p. = 225−226 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.38 (d, J = 8.4 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 
8.4 Hz, 1H), 7.51 (s, 1H), 7.41−7.28 (m, 6H), 7.28−7.20 (m, 4H), 7.20−7.12 (m, 2H), 6.86 (ddd, 
J = 7.8, 7.8, 1.3 Hz, 1H), 6.00 (d, J = 8.8 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 137.3 (Cq), 135.7 (Cq), 134.8 (Cq), 134.6 (Cq), 132.9 (Cq), 131.7 
(CH), 130.6 (CH), 130.1 (Cq), 129.5 (Cq), 129.3 (q, 
2
JC–F = 22 Hz, Cq), 128.9 (CH), 128.1 (CH), 
127.9 (Cq), 127.2 (CH), 124.1 (q, 
1
JC–F = 273 Hz, Cq), 123.8 (CH), 123.2 (q, 
2
JC–F = 19 Hz, CH), 
123.2 (q, 
3
JC–F = 11 Hz, CH), 123.2 (q, 
4
JC–F = 4 Hz, CH), 122.0 (CH), 121.0 (CH), 120.9 (Cq), 
120.6 (CH), 114.7 (CH), 96.0 (CH).  
19
F-NMR (283 MHz, CDCl3): δ = −62.3 (s).  
IR (ATR): ṽ = 3062, 1618, 1544, 1485, 1345, 1272, 1017, 977, 744, 695 cm–1.  
MS (EI) m/z (relative intensity): 437 (100) [M
+
], 359 (11).  
HR-MS (EI) m/z calcd for C29H18F3N
+
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Synthesis of 3-nitro-5,6-diphenylindolo[2,1-a]isoquinoline (207ha) 
The general procedure A was followed using 2-(4-nitrophenyl)-1H-indole 
(206h) (119 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by 
column chromatography on silica gel (n-hexane/CH2Cl2: 7/1) yielded 207ha (92 mg, 44%) as a 
yellow solid.  
M. p. = 224−225 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.38 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.71 (d, 
J = 8.2 Hz, 1H), 7.51 (s, 1H), 7.45−7.08 (m, 12H), 6.87 (dd, J = 8.2, 7.4 Hz, 1H), 6.01 (d, J = 8.8 
Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 137.3 (Cq), 135.7 (Cq), 134.9 (Cq), 134.7 (Cq), 132.9 (Cq), 131.7 
(CH), 130.6 (CH), 130.2 (Cq), 129.5 (Cq), 128.9 (CH), 128.7 (CH), 128.1 (CH), 127.9 (Cq), 127.2 
(CH), 125.9 (Cq), 123.8 (CH), 123.2 (CH), 123.1 (CH), 122.0 (CH), 121.0 (CH), 120.9 (Cq), 120.6 
(CH), 114.7 (CH), 96.0 (CH).  
IR (ATR): ṽ = 3061, 3032, 1618, 1597, 1544, 1485, 1444, 1169, 825, 658 cm–1.  
MS (EI) m/z (relative intensity): 414 (100) [M
+
], 384 (27), 368 (30).  
HR-MS (EI) m/z calcd for C28H18N2O2
+
 414.1368, found 414.1368. 
Synthesis of methyl 5,6-diphenylindolo[2,1-a]isoquinoline-3-carboxylate (207ia) 
The general procedure A was followed using methyl 
4-(1H-indol-2-yl)benzoate (206i) (126 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O 
(10 mg, 10.0 mol %). After 22 h, purification by column chromatography on silica gel 
(n-hexane/CH2Cl2: 2/1) yielded 207ia (122 mg, 57%) as a yellow solid.  
M. p. = 256−257 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.33 (d, J = 8.3 Hz, 1H), 8.13 (dd, J = 8.3, 1.6 Hz, 1H), 7.86 (s, 
1H), 7.82 (d, J = 8.0 Hz, 1H), 7.51 (s, 1H), 7.39−7.28 (m, 5H), 7.27−7.15 (m, 6H), 6.86 (dd, J = 
7.8, 7.7 Hz, 1H), 6.00 (d, J = 8.7 Hz, 1H), 3.86 (s, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.8 (Cq), 136.7 (Cq), 135.9 (Cq), 135.0 (Cq), 134.9 (Cq), 133.0 
(Cq), 131.7 (CH), 130.7 (CH), 129.9 (Cq), 129.5 (Cq), 128.9 (Cq), 128.8 (CH), 128.6 (CH), 128.5 
(Cq), 128.0 (CH), 127.8 (CH), 127.5 (CH), 127.0 (CH), 123.2 (CH), 121.9 (CH), 121.3 (Cq), 120.9 
(CH), 120.6 (CH), 114.7 (CH), 96.3 (CH), 52.1 (CH3).  
IR (ATR): ṽ = 3025, 1708, 1604, 1544, 1484, 1441, 1382, 762, 738, 701 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 367 (9), 291 (10).  
HR-MS (EI) m/z calcd for C30H21NO2
+
 387.1572, found 387.1578.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of 3-chloro-5,6-diphenylindolo[2,1-a]isoquinoline (207ja) 
The general procedure A was followed using 
2-2-(4-chlorophenyl)-1H-indole (206j) (113 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 
10.0 mol %). After 22 h, purification by column chromatography on silica gel (n-hexane/CH2Cl2: 
10/1) yielded 207ja (26mg, 13%) as a yellow solid.  
The general procedure B was followed using 2-2-(4-chlorophenyl)-1H-indole (206j) (113 mg, 
0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by column 
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chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 207ja (104 mg, 51%) as a yellow 
solid.  
M. p. = 241−238 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.17 (d, J = 8.7 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.48−7.10 (m, 
14H), 6.92 (dd, J = 8.2, 7.1 Hz, 1H), 6.03 (d, J = 8.2 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 137.1 (Cq), 135.9 (Cq), 135.0 (Cq), 134.9 (Cq), 133.1 (Cq), 132.7 
(Cq), 131.6 (CH), 131.6 (Cq), 130.6 (CH), 129.6 (Cq), 128.8 (CH), 128.6 (CH), 128.0 (CH), 127.2 
(CH), 127.0 (CH), 125.4 (CH), 124.7 (CH), 123.7 (Cq), 121.8 (CH), 120.4 (CH), 120.4 (Cq), 120.3 
(CH), 114.6 (CH), 94.6 (CH).  
IR (ATR): ṽ = 3048, 1594, 1546, 1479, 1441, 1417, 1071, 759, 700 cm–1.  
MS (EI) m/z (relative intensity): 403 (100) [M
+
], 367 (10), 291 (10).  
HR-MS (ESI) m/z calcd for C28H18ClN
+
 403.1128, found 403.1118.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of 3-methyl-5,6-diphenylindolo[2,1-a]isoquinoline (207ka) 
The general procedure A was followed using 2-2-(p-tolyl)-1H-indole (206k) 
(104 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) and 
Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 207ka (11 mg, 6%) as a yellow 
solid.  
The general procedure B was followed using 2-2-(p-tolyl)-1H-indole (206k) (104 mg, 0.50 mmol) 
and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 207ka (106 mg, 55%) as a yellow 
solid.  
M. p. = 249−250 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.21 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 7.43−7.14 (m, 
12H), 6.95 (s, 1H), 6.81 (dd, J = 7.8, 7.8 Hz, 1H), 5.99 (d, J = 8.7 Hz, 1H), 2.36 (s, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 137.3 (Cq), 136.8 (Cq), 136.1 (Cq), 136.0 (Cq), 135.4 (Cq), 132.6 
(Cq), 131.8 (CH), 130.8 (CH), 130.2 (Cq), 129.8 (Cq), 128.6 (CH), 128.5 (CH), 128.4 (CH), 127.8 
(CH), 126.7 (CH), 126.0 (CH), 123.3 (CH), 123.0 (Cq), 121.5 (CH), 121.3 (Cq), 120.0 (CH), 119.8 
(CH), 114.5 (CH), 93.4 (CH), 21.7 (CH3).  
IR (ATR): ṽ = 3024, 1595, 1541, 1483, 1341, 1021, 759, 692 cm–1.  
MS (EI) m/z (relative intensity): 383 (100) [M
+
], 367 (7), 207 (10).  
HR-MS (EI) m/z calcd for C29H21N
+
 383.1674, found 383.1664.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of 7, 8-diphenylbenzo[h]indolo[2,1-a]isoquinoline (207la) 
The general procedure A was followed using 2-(naphthalen-1-yl)-1H-indole 
(206l) (122 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 5/1) yielded 207la (97 mg, 
46%) as a yellow solid.  
M. p. = 213−215 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 9.40 (d, J = 8.6 Hz, 1H), 8.06 (s, 1H), 7.96 (dd, J = 9.0, 8.6 Hz, 
2H), 7.84 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.76 (d, J = 8.6 Hz, 1H), 7.66 (dd, J = 7.3, 7.3 Hz, 1H), 
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7.46−7.18 (m, 12H), 6.92 (ddd, 8.0, 7.8, 1.2 Hz, 1H), 6.17 (d, J = 8.7 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 137.2 (Cq), 136.6 (Cq), 135.6 (Cq), 134.9 (Cq), 132.8 (Cq), 132.0 
(CH), 131.7 (Cq), 130.7 (CH), 130.2 (Cq), 129.5 (Cq), 129.5 (Cq), 128.9 (CH), 128.6 (CH), 128.6 
(CH), 127.9 (CH), 127.9 (CH), 127.2 (CH), 126.8 (CH), 125.9 (CH), 125.7 (CH), 124.2 (CH), 
122.1 (Cq), 122.0 (CH), 121.2 (Cq), 120.3 (CH), 120.2 (CH), 114.9 (CH), 99.3 (CH).  
IR (ATR): ṽ = 3057, 1588, 1543, 1467, 1360, 1208, 1017, 818, 730, 695 cm–1.  
MS (EI) m/z (relative intensity): 419 (100) [M
+
], 341 (20).  
HR-MS (EI) m/z calcd for C32H21N
+
 419.1674, found 419.1678.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of 6,7-Diphenylbenzo[g]indolo[2,1-a]isoquinoline (207ma) 
The general procedure A was followed using 2-(naphthalen-2-yl)-1H-indole 
(206m) (121 mg, 0.50 mmol), diphenylacetylene (38a) (178 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by 
column chromatography on silica gel (n-hexane/ CH2Cl2: 5/1) yielded 
207ma (13 mg, 6%) as a yellow solid.  
The general procedure B was followed using 2-(naphthalen-2-yl)-1H-indole (206m) (121 mg, 0.50 
mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 5/1) yielded 207ma (97 mg, 46%) as a yellow 
solid.  
M. p. = 262−263 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.73 (s, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.83 (d, J = 7.7 Hz, 1H), 
7.74 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 2.8 Hz, 2H), 7.54−7.16 (m, 13H), 6.89 (dd, J = 7.8, 7.8 Hz, 
1H), 5.99 (d, J = 8.2 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 136.8 (Cq), 135.8 (Cq), 135.6 (Cq), 135.3 (Cq), 133.6 (Cq), 132.6 
(Cq), 132.2 (Cq), 131.9 (CH), 130.9 (CH), 129.5 (Cq), 129.2 (Cq), 128.6 (CH), 128.4 (CH), 128.1 
(CH), 127.9 (CH), 127.6 (CH), 126.8 (CH), 126.0 (CH), 125.8 (CH), 124.8 (CH), 124.2 (Cq), 
121.9 (CH), 121.7 (CH), 121.4 (Cq), 120.8 (CH), 120.3 (CH), 114.4 (CH), 96.7 (CH).  
IR (ATR): ṽ = 3051, 3021, 1625, 1487, 1375, 1022, 736, 722, 694 cm–1.  
MS (EI) m/z (relative intensity): 419 (100) [M
+
], 341 (18).  
HR-MS (EI) m/z calcd for C32H21N
+
 419.1674, found 419.1678.  
Synthesis of 5,6-bis{4-(trifluoromethyl)phenyl}indolo[2,1-a]isoquinoline (207ab) 
The general procedure A was followed using 2-phenyl-1H-indole (206a) 
(97.0 mg, 0.50 mmol), 1,2-bis{4-(trifluoromethyl)phenyl}ethyne (38b) 
(314 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, 
purification by column chromatography on silica gel (n-hexane/CH2Cl2: 10/1) 
yielded 207ab (137 mg, 54%) as a yellow solid.  
M. p. = 287−288 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.32 (d, J = 7.8 Hz, 1H), 7.82 (d, J =7.8 Hz, 1H), 7.64 (d, J = 
7.8 Hz, 2H), 7.59−7.48 (m, 3H), 7.48−7.33 (m, 4H), 7.33−7.18 (m, 3H), 7.05 (d, J = 7.8 Hz, 1H), 
6.88 (dd, J = 7.8, 7.8 Hz, 1H), 5.95 (d, J = 8.6 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 140.2 (Cq), 138.5 (Cq), 135.7 (Cq), 134.5 (Cq), 132.5 (Cq), 132.1 
(CH), 131.2 (q, 
2
JC–F = 33 Hz, Cq), 131.2 (CH), 129.8 (Cq), 129.7 (q, 
2
JC–F = 33 Hz, Cq), 129.2 
(Cq), 127.8 (q, 
3
JC–F = 11 Hz, CH), 125.9 (CH), 125.8 (q, 
4
JC–F = 4 Hz, CH), 125.6 (Cq), 125.1 (q, 
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3
JC–F = 11 Hz, CH), 125.1 (q, 
4
JC–F = 4 Hz, CH), 124.0 (q, 
1
JC–F = 272 Hz, Cq). 123.7 (q, 
1
JC–F = 
272 Hz, Cq), 123.5 (CH), 122.1 (CH), 120.7 (CH), 120.7 (Cq), 120.6 (CH), 114.0 (CH), 94.9 (CH). 
19
F-NMR (283 MHz, CDCl3): δ = −62.6 (s), −62.7 (s).  
IR (ATR): ṽ = 3065, 1612, 1576, 1545, 1446, 1322, 1171, 1105, 1066, 759 cm–1.  
MS (EI) m/z (relative intensity): 505 (100) [M
+
], 435 (10), 359 (15), 291 (10).  
HR-MS (EI) m/z calcd for C30H17F6N
+
 505.1265, found 505.1269.  
The spectral data were in accordance with those reported in the literature.
117
 
Synthesis of 5,6-di-(p-tolyl)indolo[2,1-a]isoquinoline (207ac) 
The general procedure A was followed using 2-phenyl-1H-indole (206a) 
(97 mg, 0.50 mmol), 1,2-bis(4-chlorophenyl)ethyne (38c) (247 mg, 1.00 mmol) 
and Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 207ac (14 mg, 
6%) as a yellow solid.  
The general procedure B was followed using 2-phenyl-1H-indole (206a) 
(97 mg, 0.50 mmol) and 1,2-bis(4-chlorophenyl)ethyne (38c) (247 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 207ac (176 
mg, 82%) as a yellow solid.  
M. p. = 251−252 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.29 (d, J = 8.2 Hz, 1H), 7.81 (d, J = 7.8 Hz, 1H), 7.50 (ddd, J = 
7.8, 7.5, 1.2 Hz, 1H), 7.38 (s, 1H), 7.39−7.35 (m, 3H), 7.29−7.21 (m, 5H), 7.13−7.06 (m, 3H), 
6.90 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 6.09 (d, J = 8.6 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 135.7 (Cq), 135.0 (Cq), 134.9 (Cq), 134.9 (Cq), 133.5 (Cq), 133.0 
(Cq), 133.0 (CH), 132.5 (Cq), 132.1 (CH), 129.7 (Cq), 129.6 (Cq), 129.2 (CH), 128.3 (CH), 127.5 
(CH), 127.4 (CH), 125.9 (CH), 125.4 (Cq), 123.4 (CH), 121.9 (CH), 120.6 (Cq), 120.5 (CH), 120.4 
(CH), 114.2 (CH), 94.6 (CH).  
IR (ATR): ṽ = 3064, 1619, 1591, 1538, 1484, 1443, 1393, 1087, 1014, 737 cm–1.  
MS (EI) m/z (relative intensity): 437 (100) [M
+
], 401 (9), 365 (11), 291 (10), 182 (18).  
HR-MS (EI) m/z calcd for C28H17Cl2N
+
 437.0738, found 437.0728.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of ethyl 5,6-diphenylpyrrolo[2,1-a]isoquinoline-2-carboxylate (209aa) 
The general procedure A was followed using 
ethyl 5-phenyl-1H-pyrrole-3-carboxylate (208a) (108 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 
10.0 mol %). After 22 h, purification by column chromatography on silica 
gel (n-hexane/CH2Cl2: 5/1) yielded 209aa (182 mg, 93%) as a yellow solid.  
M. p. = 200−201°C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.15 (d, J = 8.0 Hz, 1H), 7.54−7.37 (m, 2H), 7.38 (d, J = 1.6 Hz, 
1H), 7.36−7.19 (m, 10H), 7.19−7.11 (m, 2H), 4.33 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ = 165.1 (Cq), 136.2 (Cq), 133.8 (Cq), 133.3 (Cq), 131.3 (CH), 130.8 
(Cq), 130.5 (CH), 128.7 (CH), 128.7 (CH), 128.4 (Cq), 127.9 (CH), 127.7 (CH), 127.1 (CH), 126.6 
(CH), 126.2 (CH), 125.7 (Cq), 124.6 (Cq), 122.1 (CH), 118.7 (CH), 118.3 (Cq), 101.3 (CH), 60.1 
(CH2), 14.5 (CH3).  
IR (ATR): ṽ = 2979, 1702, 1513, 1454, 1418, 1235, 1207, 1144, 749, 700 cm–1.  
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MS (EI) m/z (relative intensity): 391 (100) [M
+
], 318 (90).  
HR-MS (EI) m/z calcd for C27H21NO2
+
 391.1572, found 391.1576. 
Synthesis of 5,6-diphenylpyrrolo[2,1-a]isoquinoline-2-carbonitrile (209ba) 
The general procedure A was followed using 
5-phenyl-1H-pyrrole-3-carbonitrile (208b) (84.0 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 10.0 
mol %). After 22 h, purification by column chromatography on silica gel 
(n-hexane/CH2Cl2: 10/1) yielded 209ba (70 mg, 40%) as a white solid.  
M. p. = 228−229 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 8.11 (d, J = 8.0 Hz, 1H), 7.55 (ddd, J = 7.6, 7.4, 1.3 Hz, 1H), 
7.40−7.30 (m, 4H), 7.30−7.21 (m, 8H), 7.21−7.10 (m, 2H).  
13
C-NMR (75 MHz, CDCl3): δ = 135.7 (Cq), 133.2 (Cq), 132.7 (Cq), 131.1 (CH), 130.9 (Cq), 130.3 
(CH), 129.1 (CH), 128.9 (CH), 128.5 (Cq), 128.0 (CH), 128.0 (CH), 127.3 (CH), 127.0 (CH), 
126.8 (CH), 125.3 (Cq), 124.7 (Cq), 122.2 (CH), 120.7 (CH), 116.5 (Cq), 103.0 (CH), 95.5 (Cq).  
IR (ATR): ṽ = 3132, 2107, 1598, 1513, 1487, 1389, 1131, 760, 754, 697 cm–1.  
MS (EI) m/z (relative intensity): 344 (100) [M
+
], 266 (10).  
HR-MS (EI) m/z calcd for C25H16N2
+
 344.1313, found 344.1324. 
Synthesis of 1-(5,6-diphenylpyrrolo[2,1-a]isoquinolin-2-yl)ethanone (209ca) 
The general procedure A was followed using 
1-(5-phenyl-1H-pyrrol-3-yl)ethanone (208c) (93.0 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 
10.0 mol %). After 22 h, purification by column chromatography on silica gel 
(n-hexane/CH2Cl2: 10/1) yielded 209ca (137 mg, 76%) as a white solid.  
M. p. = 206 °C (dec.).  
1
H-NMR (300 MHz, CDCl3): δ = 8.15 (d. J = 8.2 Hz, 1H), 7.56−7.38 (m, 2H), 7.39−7.10 (m, 
13H), 2.49 (s, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 194.6 (Cq), 136.1 (Cq), 133.8 (Cq), 133.2 (Cq), 131.3 (Cq), 131.2 
(CH), 130.4 (CH), 128.8 (CH), 128.8 (CH), 128.5 (Cq), 128.0 (CH), 127.8 (CH), 127.1 (CH), 
127.0 (Cq), 126.7 (CH), 126.4 (CH), 125.8 (Cq), 125.0 (Cq), 122.1 (CH), 118.2 (CH), 100.3 (CH), 
27.5 (CH3).  
IR (ATR): ṽ = 3023, 1651, 1511, 1458, 1241, 1143, 799, 773, 700, 644 cm–1.  
MS (EI) m/z (relative intensity): 361 (100) [M
+
], 346 (27), 318 (30).  
HR-MS (EI) m/z calcd for C26H19NO
+
 361.1467, found 361.1456. 
Synthesis of ethyl 1,5,6-triphenylpyrrolo[2,1-a]isoquinoline-2-carboxylate (209da) 
The general procedure A was followed using ethyl 
4,5-diphenyl-1H-pyrrole-3-carboxylate (208d) (146 mg, 0.50 mmol), 
diphenylacetylene (38a) (178 mg, 1.00 mmol) and Cu(OAc)2·H2O (10 mg, 
10.0 mol %). After 22 h, purification by column chromatography on silica 
gel (n-hexane/CH2Cl2: 10/1) yielded 209da (176 mg, 75%) as a white solid.  
M. p. = 243−244 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.57−7.38 (m, 7H), 7.41−7.29 (m, 5H), 7.29−7.06 (m, 8H), 4.08 
(q, J = 7.0 Hz, 2H), 1.04 (t, J = 7.0 Hz, 3H).  
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13
C-NMR (75 MHz, CDCl3): δ = 164.8 (Cq), 136.8 (Cq), 136.4 (Cq), 133.6 (Cq), 133.3 (Cq), 131.3 
(CH), 130.6 (CH), 130.5 (CH), 129.1 (Cq), 128.8 (CH), 128.8 (CH), 128.4 (CH), 127.9 (CH), 
127.2 (CH), 127.1 (CH), 127.0 (CH), 126.7 (Cq), 126.6 (CH), 126.4 (Cq), 125.7 (CH), 124.7 (Cq), 
122.7 (CH), 119.9 (Cq), 118.9 (CH), 117.6 (Cq), 59.6 (CH2), 13.9 (CH3).  
IR (ATR): ṽ = 3049, 1713, 1601, 1514, 1456, 1206, 1137, 776, 761, 699 cm–1.  
MS (EI) m/z (relative intensity): 467 (100) [M
+
], 394 (30).  
HR-MS (EI) m/z calcd for C33H25NO2
+
 467.1885, found 467.1872. 
Synthesis of ethyl 5,6-di(4-fluorophenyl)pyrrolo[2,1-a]isoquinoline-2-carboxylate (209ad) 
The general procedure A was followed using ethyl 
5-phenyl-1H-pyrrole-3-carboxylate (208a) (108 mg, 0.50 mmol) and 
1,2-bis(4-fluorophenyl)ethyne (38d) (206 mg, 1.00 mmol) and 
Cu(OAc)2·H2O (10 mg, 10.0 mol %). After 22 h, purification by column 
chromatography on silica gel (n-hexane/CH2Cl2: 10/1) yielded 209ad (116 
mg, 54%) as a yellow solid.  
M. p. = 240−241°C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.14 (d, J = 8.0 Hz, 1H), 7.56−7.41 (m, 2H), 7.41−6.84 (m, 
11H); 4.34 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 164.9 (Cq), 162.6 (d, 
1
JC–F = 250 Hz, Cq), 161.9 (d, 
1
JC–F = 
247 Hz, Cq), 133.0 (Cq), 132.9 (d, 
3
JC–F = 8 Hz, CH), 132.4 (d, 
3
JC–F = 8 Hz, CH), 132.0 (d, 
4
JC–F = 
4 Hz, Cq), 130.8 (Cq), 129.2 (d, 
4
JC–F = 4 Hz, Cq), 128.1 (Cq), 128.0 (CH), 126.4 (CH), 126.4 (CH), 
125.8 (Cq), 124.0 (Cq), 122.2 (CH), 118.6 (Cq), 118.4 (CH), 116.2 (d, 
2
JC–F = 22 Hz, CH), 111.2 (d, 
2
JC–F = 22 Hz, CH), 101.6 (CH), 60.2 (CH2), 14.4 (CH3). 
19
F-NMR (283 MHz, CDCl3): δ = −(111.2−111.4) (m), −(114.3−114.5) (m).  
IR (ATR): ṽ = 3144, 2989, 1697, 1598, 1545, 1501, 1216, 816, 789, 756 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 354 (60).  
HR-MS (EI) m/z calcd for C27H19F2NO2
+
 387.1384, found 387.1379. 
Synthesis of dimethyl 3-methyl-5,6-di(n-propyl)pyrrolo[2,1-a]isoquinoline-1,2-dicarboxylate 
(209fe) 
The general procedure A was followed using 
dimethyl 2-methyl-5-phenyl-1H-pyrrole- 3,4-dicarboxylate (208f) (137 mg, 
0.50 mmol), 4-octyne (38e) (110 mg, 1.00 mmol) and Cu(OAc)2·H2O 
(10.0 mg, 10.0 mol %). After 22 h, purification by column chromatography 
on silica gel (n-hexane/ EtOAc: 10/1) yielded 209fe (99 mg, 48%) as a 
yellow oil.  
The general procedure A was followed using dimethyl 2-methyl-5-phenyl-1H-pyrrole- 
3,4-dicarboxylate (208f) (137 mg, 0.50 mmol), 4-octyne (38e) (110 mg, 1.00 mmol) and 
Cu(OAc)2·H2O (30.0 mg, 30.0 mol %). After 22 h, purification by column chromatography on 
silica gel (n-hexane/ EtOAc: 10/1) yielded 209fe (141 mg, 74%) as a yellow oil. 
1
H-NMR (300 MHz, CDCl3): δ = 8.17 (d, J = 7.2 Hz, 1H), 7.67 (d, J = 7.0 Hz, 1H), 7.46−7.36 (m, 
2H), 3.99 (s, 3H), 3.87 (s, 3H), 3.12 (t, J = 8.2 Hz, 2H), 2.97 (s, 3H), 2.79 (t, J = 8.2 Hz, 2H), 
1.70−1.52 (m, 4H), 1.09 (t, J = 7.3 Hz, 3H), 1.02 (t, J = 7.3 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.0 (Cq), 165.7 (Cq), 154.7 (Cq), 128.8 (Cq), 128.4 (Cq), 127.9 
(Cq), 126.9 (CH), 126.8 (CH), 124.7 (Cq), 123.6 (CH), 123.1 (CH), 122.2 (Cq), 116.4 (Cq), 109.2 
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(Cq), 52.5 (CH3), 51.7 (CH3), 50.5 (CH2), 50.2 (CH2), 25.4 (CH2), 25.0 (CH2), 14.8 (CH3), 14.4 
(CH3), 13.4 (CH3).  
IR (ATR): ṽ = 2954, 1708, 1526, 1455, 1438, 1199, 1118, 1091, 755, 730 cm–1.  
MS (EI) m/z (relative intensity): 381 (100) [M
+
], 350 (30), 334 (38), 263 (28).  
HR-MS (EI) m/z calcd for C23H27NO4
+
 381.1940, found 381.1933. 
Synthesis of ethyl 5,6-dimethyl-1-phenylpyrrolo[2,1-a]isoquinoline-2-carboxylate (209de) 
The general procedure A was followed using 
ethyl 4,5-diphenyl-1H-pyrrole-3-carboxylate (208d) (72.8 mg, 0.25 mmol), 
4-octyne (38e) (55.0 mg, 0.50 mmol) and Cu(OAc)2·H2O (15.0 mg, 
30.0 mol %). After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1) yielded 209de (77 mg, 77%) as a yellow oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.97 (s, 1H), 7.69 (d, J = 8.2 Hz, 1H), 7.65−7.57 (m, 6H), 7.32 
(ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 7.09 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.02 
(t, J = 8.0 Hz, 2H), 2.87 (t, J = 8.0 Hz, 2H), 1.92−1.77 (m, 2H), 1.75−1.61 (m, 2H), 1.22−1.01 (m, 
9H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.0 (Cq), 157.2 (Cq), 152.5 (Cq), 150.6 (CH), 128.5 (CH), 
127.7 (Cq), 127.0 (CH), 126.5 (Cq), 126.5 (Cq), 126.1 (CH), 125.7 (CH), 123.6 (CH), 123.1 (CH), 
119.8 (Cq), 119.4 (Cq), 117.4 (Cq), 116.5 (CH), 59.6 (CH2), 30.7 (CH2), 30.0 (CH2), 23.4 (CH2), 
20.3 (CH2), 14.5 (CH3), 14.3 (CH3), 13.9 (CH3).  
IR (ATR): ṽ = 2958, 1698, 1604, 1519, 1457, 1202, 1111, 758, 731, 698 cm–1.  
MS (EI) m/z (relative intensity): 399 (100) [M
+
], 370 (45), 282 (35).  
HR-MS (EI) m/z calcd for C27H29NO2
+
 399.2178, found 399.2178. 
Synthesis of dimethyl 5,6-diethyl-3-methylpyrrolo[2,1-a]isoquinoline-1,2-dicarboxylate 
(209ff) 
The general procedure A was followed using dimethyl 
2-methyl-5-phenyl-1H-pyrrole- 3,4-dicarboxylate (208f) (137 mg, 
0.50 mmol), 3-hexyne (38f) (82.0 mg, 1.00 mmol) and Cu(OAc)2·H2O 
(30.0 mg, 30.0 mol %). After 22 h, purification by column chromatography 
on silica gel (n-hexane/ EtOAc: 10/1) yielded 209ff (152 mg, 86%) as a yellow oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.17 (d, J = 6.8 Hz, 1H), 7.71 (d, J = 6.7 Hz, 1H), 7.46−7.34 (m, 
2H), 3.99 (s, 3H), 3.88 (s, 3H), 3.21 (q, J = 7.4 Hz, 2H), 3.01 (s, 3H), 2.89 (q, J = 7.5 Hz, 2H), 
1.25 (t, J = 7.5 Hz, 3H), 1.24 (t, J = 7.4 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 168.8 (Cq), 165.7 (Cq), 155.7 (Cq), 128.6 (Cq), 128.5 (Cq), 127.6 
(Cq), 126.9 (CH), 126.8 (CH), 125.0 (Cq), 125.4 (CH), 125.4 (CH), 125.2 (Cq), 116.6 (Cq), 109.6 
(Cq), 52.4 (CH3), 51.6 (CH3), 21.6 (CH2), 20.9 (CH2), 14.9 (CH3), 14.4 (CH3), 14.4 (CH3). IR 
(ATR): ṽ = 2948, 1706, 1525, 1482, 1439, 1200, 1131, 1083, 784, 755 cm–1.  
MS (EI) m/z (relative intensity): 353 (76) [M
+
], 322 (38), 306 (100), 235 (74).  
HR-MS (EI) m/z calcd for C21H23NO4
+
 353.1627, found 353.1636. 
Synthesis of ethyl 5,6-diethyl-1-phenylpyrrolo[2,1-a]isoquinoline-2-carboxylate (209df) 
The general procedure A was followed using ethyl 2-methyl-4,5-diphenyl- 
1H-pyrrole-3-carboxylate (208d) (72.8 mg, 0.25 mmol), 3-hexyne (38f) 
(55.0 mg, 0.50 mmol) and Cu(OAc)2·H2O (15.0 mg, 30.0 mol %). After 22 h, 
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purification by column chromatography on silica gel (n-hexane/EtOAc: 20/1) yielded 209df 
(74 mg, 76%) as a white solid. M. p. = 141−138 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.01 (s, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.64−7.38 (m, 6H), 7.32 
(ddd, J = 7.7, 7.6, 1.3 Hz, 1H), 7.09 (ddd, J = 7.7, 7.6, 1.2 Hz, 1H), 4.16 (q, J = 7.4 Hz, 2H), 3.09 
(q, J = 7.6 Hz, 2H), 2.96 (q, J = 7.6 Hz, 2H), 1.45 (t, J = 7.6 Hz, 3H), 1.31 (t, J = 7.6 Hz, 3H), 1.11 
(t, J = 7.4 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.0 (Cq), 157.3 (Cq), 155.4 (Cq), 150.7 (CH), 128.5 (CH), 
127.6 (Cq), 127.0 (CH), 126.5 (Cq), 126.5 (Cq), 126.2 (CH), 125.8 (CH), 123.6 (CH), 123.3 (CH), 
120.8 (Cq), 119.6 (Cq), 117.7 (Cq), 116.4 (CH), 59.6 (CH2), 21.8 (CH2), 20.8 (CH2), 14.7 (CH3), 
14.0 (CH3), 11.7 (CH3).  
IR (ATR): ṽ = 2966, 1695, 1602, 1521, 1444, 1268, 1219, 1034, 757, 703 cm–1.  
MS (EI) m/z (relative intensity): 371 (100) [M
+
], 298 (23), 282 (20).  
HR-MS (EI) m/z calcd for C25H25NO2
+
 371.1885, found 371.1887. 
Synthesis of dimethyl 6-(n-butyl)-5-(4-methoxyphenyl)-3-methylpyrrolo[2,1-a]isoquinoline- 
1,2-di-caboxylate (209fg) 
The general procedure A was followed using dimethyl 
2-methyl-5-phenyl-1H-pyrrole- 3,4-dicarboxylate (208f) (137 mg, 
0.50 mmol), 1-(hex-1-yn-1-yl)-4-methoxybenzene (38g) (188 mg, 1.00 
mmol) and Cu(OAc)2·H2O (30 mg, 30.0 mol %). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 209fg 
(169 mg, 74%, 6:1 mixture of regioisomers according to 
1
H-NMR as a 
yellow oil. Purification by a second column chromatography on silica gel (n-hexane/EtOAc: 20/1) 
yielded the major regioisomer (146 mg, 64%) as a yellow solid.  
M. p. = 138−143 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.31−8.24 (d, J = 7.1 Hz, 1H), 7.76−7.71 (d, J = 7.0 Hz, 1H), 
7.50−7.45 (m, 2H), 7.27 (d, J = 10.8 Hz, 2H), 6.99 (d, J = 10.8 Hz, 2H), 4.00 (s, 3H), 3.90 (s, 3H), 
3.82 (s, 3H), 2.49 (t, J = 8.2 Hz, 2H), 1.92 (s, 3H), 1.52−1.39 (m, 2H), 1.31−1.18 (m, 2H), 0.76 (t, 
J = 7.3 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 168.9 (Cq), 165.6 (Cq), 160.0 (Cq), 133.2 (Cq), 132.0 (CH), 130.1 
(Cq), 127.6 (Cq), 127.5 (Cq), 127.4 (CH), 126.9 (CH), 125.3 (Cq), 124.1 (CH), 124.0 (Cq), 123.4 
(CH), 111.9 (Cq), 113.6 (CH), 112.2 (Cq), 109.0 (Cq), 55.3 (CH3), 52.5 (CH3), 51.6 (CH3), 32.3 
(CH2), 28.2 (CH2), 22.9 (CH2), 14.1 (CH3), 13.6 (CH3).  
IR (ATR): ṽ = 2954, 1705, 1604, 1525, 1509, 1438, 1240, 1171, 1021, 798 cm–1.  
MS (EI) m/z (relative intensity): 459 (100) [M
+
], 386 (70), 341 (60).  
HR-MS (EI) m/z calcd for C28H29NO5
+
 459.2046, found 459.2041. 
Synthesis of ethyl 6-butyl-5-(4-methoxyphenyl)pyrrolo[2,1-a]isoquinoline-2-carboxylate 
(209ag) 
The general procedure A was followed using 
ethyl 5-phenyl-1H-pyrrole-3-carboxylate (208a) (108 mg, 0.50 mmol), 
1-(hex-1-yn-1-yl)-4-methoxybenzene (38g) (188 mg, 1.00 mmol) and 
Cu(OAc)2·H2O (30.0 mg, 30.0 mol%). After 22 h, purification by column 
chromatography on silica gel (n-hexane/ EtOAc: 30/1) yielded 209ag 
(160 mg, 76%, 8:1 mixture of regioisomers according to 
1
H-NMR) as a 
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yellow oil. Purification by a second column chromatography on silica gel (n-hexane/EtOAc: 30/1) 
yielded the major regioisomer (95 mg, 47%) as a yellow oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 7.6 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.55−7.45 (m, 
2H), 7.40 (s, 1H), 7.51 (d, J = 8.4 Hz, 2H), 7.20 (s, 1H), 7.10 (d, J = 8.4 Hz, 2H), 4.52 (q, J = 
7.4 Hz, 2H), 3.92 (s, 3H), 2.60 (t, J = 8.0 Hz, 2H), 1.61−1.49 (m, 2H), 1.36 (t, J = 7.0 Hz, 3H), 
1.29 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ = 165.1 (Cq), 160.0 (Cq), 152.8 (Cq), 131.2 (CH), 130.4 (Cq), 127.2 
(CH), 127.1 (Cq), 126.2 (Cq), 126.2 (CH), 125.9 (Cq), 124.5 (CH), 122.6 (CH), 121.7 (Cq), 118.4 
(CH), 117.6 (Cq), 114.8 (CH), 100.9 (CH), 60.0 (CH2), 55.3 (CH3), 32.5 (CH2), 28.2 (CH2), 22.9 
(CH2), 14.4 (CH3), 13.7 (CH3). 
IR (ATR): ṽ = 2955, 1705, 1607, 1508, 1454, 1289, 1241, 1173, 1025, 751 cm–1.  
MS (EI) m/z (relative intensity): 401 (100) [M
+
], 358 (20), 285 (35).  
HR-MS (EI) m/z calcd for C26H27NO3
+
 401.1991, found 401.1989. 
Synthesis of ethyl 6-methyl-5-phenylpyrrolo[2,1-a]isoquinoline-2-carboxylate (209ah) 
The general procedure A was followed using ethyl 
5-phenyl-1H-pyrrole-3-carboxylate (108 mg, 0.50 mmol) (208a), 
1-phenyl-1-propyne (38h) (116 mg, 1.00 mmol) and Cu(OAc)2·H2O 
(30.0 mg, 30.0 mol%). After 22 h, purification by column chromatography 
on silica gel (n-hexane/EtOAc: 20/1) yielded 209ah (120 mg, 73%, 5:1 mixture of regioisomers 
according to 
1
H-NMR) as a yellow solid. Purification by a second column chromatography on 
silica gel (n-hexane/EtOAc: 30/1) yielded the major regioisomer (41 mg, 25%) as a yellow solid.  
M. p. = 114−111 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 7.8 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.60−7.38 (m, 
8H), 7.25 (d, J = 1.6 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 2.21 (s, 3H), 1.55 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ = 165.2 (Cq), 153.9 (Cq), 153.0 (Cq), 150.6 (Cq), 150.1 (CH), 129.6 
(CH), 129.5 (CH), 128.1 (Cq), 127.6 (CH), 126.5 (CH), 125.9 (Cq), 124.2 (CH), 122.5 (CH), 118.5 
(CH), 117.7 (Cq), 116.6 (Cq), 101.1 (CH), 60.0 (CH2), 15.0 (CH3), 14.4 (CH3).  
IR (ATR): ṽ = 2974, 1695, 1544, 1516, 1454, 1240, 1178, 1019, 747, 703 cm–1.  
MS (EI) m/z (relative intensity): 329 (100) [M
+
], 256 (55).  
HR-MS (EI) m/z calcd for C22H19NO2
+
 329.1416, found 329.1417. 
Intermolecular competition experiment with indoles 206b and 206o (Scheme 64a) 
 
A mixture of 2-(4-fluorophenyl)-1H-indole (206b) (219 mg, 1.00 mmol), 
2-(4-methoxyphenyl)-1H-indole (206o) (209 mg, 1.00 mmol), diphenylacetylene (38a) (89.0 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (10.0 mg, 10.0 mol %) 
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in t-AmOH (2.0 mL) was stirred at 100 °C under air for 22 h. At ambient temperature, the mixture 
was diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic 
phase was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and 
evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc: 50/1) to yield 207ba as a yellow solid (66 mg, 
34%). 
Intermolecular competition experiment with alkynes 38b and 38i (Scheme 64b) 
 
A mixture of 2-phenylindole (206a) (48.0 mg, 0.25 mmol), 1,2-di-(p-tolyl)ethyne (38i) (103 mg, 
0.50 mmol), 1,2-bis{4-(trifluoromethyl)phenyl}ethyne (38b) (157 mg, 0.50 mmol), 
[RuCl2(p-cymene)]2 (7.7 mg, 5.0 mol %) and Cu(OAc)2·H2O (5.0 mg, 10.0 mol %) in t-AmOH 
(2.0 mL) was stirred at 100 °C under air for 22 h. At ambient temperature, the mixture was diluted 
with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic phase was 
washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and evaporation of 
the solvents under reduced pressure, the crude product was purified by column chromatography on 
silica gel (n-hexane/EtOAc: 50/1) to yield 207ab as a yellow solid (43 mg, 34%). 
Annulation with meta-fluorophenyl-substituted indole 206p (Scheme 65) 
 
A mixture of 2-(3-fluorophenyl)-1H-indole (206p) (106 mg, 0.50 mmol), diphenylacetylene (38a) 
(178 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol%) and Cu(OAc)2·H2O (10.0 mg, 
10.0 mol %) in t-AmOH (2.0 mL) was stirred at 100 °C under air for 22 h. At ambient temperature, 
the mixture was diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined 
organic phase was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration 
and evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/CH2Cl2: 10/1) to yield 207'pa (78 mg, 40%) as yellow 
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4-Fluoro-5,6-diphenylindolo[2,1-a]isoquinoline (207'pa) 
M. p. = 209−210 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.12 (d, J = 7.8 Hz, 1H), 7.83 (d, J = 7.8 Hz, 
1H), 7.52−7.10 (m, 13H), 7.05 (dd, J = 12.4, 7.8 Hz, 1H), 6.88 (dd, J = 7.8, 
7.8 Hz, 1H), 5.96 (d, J = 8.8 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 159.1 (d, 
1
JC–F = 254 Hz, Cq), 138.7 (d, 
4
JC–F = 3 Hz, Cq), 137.5 
(Cq), 134.9 (d, 
4
JC–F = 3 Hz, Cq), 134.8 (Cq), 132.8 (Cq), 131.0 (CH), 130.9 (CH), 129.6 (Cq), 
128.7 (CH), 128.5 (CH), 128.0 (d, 
3
JC–F = 9 Hz, CH), 127.7 (d, 
3
JC–F = 4 Hz, Cq), 127.1 (CH), 
126.3 (CH), 121.9 (CH), 120.6 (CH), 120.4 (CH), 119.4 (d, 
4
JC–F = 4 Hz, CH), 118.6 (d, 
2
JC–
F = 9 Hz, Cq), 117.0 (d, 
4
JC–F = 3 Hz, Cq), 114.7 (CH), 114.4 (d, 
2
JC–F = 22 Hz, CH), 96.1 (CH). 
19
F-NMR (283 MHz, CDCl3): δ = −(107.8−108.9) (m).  
IR (ATR): ṽ = 3056, 1608, 1539, 1487, 1461, 1440, 1230, 773, 739, 693 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 309 (13).  
HR-MS (EI) m/z calcd for C28H18FN
+
 387.1383, found 387.1411. 
2-Fluoro-5,6-diphenylindolo[2,1-a]isoquinoline (207''pa) 
M. p. = 226−227 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.93 (dd, J = 9.7, 2.6 Hz, 1H), 7.81 (d, J = 
8.0 Hz, 1H), 7.43−7.27 (m, 6H), 7.27−7.09 (m, 7H), 7.05 (ddd, J = 8.8, 8.6, 2.6 
Hz, 1H), 6.84 (ddd, J = 8.0, 7.7, 1.3 Hz, 1H), 6.01 (d, J = 8.8 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3): δ = 161.8 (d, 
1
JC–F = 247 Hz, Cq), 136.7 (Cq), 
136.7 (Cq), 135.3 (Cq), 135.3 (Cq), 133.0 (Cq), 131.8 (CH), 131.0 (CH), 129.6 (Cq), 129 (CH), 
128.6 (CH), 128.5 (d, 
3
JC–F = 9 Hz, CH), 127.9 (CH), 127.2 (d, 
3
JC–F = 9 Hz, Cq), 126.9 (CH), 
126.8 (d, 
4
JC–F = 2 Hz, Cq), 121.9 (CH), 121.0 (Cq), 120.6 (CH), 120.5 (CH), 111.3 (CH, 
2
JC–F = 23 
Hz), 114.7 (CH), 108.7 (d, 
2
JC–F = 23 Hz, CH), 96.1 (CH). 
19
F-NMR (283 MHz, CDCl3): δ = −(113.7−113.8) (m).  
IR (ATR): ṽ = 3061, 1608, 1538, 1487, 1340, 1167, 956, 732, 694, 651 cm–1.  
MS (EI) m/z (relative intensity): 387 (100) [M
+
], 309 (9).  
HR-MS (EI) m/z calcd for C28H18FN
+ 
387.1383, found 387.1419.  
Aerobic oxidative annulation in [D]4-MeOH (Scheme 66a) 
 
A mixture of 5-nitro-2-phenyl-1H-indole (206d) (119 mg, 0.50 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and Cu(OAc)2 (9.1 mg, 10.0 mol %) in [D]4-MeOH (2.0 mL) was stirred at 
76 °C under air for 22 h. At ambient temperature, the crude mixture was evaporated under reduced 
pressure and purified by column chromatography on silica gel (n-hexane/EtOAc: 10/1) to yield 
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Aerobic oxidative annulation in [D]4-MeOH (Scheme 66b) 
 
A mixture of 5-nitro-2-phenyl-1H-indole (206d) (119 mg, 0.50 mmol), 4-octyne (38e) (110 mg, 
1.00 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2 (27.1 mg, 30.0 mol %) in 
[D]4-MeOH (2.0 mL) was stirred at 76 °C under air for 22 h. At ambient temperature, the mixture 
was diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic 
phase was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and 
evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1→10/1) to yield 207de (76 mg, 46%) as a 




8.4.2 Analytical Data for the Products of Ruthenium-Catalyzed Oxidative 
Annulation of Alkynes 38 with Enamines 210 
Synthesis of methyl 1-acetyl-4,5-diphenyl-1H-pyrrole-2-carboxylate (211aa) 
The general procedure C was followed using 2-acetamidoacrylate (210a) 
(71.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 
22 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 
10/1) yielded 211aa (111 mg, 70%) as a yellow oil. 
1




C-NMR (75 MHz, CDCl3): δ = 173.8 (Cq), 161.0 (Cq), 134.5 (Cq), 133.9 (Cq), 130.6 (Cq), 
130.6 (CH), 128.8 (CH), 128.5 (CH), 128.2 (CH), 128.0 (CH), 126.4 (CH), 124.8 (Cq), 122.9 (Cq), 
118.3 (CH), 51.8 (CH3), 28.8 (CH3).  
IR (ATR): ṽ = 3060, 2953, 1759, 1702, 1440, 1381, 1253, 1207, 756, 694 cm–1.  
MS (EI) m/z (relative intensity): 319 (18) [M
+
], 277 (100), 245 (33), 215 (34), 43 (27).  
HR-MS (EI) m/z calcd for C20H17NO3
+
 319.1206, found 319.1197.  
The spectral data were in accordance with those reported in the literature.
123a
 
Synthesis of methyl 4,5-diphenyl-1H-pyrrole-2-carboxylate (212aa) 
The general procedure C was followed using 
2-(2,2,2-trifluoroacetamido)acrylate (98.5 mg, 0.50 mmol), and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 212aa as a white solid 
(21 mg, 15%).  
M.p. = 174−175 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 9.56 (sbr, 1H), 7.55−7.18 (m, 10H), 7.07 (d, J = 2.8 Hz, 1H), 
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C-NMR (75 MHz, CDCl3): δ = 161.7 (Cq), 136.3 (Cq), 133.4 (Cq), 131.8 (Cq), 128.6 (CH), 128.4 
(CH), 128.3 (CH), 128.0 (CH), 127.9 (CH), 126.3 (CH), 124.1 (Cq), 122.0 (Cq), 116.8 (CH), 51.6 
(CH3).  
IR (ATR): ṽ = 3257, 1668, 1602, 1454, 1440, 1225, 1203, 1009, 762, 692 cm–1.  
MS (EI) m/z (relative intensity): 277 (100) [M
+
], 245 (72), 215 (70), 189 (28), 43 (20).  
HR-MS (EI) m/z calcd for C18H15NO2
+
 277.1103, found 277.1094. 
Synthesis of ethyl 1-acetyl-4,5-diphenyl-1H-pyrrole-2-carboxylate (211ba) 
The general procedure C was followed using ethyl 2-acetamidoacrylate (210b) 
(78.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 
22 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 
20/1) yielded 211ba (113 mg, 68%) as a white solid. 
M.p. = 94−95 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.49−7.26 (m, 5H), 7.25−7.03 (m, 6H), 4.36 (q, J = 7.2 Hz, 2H), 
3.00 (s, 3H), 1.39 (t, J = 7.2 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 173.9 (Cq), 160.6 (Cq), 134.4 (Cq), 134.0 (Cq), 130.7 (Cq), 130.7 
(CH), 128.8 (CH), 128.5 (CH), 128.2 (CH), 128.0 (CH), 126.4 (CH), 124.7 (Cq), 123.3 (Cq), 
118.2 (CH), 60.8 (CH2), 28.9 (CH3), 14.3 (CH3).  
IR (ATR): ṽ = 2998, 1753, 1697, 1499, 1460, 1258, 1219, 1190, 770, 701 cm–1.  
MS (EI) m/z (relative intensity): 333 (5) [M
+
], 291 (100), 245 (62), 215 (38), 189 (20).  
HR-MS (EI) m/z calcd for C21H19NO3
+
 333.1365, found 333.1356. 
Synthesis of isopropyl 1-acetyl-4,5-diphenyl-1H-pyrrole-2-carboxylate (211ca) 
The general procedure C was followed using isopropyl 2-acetamidoacrylate 
(210c) (85.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 210ca (111 mg, 66%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.38−7.27 (m, 5H), 7.21−7.11 (m, 6H), 5.21 (sept., J = 6.2 Hz, 
1H), 2.30 (s, 3H), 1.36 (d, J = 6.2 Hz, 6H).
  
13
C-NMR (75 MHz, CDCl3): δ = 173.9 (Cq), 160.2 (Cq), 134.2 (Cq), 134.0 (Cq), 130.7 (Cq), 130.7 
(CH), 128.8 (CH), 128.5 (CH), 128.2 (CH), 128.0 (CH), 126.3 (CH), 124.7 (Cq), 123.7 (Cq), 
118.0 (CH), 68.5 (CH), 28.9 (CH3), 21.9 (CH3).  
IR (ATR): ṽ = 3030, 1760, 1695, 1460, 1385, 1254, 1206, 1104, 757, 695 cm–1.  
MS (EI) m/z (relative intensity): 347 (9) [M
+
], 305 (100), 263 (70), 245 (77), 214 (47), 191 (22).  
HR-MS (EI) m/z calcd for C22H21NO3
+
 347.1521, found 347.1516. 
Synthesis of 1-acetyl-2-methyl-4,5-diphenyl-1H-pyrrole-3-carbonitrile (211fa) 
The general procedure C was followed using N-(1-cyanoprop-1-en-2-yl)acetamide 
(210f) (62.0 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 
10/1) yielded 211fa (65 mg, 43%) as a white solid. 
M.p. = 243−244 °C.  
1
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13
C-NMR (75 MHz, CDCl3): δ = 172.2 (Cq), 140.8 (Cq), 131.4 (Cq), 131.4 (Cq), 130.2 (CH), 129.6 
(Cq), 129.1 (CH), 129.0 (CH), 128.8 (CH), 128.3 (CH), 127.4 (CH), 125.4 (Cq), 111.6 (Cq), 97.2 
(Cq), 27.9 (CH3), 14.2 (CH3).  
IR (ATR): ṽ = 2977, 2198, 1521, 1441, 1362, 1072, 1003, 717, 703, 574 cm–1.  
MS (EI) m/z (relative intensity): 300 (20) [M
+
], 258 (100), 238 (20), 43 (32).  
HR-MS (EI) m/z calcd for C20H16N2O
+
 300.1263, found 300.1259.  
The spectral data were in accordance with those reported in the literature.
122
 
Synthesis of 1-(2,3,5-triphenyl-1H-pyrrol-1-yl)ethanone (211ga) 
The general procedure C was followed using N-(1-phenylvinyl)acetamide (210g) 
(76.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 
22 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 30/1) 
yielded 211ga (88 mg, 52%) as a yellow solid. 
M.p. = 131−132 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.46−7.40 (m, 4H), 7.38−7.33 (m, 6H), 7.21−7.14 (m, 5H), 6.54 
(s, 1H), 2.02 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.8 (Cq), 134.8 (Cq), 134.7 (Cq), 133.4 (Cq), 132.8 (Cq), 131.0 
(CH), 130.9 (Cq), 128.5 (CH), 128.4 (CH), 128.4 (CH), 128.1 (CH), 128.1 (CH), 128.1 (CH), 
127.6 (CH), 126.2 (CH), 125.5 (Cq), 113.6 (CH), 28.6 (CH3).  
IR (ATR): ṽ = 3061, 3029, 1721, 1620, 1485, 1288, 1268, 1026, 789, 762 cm–1.  
MS (EI) m/z (relative intensity): 337 (23) [M
+
], 295 (100), 189 (23), 43 (33).  
HR-MS (EI) m/z calcd for C24H19NO
+
 337.1467, found 337.1461. 
Synthesis of 1-{5-[4-(trifluoromethyl)phenyl]-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211ha) 
The general procedure C was followed using 
N-{1-[4-(trifluoromethyl)phenyl]vinyl}-acetamide (210h) (111 mg, 
0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 40/1) 
yielded 211ha (138 mg, 68%) as a white solid.  
M.p. = 133−134 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.67 (d, J = 8.2 Hz, 2H), 7.53 (d, J = 8.2 Hz, 2H), 7.43−7.33 (m, 
5H), 7.24−7.13 (m, 5H), 6.59 (s, 1H), 2.03 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.5 (Cq), 137.0 (Cq), 134.4 (Cq), 133.6 (Cq), 132.5 (Cq), 131.5 
(Cq), 130.9 (CH), 129.7 (q, 
2
JC–F = 32 Hz, Cq), 128.6 (CH), 128.5 (CH), 128.5 (CH), 128.2 (CH), 
128.1 (CH), 127.7 (q, 
1
JC–F = 273 Hz, Cq), 126.4 (CH), 125.9 (Cq), 125.3 (q, 
3
JC–F = 4 Hz, CH), 
114.8 (CH), 28.5 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −62.5 (s).  
IR (ATR): ṽ = 3063, 3032, 1723, 1615, 1268, 1111, 1064, 847, 766, 694 cm–1.  
MS (EI) m/z (relative intensity): 405 (18) [M
+
], 363 (100), 293 (4), 189 (10), 43 (15).  
HR-MS (EI) m/z calcd for C25H18F3NO
+
 405.1340, found 405.1346. 
Synthesis of 1-{5-(4-fluorophenyl)-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211ia) 
The general procedure C was followed using 
N-{1-(4-fluorophenyl)vinyl}acetamide (210i) (89.5 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
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column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 211ia (94 mg, 53%) as a 
white solid.  
M.p. = 144−145 °C.  
1




C-NMR (75 MHz, CDCl3): δ = 172.7 (Cq), 162.3 (d, 
1
JC–F = 248 Hz, Cq), 134.7 (Cq), 133.9 (Cq), 
132.8 (Cq), 130.8 (CH), 130.7 (Cq), 130.4 (d, 
3
JC–F = 8 Hz, CH), 129.5 (d, 
4
JC–F = 3 Hz, Cq), 128.5 
(CH), 128.2 (CH), 128.2 (CH), 128.1 (CH), 126.3 (CH), 125.5 (Cq), 111.4 (d, 
2
JC–F = 21 Hz, CH), 
113.7 (CH), 28.6 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(114.1−114.2) (m).  
IR (ATR): ṽ = 3024, 1722, 1585, 1493, 1365, 1279, 958, 840, 767, 694 cm–1.  
MS (EI) m/z (relative intensity): 355 (15) [M
+
], 313 (100), 207 (7), 189 (7), 43 (13).  
HR-MS (EI) m/z calcd for C24H18FNO
+
 355.1372, found 355.1384. 
Synthesis of 1-{5-(4-bromophenyl)-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211ja) 
The general procedure C was followed using 
N-{1-(4-bromophenyl)vinyl}acetamide (210j) (119 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 211ja 
(120 mg, 58%) as a white solid.  
M.p. = 120−121 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.54 (d, J = 8.6 Hz, 2H), 7.40−7.34 (m, 5H), 7.31 (d, J = 8.6 Hz, 
2H), 7.23−7.14 (m, 5H), 6.53 (s, 1H), 2.02 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.5 (Cq), 134.5 (Cq), 133.7 (Cq), 132.6 (Cq), 132.3 (Cq), 131.5 
(CH), 131.0 (Cq), 130.8 (CH), 130.0 (CH), 128.5 (CH), 128.2 (CH), 128.1 (CH), 128.1 (CH), 
126.3 (CH), 125.7 (Cq), 121.6 (Cq), 114.0 (CH), 28.5 (CH3).  
IR (ATR): ṽ = 3060, 3026, 1722, 1585, 1482, 1365, 1278, 1069, 1011, 743 cm–1.  








Br), 373 (100), 293 (20), 
189 (27), 43 (52).  
HR-MS (EI) m/z calcd for C24H18BrNO
+
 415.0572, found 415.0589. 
Synthesis of 4-(1-acetyl-4,5-diphenyl-1H-pyrrol-2-yl)benzonitrile (211ka) 
The general procedure C was followed using 
N-{1-(4-cyanophenyl)vinyl}acetamide (210k) (93.0 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1) yielded 211ka 
(134 mg, 74%) as a yellow solid.  
M.p. = 145−146 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.66 (d, J = 8.5 Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H), 7.41−7.31 (m, 
5H), 7.21−7.10 (m, 5H), 6.59 (s, 1H), 2.00 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.4 (Cq), 138.0 (Cq), 134.2 (Cq), 133.3 (Cq), 132.3 (Cq), 132.0 
(CH), 132.0 (Cq), 130.9 (CH), 128.7 (CH), 128.7 (CH), 128.7 (CH), 128.2 (CH), 128.1 (CH), 
126.6 (CH), 126.2 (Cq), 118.8 (Cq), 111.4 (CH), 110.7 (Cq), 28.4 (CH3).  
IR (ATR): ṽ = 3061, 2103, 1731, 1603, 1490, 1267, 1208, 824, 696, 552 cm–1.  
MS (EI) m/z (relative intensity): 362 (10) [M
+
], 320 (100), 214 (6), 189 (8), 43 (15).  
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HR-MS (EI) m/z calcd for C25H18N2O
+
 362.1419, found 362.1416. 
Synthesis of 1-{5-(4-nitrophenyl)-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211la) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (211l) (103 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1) yielded 211la 
(136 mg, 71%) as a yellow solid.  
M.p. = 184−185 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.27 (d, J = 8.6 Hz, 2H), 7.55 (d, J = 8.6 Hz, 2H), 7.44−7.32 (m, 
5H), 7.24−7.11 (m, 5H), 6.66 (s, 1H), 2.03 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.3 (Cq), 146.6 (Cq), 139.9 (Cq), 134.1 (Cq), 133.0 (Cq), 132.3 
(Cq), 132.2 (Cq), 130.9 (CH), 128.8 (CH), 128.8 (CH), 128.7 (CH), 128.3 (CH), 128.1 (CH), 126.6 
(CH), 126.4 (Cq), 123.6 (CH), 111.9 (CH), 28.4 (CH3).  
IR (ATR): ṽ = 3104, 1733, 1595, 1508, 1338, 1264, 1206, 784, 692, 491 cm–1.  
MS (EI) m/z (relative intensity): 382 (10) [M
+
], 340 (100), 310 (17), 294 (30), 189 (20), 43 (50).  
HR-MS (EI) m/z calcd for C24H18N2O3
+
 382.1317, found 382.1330. 
Synthesis of 1-{2,3-diphenyl-5-(p-tolyl)-1H-pyrrol-1-yl}ethanone (211ma) 
The general procedure C was followed using N-{1-(p-tolyl)vinyl}acetamide 
(210m) (87.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 
1.00 mmol). After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1) yielded 211ma (32 mg, 18%) as a white solid.  
M.p. = 104−105 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.44−7.30 (m, 7H), 7.26−7.13 (m, 7H), 6.53 (s, 1H), 2.38 (s, 
3H), 2.05 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.9 (Cq), 137.5 (Cq), 134.9 (Cq), 134.8 (Cq), 132.9 (Cq), 130.9 
(CH), 130.6 (Cq), 130.5 (Cq), 129.2 (CH), 128.3 (CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 128.0 
(CH), 126.1 (CH), 125.4 (Cq), 113.2 (CH), 28.6 (CH3), 21.2 (CH3).  
IR (ATR): ṽ = 3050, 1723, 1601, 1495, 1276, 1206, 957, 764, 694, 546 cm–1.  
MS (EI) m/z (relative intensity): 351 (13) [M
+
], 309 (100), 189 (7), 43 (10).  
HR-MS (EI) m/z calcd for C25H21NO
+
 351.1623, found 351.1627. 
Synthesis of 1-{5-(4-methoxyphenyl)-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211na) 
The general procedure C was followed using 
N-{1-(4-methoxyphenyl)vinyl}acetamide (210n) (95.5 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1) yielded 
211na (52 mg, 28%) as a white solid.  
M.p. = 105−106 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.38−7.32 (m, 7H), 7.23−7.11 (m, 5H), 6.97 (d, J = 8.4 Hz, 2H), 
6.48 (s, 1H), 3.86 (s, 3H), 2.03 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.9 (Cq), 159.2 (Cq), 134.9 (Cq), 134.6 (Cq), 132.9 (Cq), 130.9 
(CH), 130.4 (Cq), 129.8 (CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 127.9 (CH), 126.1 (CH), 
125.8 (Cq), 125.4 (Cq), 113.9 (CH), 113.0 (CH), 55.3 (CH3), 28.6 (CH3).  
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IR (ATR): ṽ = 3058, 3028, 1730, 1599, 1281, 1246, 1174, 1023, 764, 694 cm–1.  
MS (EI) m/z (relative intensity): 367 (30) [M
+
], 325 (100), 310 (27), 276 (13), 178 (14), 43 (52).  
HR-MS (EI) m/z calcd for C25H21NO2
+
 367.1572, found 367.1562. 
Synthesis of 1-{5-[3-(trifluoromethyl)phenyl]-2,3-diphenyl-1H-pyrrol-1-yl}ethanone (211oa) 
The general procedure C was followed using 
N-{1-[3-(trifluoromethyl)phenyl]vinyl}-acetamide (210o) (111 mg, 
0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
30/1) yielded 211oa (146 mg, 72%) as a white solid.  
M.p. = 111−112 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.70 (s, 1H), 7.59 (d, J = 7.3 Hz, 1H), 7.59 (d, J = 7.8 Hz, 1H), 
7.50 (dd, J = 7.8, 7.3 Hz, 1H), 7.38−7.31 (m, 5H), 7.22−7.12 (m, 5H), 6.56 (s, 1H), 1.99 (s, 3H).
 
13
C-NMR (75 MHz, CDCl3): δ = 172.4 (Cq), 134.4 (Cq), 134.3 (Cq), 133.6 (Cq), 132.6 (Cq), 131.8 
(q, 
4
JC–F = 1 Hz, CH), 131.2 (Cq), 130.9 (CH), 130.7 (q, 
2
JC–F = 32 Hz, Cq), 128.7 (CH), 128.6 
(CH), 128.4 (CH), 128.2 (CH), 128.2 (CH), 127.7 (q, 
1
JC–F = 272 Hz, Cq), 126.4 (CH), 125.9 (Cq), 
125.3 (q, 
3
JC–F = 4 Hz, CH), 124.1 (q, 
3
JC–F = 4 Hz, CH), 114.7 (CH), 28.5 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −62.7 (s).  
IR (ATR): ṽ = 3072, 1733, 1585, 1446, 1365, 1119, 1111, 1072, 763, 693 cm–1.  
MS (EI) m/z (relative intensity): 405 (10) [M
+
], 363 (100), 189 (9), 43 (12).  
HR-MS (EI) m/z calcd for C25H18F3NO
+
 405.1340, found 405.1327. 
Synthesis of 1-{2,3-diphenyl-5-(o-tolyl)-1H-pyrrol-1-yl}ethanone (211pa) 
The general procedure C was followed using N-{1-(o-tolyl)vinyl}acetamide 
(210p) (87.5 mg, 0.50 mmol) and diphenylacetylene (38) (178 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 211pa (120 mg, 68%) as a yellow solid.  
M.p. = 145−146 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.46−7.15 (m, 14H), 6.45 (s, 1H), 2.37 (s, 3H), 1.94 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.6 (Cq), 137.6 (Cq), 137.6 (Cq), 134.8 (Cq), 133.8 (Cq), 133.7 
(Cq), 133.3 (Cq), 130.7 (CH), 130.3 (CH), 129.9 (CH), 128.4 (CH), 128.3 (CH), 128.1 (CH), 128.1 
(CH), 127.8 (CH), 126.1 (CH), 125.6 (CH), 125.5 (Cq), 113.7 (CH), 27.6 (CH3), 20.2 (CH3).  
IR (ATR): ṽ = 3053, 1733, 1615, 1445, 1318, 1267, 1111, 1071, 762, 692 cm–1.  
MS (EI) m/z (relative intensity): 351 (25) [M
+
], 309 (100), 230 (11), 202 (12), 191 (10), 43 (65).  
HR-MS (EI) m/z calcd for C25H21NO
+
 351.1623, found 351.1634. 
Synthesis of 1-{2,3-diphenyl-5-(pyridin-3-yl)-1H-pyrrol-1-yl}ethanone (211qa) 
The general procedure C was followed using 
N-{1-(pyridin-3-yl)vinyl}acetamide (211q) (81.0 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 3/1) yielded 211qa 
(54 mg, 32%) as a yellow solid.  
M.p. = 100−101 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.71 (s, 1H), 7.57 (d. J = 5.2 Hz, 1H), 7.75 (dt, J = 7.8, 1.6 Hz, 
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13
C-NMR (75 MHz, CDCl3): δ = 172.2 (Cq), 149.2 (CH), 148.4 (CH), 136.1 (CH), 134.3 (Cq), 
132.6 (Cq), 131.7 (Cq), 131.2 (Cq), 130.7 (CH), 129.5 (Cq), 128.7 (CH), 128.4 (CH), 128.2 (CH), 
128.1 (CH), 126.4 (CH), 126.0 (Cq), 122.8 (CH), 114.8 (CH), 28.3 (CH3).  
IR (ATR): ṽ = 3060, 3030, 1720, 1672, 1599, 1571, 1267, 1208, 764, 693 cm–1.  
MS (EI) m/z (relative intensity): 338 (20) [M
+
], 296 (100), 191 (11), 43 (12).  
HR-MS (EI) m/z calcd for C23H18N2O
+
 338.1419, found 338.1410. 
Synthesis of 1-{2,3-diphenyl-5-(thiophen-2-yl)-1H-pyrrol-1-yl}ethanone (211ra) and 
2,3-diphenyl-5-(thiophen-2-yl)-1H-pyrrole (212ra) 
The general procedure C was followed using N-{1-(thiophen-2-yl)vinyl}acetamide (210r) 
(83.5 mg, 0.50 mmol) and diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 211ra (57 mg, 33%) as a 
yellow solid and 212ra (46 mg, 30%) as a yellow solid.  
1-{2,3-diphenyl-5-(thiophen-2-yl)-1H-pyrrol-1-yl}ethanone (211ra): 
M.p. = 171−172 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.38−7.29 (m, 6H), 7.21−7.12 (m, 6H), 7.06 
(dd, J = 5.1, 5.1 Hz, 1H), 6.59 (s, 1H), 2.02 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.8 (Cq), 134.6 (Cq), 134.0 (Cq), 132.6 (Cq), 
131.0 (Cq), 130.6 (CH), 128.5 (CH), 128.2 (CH), 128.2 (CH), 128.1 (CH), 127.6 (CH), 127.2 
(CH), 127.1 (Cq), 126.3 (CH), 126.1 (CH), 125.6 (Cq), 114.8 (CH), 28.3 (CH3).  
IR (ATR): ṽ = 3097, 1722, 1600, 1496, 1363, 1277, 1197, 1028, 767, 695 cm–1.  
MS (EI) m/z (relative intensity): 343 (13) [M
+
], 301 (100), 267 (10), 197 (10), 43 (17).  
HR-MS (EI) m/z calcd for C22H17NOS
+
 343.1031, found 343.1043. 
2,3-Diphenyl-5-(thiophen-2-yl)-1H-pyrrole (212ra): 
M.p. = 92−94 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.27 (sbr, 1H), 7.44−7.16 (m, 11H), 7.11 (d, J = 
3.5 Hz, 1H), 7.05 (dd, J = 5.1, 5.1 Hz, 1H), 6.61 (d, J = 2.7 Hz, 1H).
  
13
C-NMR (75 MHz, CDCl3): δ = 136.0 (Cq), 135.6 (Cq), 132.8 (Cq), 128.9 (Cq), 
128.7 (CH), 128.4 (CH), 128.3 (CH), 127.7 (CH), 127.4 (CH), 127.0 (CH), 126.9 (Cq), 126.0 
(CH), 123.6 (Cq), 123.0 (CH), 121.1 (CH), 109.2 (CH).  
IR (ATR): ṽ = 3411, 3055, 3024, 1600, 1492, 1439, 1199, 1070, 759, 689 cm–1.  
MS (EI) m/z (relative intensity): 301 (100) [M
+
], 267 (7), 197 (10).  
HR-MS (EI) m/z calcd for C20H15NS
+
 301.0925, found 301.0939. 
Synthesis of (E)-2,3-diphenyl-5-styryl-1H-pyrrole (212sa) 
The general procedure C was followed using 
(E)-N-(4-phenylbuta-1,3-dien-2-yl)acetamide (210s) (87.5 mg, 0.50 mmol) and 
diphenylacetylene (38a) (178 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 211sa (78 mg, 48%) as a 
yellow solid.  
M.p. = 87−88 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.35 (sbr, 1H), 7.54−7.44 (m, 2H), 7.38−7.23 (m, 13 H), 7.01 (d, 
J = 16.6 Hz, 1H), 6.77 (d, J = 16.6 Hz, 1H), 6.55 (d, J = 2.7 Hz, 1H).
  
13
C-NMR (75 MHz, CDCl3): δ = 137.3 (Cq), 136.2 (Cq), 132.8 (Cq), 130.9 (Cq), 129.5 (Cq), 128.7 
(CH), 128.7 (CH), 128.4 (CH), 128.3 (CH), 127.4 (CH), 127.1 (CH), 127.0 (CH), 125.9 (CH), 
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125.9 (CH), 123.9 (CH), 123.8 (Cq), 118.3 (CH), 111.7 (CH).  
IR (ATR): ṽ = 3058, 3026, 2951, 2925, 1684, 1598, 1504, 1447, 1261, 760, 693 cm–1.  
MS (EI) m/z (relative intensity): 321 (100) [M
+
], 243 (9), 213 (8).  
HR-MS (EI) m/z calcd for C24H19N
+
 321.1517, found 321.1519. 
Synthesis of 1-{5-(4-nitrophenyl)-2,3-di-p-tolyl-1H-pyrrol-1-yl}ethanone (211li) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and 1,2-di-p-tolylacetylene (38i) (206 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 211li (130 mg, 63%) as a yellow 
solid.  
M.p. = 143−144 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.23 (d, J = 8.6 Hz, 2H), 7.52 (d, J = 8.6 Hz, 2H), 7.24 (d, J = 
8.2 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.2 Hz, 2H), 7.01 (d, J = 8.0 Hz, 2H), 6.61 (s, 
1H), 2.39 (CH3), 2.28 (CH3), 2.01 (CH3).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.5 (Cq), 146.4 (Cq), 140.1 (Cq), 138.7 (Cq), 136.2 (Cq), 132.8 
(Cq), 132.2 (Cq), 131.2 (Cq), 130.7 (CH), 129.5 (CH), 129.3 (Cq), 129.0 (CH), 128.6 (CH), 
127.9 (CH), 126.1 (Cq), 123.6 (CH), 116.0 (CH), 28.4 (CH3), 21.4 (CH3), 21.1 (CH3).  
IR (ATR): ṽ = 3025, 2905, 1723, 1593, 1502, 1334, 1262, 1108, 817, 752 cm–1.  
MS (EI) m/z (relative intensity): 410 (20) [M
+
], 368 (100), 322 (23), 43 (17).  
HR-MS (EI) m/z calcd for C26H22N2O3
+
 410.1630, found 410.1633. 
Synthesis of 1-{2,3-bis(4-methoxyphenyl)-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone (211lj) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and 1,2-bis(4-methoxyphenyl)ethyne (38j) (238 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1) yielded 210lj (111 mg, 52%) as a yellow 
solid.  
M.p. = 117−118 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.22 (d, J = 8.8 Hz, 2H), 7.51 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 
8.8 Hz, 2H), 7.08 (d, J = 8.7 Hz, 2H), 6.92 (d, J = 8.7 Hz, 2H), 6.75 (d, J = 8.8 Hz, 2H), 6.59 (s, 
1H), 3.84 (s, 3H), 3.75 (s, 3H), 2.01 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.4 (Cq), 159.8 (Cq), 158.3 (Cq), 146.4 (Cq), 140.1 (Cq), 132.7 
(Cq), 132.2 (CH), 131.8 (Cq), 129.1 (CH), 128.5 (CH), 126.6 (Cq), 125.9 (Cq), 124.4 (Cq), 123.6 
(CH), 111.9 (CH), 114.2 (CH), 113.7 (CH), 55.2 (CH3), 55.1 (CH3), 28.4 (CH3).  
IR (ATR): ṽ = 2952, 2836, 1726, 1595, 1515, 1493, 1339, 1245, 1029, 752 cm–1.  
MS (EI) m/z (relative intensity): 438 (26) [M
+
], 400 (100), 385 (23), 354 (17), 339 (15), 43 (26).  
HR-MS (EI) m/z calcd for C26H22N2O5
+
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Synthesis of 1-{2,3-bis[4-(trifluoromethyl)phenyl]-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone 
(211lb) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and 1,2-bis{4-(trifluoromethyl)phenyl}acetylene (38b) (314 mg, 
1.00 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1) yielded 211lb (174 mg, 67%) as a 
yellow solid.  
M.p. = 161−162 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.30 (d, J = 8.9 Hz, 2H), 7.68 (d, J = 7.2 Hz, 2H), 7.60 (d, J = 
8.4 Hz, 2H), 7.54−7.43 (m, 4H), 7.22 (d, J = 8.4 Hz, 2H), 6.68 (s, 1H), 2.07 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.7 (Cq), 147.0 (Cq), 139.0 (Cq), 137.3 (q, 
4
JC–F = 1 Hz, Cq), 
135.2 (q, 
4
JC–F = 1 Hz, Cq), 133.5 (Cq), 131.3 (Cq), 131.2 (CH), 130.8 (
2
JC–F = 32 Hz, Cq), 128.9 (q, 
2
JC–F = 32 Hz, Cq), 128.7 (CH), 128.3 (CH), 125.8 (Cq), 125.7 (q, 
3
JC–F = 4 Hz, CH), 125.4 (q, 
3
JC–
F = 4 Hz, CH), 124.1 (d, 
1
JC–F = 272 Hz, Cq), 123.9 (CH), 123.7 (q, 
1
JC–F = 272 Hz, Cq), 111.5 
(CH), 28.8 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −62.6 (s), −62.7 (s).  
IR (ATR): ṽ = 1727, 1613, 1593, 1514, 1338, 1321, 1265, 1117, 854, 832 cm–1.  
MS (EI) m/z (relative intensity): 518 (4) [M
+
], 476 (100), 446 (28), 430 (30), 43 (52).  
HR-MS (EI) m/z calcd for C26H16F6N2O3
+
 518.1065, found 518.1081. 
Synthesis of 1-{2,3-bis(4-fluorophenyl)-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone (211lk) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and 1,2-bis(4-fluorophenyl)acetylene (38k) (212 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1) yielded 211lk (140 mg, 67%) as a yellow 
solid.  
M.p. = 172−173 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.25 (d, J = 9.0 Hz, 2H), 7.53 (d, J = 9.0 Hz, 2H), 7.31 (dd, J = 
8.8, 8.4 Hz, 2H), 7.14−7.03 (m, 4H), 6.90 (dd, J = 8.8, 8.7 Hz, 2H), 6.59 (s, 1H), 2.04 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.0 (Cq), 162.7 (d, 
1
JC–F = 251 Hz, Cq), 161.9 (d, 
1
JC–F = 
245 Hz, Cq), 146.7 (Cq), 139.6 (Cq), 132.9 (Cq), 132.9 (d, 
3
JC–F = 8 Hz, CH), 131.2 (Cq), 130.0 (d, 
4
JC–F = 3 Hz, Cq), 129.7 (d, 
3
JC–F = 8 Hz, CH), 128.5 (CH), 127.9 (d, 
4
JC–F = 3 Hz, Cq), 125.8 (Cq), 
123.8 (CH), 116.0 (d, 
2
JC–F = 22 Hz, CH), 111.7 (CH), 111.3 (d, 
2
JC–F = 22 Hz, CH), 28.5 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(114.4−114.7) (m), −(111.2−111.5) (m).  
IR (ATR): ṽ = 1721, 1595, 1492, 1333, 1217, 1118, 1104, 847, 816, 523 cm–1.  
MS (EI) m/z (relative intensity): 418 (10) [M
+
], 376 (100), 346 (20), 330 (30), 207 (12), 43 (20).  
HR-MS (EI) m/z calcd for C24H16F2N2O3
+
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Synthesis of 1-{2,3-bis(4-chlorophenyl)-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone (211lc) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and 1,2-bis(4-chlorophenyl)acetylene (38c) (247 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 211lc (154 mg, 68%) as a yellow 
solid.  
M.p. = 117−118 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.25 (d, J = 8.6 Hz, 2H), 7.54 (d, J = 8.6 Hz, 2H), 7.37 (d, J = 
8.6 Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H), 7.19 (d, J = 8.6 Hz, 2H), 7.04 (d, J = 8.6 Hz, 2H), 6.59 (s, 
1H), 2.04 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.8 (Cq), 146.7 (Cq), 139.3 (Cq), 135.0 (Cq), 133.1 (Cq), 132.6 
(Cq), 132.3 (Cq), 132.1 (CH), 131.2 (Cq), 130.2 (Cq), 129.3 (CH), 129.0 (CH), 128.6 (CH), 
128.5 (CH), 125.6 (Cq), 123.7 (CH), 111.5 (CH), 28.7 (CH3).  
IR (ATR): ṽ = 3104, 1729, 1514, 1486, 1341, 1257, 1091, 1012, 832 cm–1.  
MS (EI) m/z (relative intensity): 450 (9) [M
+
], 408 (100), 378 (20), 362 (28), 327 (13), 291 (15), 
189 (12), 43 (43).  
HR-MS (EI) m/z calcd for C24H16Cl2N2O3
+
 450.0538, found 450.0539. 
Synthesis of diethyl 4,4'-{1-acetyl-5-(4-nitrophenyl)-1H-pyrrole-2,3-diyl}dibenzoate (211ll) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) 
and diethyl 4,4'-(ethyne-1,2-diyl)dibenzoate (38l) (322 mg, 
1.00 mmol). After 22 h, purification by column chromatography 
on silica gel (n-hexane/EtOAc: 5/1) yielded 211ll (168 mg, 64%) 
as a yellow solid.  
M.p. = 188−189 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.26 (d. J = 9.0 Hz, 2H), 8.06 (d, J = 8.2 Hz, 2H), 7.87 (d, J = 
8.2 Hz. 2H), 7.56 (d, J = 9.0 Hz, 2H), 7.40 (d, J = 8.7 Hz, 2H), 7.16 (d, J = 8.7 Hz, 2H), 6.66 (s, 
1H), 4.39 (q, J = 7.2 Hz, 2H), 4.32 (q, J = 7.2 Hz, 2H), 2.04 (s, 3H), 1.40 (t, J = 7.2 Hz, 3H), 1.37 
(t, J = 7.2 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.8 (Cq), 166.1 (Cq), 165.8 (Cq), 146.9 (Cq), 139.2 (Cq), 138.4 
(Cq), 136.2 (Cq), 133.5 (Cq), 131.8 (Cq), 130.7 (CH), 129.8 (CH), 129.6 (CH), 128.8 (CH), 128.7 
(Cq), 128.7 (Cq), 127.9 (CH), 126.1 (Cq), 123.7 (CH), 111.5 (CH), 61.3 (CH2), 61.0 (CH2), 28.7 
(CH3), 14.4 (CH3), 14.4 (CH3).  
IR (ATR): ṽ = 2995, 1723, 1707, 1594, 1514, 1341, 1269, 1104, 1024, 752 cm–1.  
MS (EI) m/z (relative intensity): 526 (7) [M
+
], 484 (100), 454 (38), 438 (17), 291 (11), 43 (77).  
HR-MS (EI) m/z calcd for C30H26N2O7
+
 526.1740, found 526.1735. 
Synthesis of 1-{2,3-bis(3-chlorophenyl)-5-(4-nitrophenyl)-1H-pyrrol-1-yl}ethanone (211lm) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) and 
1,2-bis(3-chlorophenyl)acetylene (38m) (247 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
20/1) yielded 211lm (152 mg, 67%) as a yellow solid.  
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M.p. = 120−121 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.25 (d, J = 9.0 Hz, 2H), 7.54 (d, J = 9.0 Hz, 2H), 7.38−7.30 (m, 
3H), 7.24 (dt, J = 7.2, 1.4 Hz, 1H), 7.18 (s, 1H), 7.16−7.08 (m, 2H), 6.94 (dt, J = 7.2, 1.7 Hz, 1H), 
6.61 (s, 1H), 2.06 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.8 (Cq), 146.9 (Cq), 139.4 (Cq), 135.6 (Cq), 134.7 (Cq), 134.3 
(Cq), 133.5 (Cq), 133.3 (Cq), 131.0 (Cq), 130.8 (CH), 130.0 (CH), 129.6 (CH), 129.2 (CH), 129.1 
(CH), 128.7 (CH), 128.2 (CH), 126.9 (CH), 126.2 (CH), 125.6 (Cq), 123.8 (CH), 111.5 (CH), 28.6 
(CH3).  
IR (ATR): ṽ = 3062, 1749, 1593, 1565, 1508, 1340, 1200, 1096, 853, 789 cm–1.  
MS (EI) m/z (relative intensity): 450 (10) [M
+
], 408 (100), 362 (22), 327 (15), 291 (15), 43 (39).  
HR-MS (EI) m/z calcd for C24H16Cl2N2O3
+
 450.0538, found 450.0534. 
Synthesis of methyl 1-acetyl-4,5-di(naphthalen-1-yl)-1H-pyrrole-2-carboxylate (211an) 
The general procedure C was followed using methyl 2-acetamidoacrylate 
(210a) (71.5 mg, 0.50 mmol),  and 1,2-di(naphthalen-1-yl)acetylene (38n) 
(278 mg, 1.00 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 10/1) yielded 211an (120 mg, 57%) as a white 
solid.  
M.p. = 176−181 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.11 (d, J = 7.2 Hz, 1H), 7.84−7.71 (m, 3H), 7.70−7.55 (m, 2H), 
7.52−7.27 (m 7H), 7.16−7.03 (m, 2H), 3.93 (s, 3H), 2.16 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 172.7 (Cq), 161.4 (Cq), 134.6 (Cq), 133.5 (Cq), 133.2 (Cq), 133.1 
(Cq), 132.3 (Cq), 131.5 (Cq), 129.8 (CH), 129.5 (CH), 128.3 (CH), 128.2 (Cq), 128.2 (CH), 127.6 
(CH), 127.5 (CH), 126.7 (CH), 126.1 (CH), 125.9 (CH), 125.7 (CH), 125.6 (CH), 125.3 (CH), 
125.1 (Cq), 125.0 (CH), 124.9 (CH), 123.8 (Cq), 121.4 (CH), 52.0 (CH3), 27.7 (CH3).  
IR (ATR): ṽ = 3056, 1744, 1708, 1486, 1382, 1249, 1230, 760, 775 cm–1.  
MS (EI) m/z (relative intensity): 419 (16) [M
+
], 377 (100), 317 (70), 289 (25), 163 (7).  
HR-MS (EI) m/z calcd for C29H21NO3
+
 419.1521, found 419.1519. 
Synthesis of methyl 1-acetyl-4,5-dipropyl-1H-pyrrole-2-carboxylate (211ae) 
The general procedure C was followed using methyl 2-acetamidoacrylate 
(210a) (71.5 mg, 0.50 mmol), and 4-octyne (38e) (110 mg, 1.00 mmol). After 
22 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 
20/1) yielded 211ae (72 mg, 57%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 6.82 (s, 1H), 3.76 (s, 3H), 2.57 (t, J = 7.6 Hz, 2H), 2.50 (s, 3H), 
2.32 (t, J = 7.4 Hz, 2H), 1.63−1.43 (m, 4H), 0.93 (t, J = 7.2 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 174.0 (Cq), 161.1 (Cq), 138.4 (Cq), 123.3 (Cq), 121.5 (Cq), 
121.4 (CH), 51.5 (CH3), 28.5 (CH3), 27.4 (CH2), 27.0 (CH2), 23.6 (CH2), 23.6 (CH2), 13.9 (CH3), 
13.9 (CH3).  
IR (ATR): ṽ = 2960, 1738, 1702, 1478, 1437, 1374, 1227, 1186, 1054, 762 cm–1.  
MS (EI) m/z (relative intensity): 251 (5) [M
+
], 207 (36), 176 (100), 148 (25), 43 (34).  
HR-MS (EI) m/z calcd for C14H21NO3
+
 251.1521, found 251.1525.  
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Synthesis of methyl 1-acetyl-4,5-diethyl-1H-pyrrole-2-carboxylate (211af) 
The general procedure C was followed using methyl 2-acetamidoacrylate (210a) 
(71.5 mg, 0.50 mmol), and 3-hexyne (38f) (82 mg, 1.00 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 20/1) 
yielded 211af (76 mg, 71%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 6.84 (s, 1H), 3.79 (s, 3H), 2.62 (q, J = 7.2 Hz, 2H), 2.50 (s, 3H), 
2.37 (q, J = 7.2 Hz, 2H), 1.14 (t, J = 7.2 Hz, 3H), 1.11 (t, J = 7.2 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 173.9 (Cq), 161.0 (Cq), 139.4 (Cq), 124.3 (Cq), 121.4 (Cq), 120.9 
(CH), 51.5 (CH3), 28.4 (CH3), 18.4 (CH2), 18.4 (CH2), 14.9 (CH3), 14.7 (CH3).  
IR (ATR): ṽ = 2966, 1738, 1698, 1481, 1437, 1378, 1239, 1186, 940, 762 cm–1.  
MS (EI) m/z (relative intensity): 219 (5) [M
+
], 181 (52), 166 (100), 134 (43).  
HR-MS (EI) m/z calcd for C12H17NO3
+
 219.1206, found 219.1208. 
Synthesis of 1-{3-methyl-5-(4-nitrophenyl)-2-phenyl-1H-pyrrol-1-yl}ethanone (211lh) 
The general procedure C was followed using 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol) and 
propyn-1-benzene (38h) (116 mg, 1.00 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 211lh 
(72 mg, 45%) as a yellow solid.  
M.p. = 149−150 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.19 (d, J = 8.9 Hz, 2H), 7.50−7.38 (m, 5H), 7.36−7.28 (m, 2H), 
6.32 (s, 1H), 1.99 (s, 3H), 1.99 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 171.8 (Cq), 146.3 (Cq), 140.4 (Cq), 133.1 (Cq), 132.7 (Cq), 132.7 
(Cq), 130.0 (CH), 128.7 (CH), 128.6 (CH), 128.2 (CH), 123.4 (CH), 121.9 (Cq), 117.7 (CH), 
28.1 (CH3), 11.3 (CH3).  
IR (ATR): ṽ = 2924, 1720, 1592, 1506, 1344, 1264, 1107, 853, 752, 701 cm–1.  
MS (EI) m/z (relative intensity): 320 (15) [M
+
], 278 (100), 248 (12), 232 (30), 43 (27).  
HR-MS (EI) m/z calcd for C19H16N2O3
+
 320.1161, found 320.1114. 
Synthesis of methyl 1-acetyl-4-methyl-5-phenyl-1H-pyrrole-2-carboxylate (211ah) 
The general procedure C was followed using methyl 2-acetamidoacrylate (210a) 
(71.5 mg, 0.50 mmol),  and prop-1-yn-1-ylbenzene (38h) (116 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 211ah (85 mg, 66%) as a white solid.  
M.p. = 109−110 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.46−7.37 (m, 3H), 7.32−7.26 (m, 2H), 6.85 (s, 1H), 3.84 (s, 
3H), 2.27 (s, 3H), 1.99 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 173.5 (Cq), 161.2 (Cq), 135.6 (Cq), 131.0 (Cq), 129.8 (CH), 128.4 
(CH), 128.4 (CH), 122.6 (Cq), 120.5 (CH), 119.6 (Cq), 51.7 (CH3), 28.5 (CH3), 11.1 (CH3).  
IR (ATR): ṽ = 2952, 1747, 1696, 1556, 1464, 1443, 1375, 1230, 772, 584 cm–1. MS (EI) m/z 
(relative intensity): 257 (7) [M
+
], 213 (100), 183 (63), 155 (39), 43 (25).  
HR-MS (EI) m/z calcd for C15H15NO3
+
 257.1052, found 257.1056.  
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Synthesis of methyl 1-acetyl-4-ethyl-5-phenyl-1H-pyrrole-2-carboxylate (211ao) 
The general procedure C was followed using methyl 2-acetamidoacrylate (210a) 
(71.5 mg, 0.50 mmol), and but-1-yn-1-ylbenzene (38o) (130 mg, 1.00 mmol). 
After 22 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 211ao (74 mg, 54%) as a yellow oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.45−7.37 (m 3H), 7.32−7.26 (m, 2H), 6.92 (s, 1H), 3.85 (s, 3H), 
2.34 (q, J = 7.2 Hz, 2H), 2.26 (s, 3H), 1.11 (t, J = 7.2 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 173.3 (Cq), 161.0 (Cq), 135.0 (Cq), 131.0 (Cq), 129.9 (CH), 
128.4 (CH), 128.3 (CH), 126.3 (Cq), 122.7 (Cq), 118.8 (CH), 51.8 (CH3), 28.5 (CH3), 18.8 (CH2), 
15.2 (CH3).  
IR (ATR): ṽ = 2961, 2927, 1726, 1599, 1448, 1261, 1070, 759, 699 cm–1.  
MS (EI) m/z (relative intensity): 271 (4) [M
+
], 229 (100), 212 (73), 197 (20), 182 (40), 169 (15), 
154 (32), 43 (57).  
HR-MS (EI) m/z calcd for C16H17NO3
+
 271.1206, found 271.1211. 
Ruthenium-catalyzed aerobic oxidative coupling with enamine 210a (Scheme 69) 
 
A mixture of methyl 2-acetamidoacrylate (210a) (71.5 mg, 0.50 mmol), diphenylacetylene (38a) 
(178 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (30.0 mg, 
30 mol %) in t-AmOH (2.0 mL) was stirred at 100 °C under ambient air for 22 h. At ambient 
temperature, the reaction mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 75 mL) and extracted 
with EtOAc (3  75 mL). The combined organic phase was washed with sat. aq. NH4Cl/NH3 (1:1, 
50 mL) and dried over anhydrous Na2SO4. After filtration and evaporation of the solvents under 
reduced pressure, the crude product was purified by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1) to yield 211aa (128 mg, 76%) as a yellow oil. 
Intermolecular competition experiment with alkynes 38m and 38b (Scheme 70) 
 
A mixture of N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol),  
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1,2-bis(4-methoxyphenyl)acetylene (38j) (238 mg, 1.00 mmol), 
1,2-bis{4-(trifluoromethyl)phenyl}acetylene (38b) (314 mg, 1.00 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (200 mg, 1.00 mmol) in t-AmOH (2.0 mL) was stirred 
at 120 °C under N2 for 22 h. At ambient temperature, the reaction mixture was diluted with sat. aq. 
NH4Cl/NH3 (1:1, 75 mL) and extracted with EtOAc (3  75 mL). The combined organic phase 
was washed with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and dried over anhydrous Na2SO4. After 
filtration and evaporation of the solvents under reduced pressure, the crude product was purified 
by column chromatography on silica gel (n-hexane/EtOAc: 20/1) to yield a mixture of 211lj and 




Intermolecular competition experiment with enamines 210n and 210l (Scheme 71a) 
 
A mixture of N-{1-(4-methoxyphenyl)vinyl}acetamide (210n) (191 mg, 1.00 mmol), 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (206 mg, 1.00 mmol), diphenylacetylene (38a) 
(89.0 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (200 mg, 
1.00 mmol) in t-AmOH (2.0 mL) was stirred at 120 °C under N2 for 22 h. At ambient temperature, 
the reaction mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 75 mL) and extracted with EtOAc 
(3  75 mL). The combined organic phase was washed with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and 
dried over anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced 
pressure, the crude product was purified by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1) to yield a mixture of 211na and 211la as a yellow oil. The ratio of 
products 211na/211la was found to be 2.0/1.0 by 
1
H-NMR spectroscopy. 
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A mixture of N-{1-(4-methoxyphenyl)vinyl}acetamide (210n) (191 mg, 1.00 mmol), 
N-(1-phenylvinyl)acetamide (210g) (161 mg, 1.00 mmol), diphenylacetylene (38a) (89.0 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (200 mg, 1.00 mmol) 
in t-AmOH (2.0 mL) was stirred at 120 °C under N2 for 22 h. At ambient temperature, the reaction 
mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 75 mL) and extracted with EtOAc (3  75 mL). 
The combined organic phase was washed with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and dried over 
anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced pressure, the 
crude product was purified by column chromatography on silica gel (n-hexane/EtOAc: 20/1) to 
yield a mixture of 211na and 211ga as a yellow oil. The ratio of products 211na/211ga was found 
to be 1.2/1.0 by 
1
H-NMR spectroscopy. 
Intermolecular competition experiment with enamines 210g and 210l (Scheme 71c) 
 
A mixture of N-(1-phenylvinyl)acetamide (210g) (161 mg, 1.00 mmol), 
N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (206 mg, 1.00 mmol), diphenylacetylene (38a) 
(89.0 mg, 0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and Cu(OAc)2·H2O (200 mg, 
1.00 mmol) in t-AmOH (2.0 mL) was stirred at 120 °C under N2 for 22 h. At ambient temperature, 
the reaction mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 75 mL) and extracted with EtOAc 
(3  75 mL). The combined organic phase was washed with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and 
dried over anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced 
pressure, the crude product was purified by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1) to yield a mixture of 211ga and 211la as a yellow oil. The ratio of 
products 211ga/211la was found to be 3.0/1.0 by 
1
H-NMR spectroscopy. 
Ruthenium-catalyzed H/D exchange with 210l (Scheme 72a) 
 
A mixture of N-{1-(4-nitrophenyl)vinyl}acetamide (210) (103 mg, 0.50 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), and Cu(OAc)2 (182 mg, 1.00 mmol) in [D]4-MeOH 
(2.0 mL) was stirred at 80 °C under N2 for 18 h. After cooling to ambient temperature, the reaction 
mixture was diluted with sat. aq. NH4Cl/NH3 (50 mL) and extracted with EtOAc (3  40 mL). The 
combined organic phase was washed with brine (30 mL) and dried over Na2SO4. After filtration 
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and evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc: 1/1) to give the mixture of [D]n-210l and 210l as 




Ruthenium-catalyzed oxidative annulation of alkyne with enamine 210l in [D]4-MeOH 
(Scheme 72b) 
 
A mixture of N-{1-(4-nitrophenyl)vinyl}acetamide (210l) (103 mg, 0.50 mmol), 
diphenylacetylene (38e) (178 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), and 
Cu(OAc)2 (182 mg, 1.00 mmol) in [D]4-MeOH (2.0 mL) was stirred at 80 °C under N2 for 18 h. 
After cooling to ambient temperature, the reaction mixture was diluted with sat. aq. NH4Cl/NH3 
(50 mL) and extracted with EtOAc (3  40 mL). The combined organic phase was washed with 
brine (30 mL) and dried over Na2SO4. After filtration and evaporation of the solvents under 
reduced pressure, the mixture was separated by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1 to 1/1) to give 211le as a red solid (33 mg, 17%) and 210l as a white solid 
(35 mg, 34%). No deuterium incorporation was detected by 
1
H-NMR spectroscopy. 
8.4.3 Analytical Data for the Products of Ruthenium-Catalyzed Oxidative 
Alkenylation of Anilides 212 and Heteroamides 214 
Synthesis of (E)-ethyl 3-(2-acetamido-4-methylphenyl)acrylate (213aa) 
The general procedure D was followed using acetanilide 212a (74.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(7.7 mg, 5.0 mol %) and KPF6 (9.2 mg, 10 mol %). After 20 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 3/1) yielded 213aa 
(108 mg, 87%) as a white solid. 
M.p. = 155−156 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 15.6 Hz, 1H), 7.54 (sbr, 1H), 7.50 (s, 1H), 7.43 (d, 
J = 8.2 Hz, 1H), 6.99 (d, J = 8.2 Hz, 1H), 6.33 (d, J = 15.6 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 2.38 
(s, 3H), 2.20 (s, 3H), 1.30 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 168.9 (Cq), 166.9 (Cq), 141.4 (Cq), 139.2 (CH), 135.7 (Cq), 126.9 
(CH), 126.9 (CH), 125.9 (CH), 124.9 (Cq), 119.3 (CH), 60.6 (CH2), 24.1 (CH3), 21.4 (CH3), 14.2 
(CH3).  
IR (ATR): ṽ = 3226, 1711, 1660, 1635, 1609, 1537, 1493, 1163, 984, 814 cm–1.  
MS (EI) m/z (relative intensity): 247 (28) [M
+
], 204 (25), 160 (97), 138 (20) 132 (92), 117 (22).  
HR-MS (EI) m/z calcd for C14H17NO3
+
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Synthesis of (E)-ethyl 3-(2-pivalamidophenyl)acrylate (213ea)  
The representative procedure D was followed using acetanilide 213e (88.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 213ea 
(86 mg, 62%) as a white solid.  
M.p. = 81−82 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.75 (d, J = 16.4 Hz, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.54 (d, J = 
8.0 Hz, 1H), 7.40 (sbr, 1H), 7.37 (dd, J = 8.4, 7.8 Hz, 1H), 7.20 (dd, J = 8.0, 7.8 Hz, 1H), 6.38 (d, 
J = 16.4 Hz, 1H), 4.34 (q, J = 7.1 Hz, 2H), 1.36 (s, 9H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 176.9 (Cq), 166.5 (Cq), 139.2 (CH), 136.1 (Cq), 130.6 (CH), 
128.1 (Cq), 127.1 (CH), 125.8 (CH), 125.1 (CH), 120.8 (CH), 60.3 (CH2), 39.6 (Cq), 27.6 (CH3), 
14.2 (CH3).  
IR (ATR): ṽ = 3266, 2979, 1711, 1638, 1477, 1365, 1173, 1036, 984, 760 cm–1.  
MS (EI) m/z (relative intensity): 275 (20) [M
+
], 190 (22), 174 (12), 146 (38), 117 (36), 90 (15), 57 
(100).  
HR-MS (EI) m/z calcd for C16H21NO3
+
 275.1521, found 275.1522. 
Synthesis of (E)-ethyl 3-(2-acetamido-5-methylphenyl)acrylate (213ga) 
The general procedure D was followed using acetanilide 212g (74.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 2/1) yielded 
213ga (83 mg, 67%) as a white solid.  
M.p. = 134−135 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 15.8 Hz, 1H), 7.53 (d, J = 8.2 Hz, 1H), 7.38 (s, 1H), 
7.35 (sbr, 1H), 7.17 (d, J = 8.2 Hz, 1H), 6.37 (d, J = 15.8 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 2.32 (s, 
3H), 2.20 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.0 (Cq), 166.8 (Cq), 139.4 (CH), 135.7 (Cq), 133.4 (Cq), 131.5 
(CH), 127.8 (Cq), 127.3 (CH), 125.5 (CH), 120.2 (CH), 60.6 (CH2), 24.0 (CH3), 20.9 (CH3), 14.2 
(CH3).  
IR (ATR): ṽ = 3269, 1712, 1658, 1636, 1525, 1363, 1299, 1174, 970, 815 cm–1.  
MS (EI) m/z (relative intensity): 247 (40) [M
+
], 205 (37), 160 (100), 132 (76), 117 (12).  
HR-MS (EI) m/z calcd for C14H17NO3
+
 247.1206, found 247.1204. 
Synthesis of (E)-(n)-butyl 3-(2-acetamido-5-methylphenyl)acrylate (213gb) 
The general procedure D was followed using acetanilide 212g (74.5 mg, 
0.50 mmol), n-butyl acrylate (76b) (96.0 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). 
After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 1/1) yielded 213gb (75 mg, 55%) as a white solid.  
M.p. = 112−113 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 16.0 Hz, 1H), 7.51 (d, J = 8.4 Hz, 1H), 7.37 (s, 1H), 
7.34 (sbr, 1H), 7.16 (d, J = 8.4 Hz, 1H), 6.35 (d, J = 16.0 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 2.30 (s, 
3H), 2.18 (s, 3H), 1.70−1.59 (m, 2H), 1.47−1.32 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H).  
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13
C-NMR (75 MHz, CDCl3): δ = 168.9 (Cq), 166.9 (Cq), 139.4 (CH), 135.7 (Cq), 133.3 (Cq), 131.5 
(CH), 127.8 (Cq), 127.3 (CH), 125.6 (CH), 120.2 (CH), 64.5 (CH2), 30.7 (CH2), 24.0 (CH3), 20.9 
(CH3), 19.1 (CH2), 13.7 (CH3).  
IR (ATR): ṽ = 3269, 1711, 1656, 1584, 1527, 1277, 1241, 1161, 979, 812 cm–1.  
MS (EI) m/z (relative intensity): 275 (25) [M
+
], 233 (20), 160 (100), 132 (64), 117 (9).  
HR-MS (EI) m/z calcd for C16H21NO3
+
 275.1521, found 275.1529.  
The spectral data were in accordance with those reported in the literature.
178
 
Synthesis of (E)-ethyl 3-(2-acetamido-5-fluorophenyl)acrylate (213ha) 
The general procedure D was followed using acetanilide 212h (76.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 2/1) yielded 213ha 
(93 mg, 74%) as a white solid.  
M.p. = 143−144 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.72 (d, J = 15.6 Hz, 1H), 7.59 (s, 1H), 7.55 (d, J = 7.6 Hz, 1H), 
7.21 (d, J = 8.2 Hz, 1H), 7.05 (dd, J = 8.2, 8.0 Hz, 1H), 6.34 (d, J = 15.6 Hz, 1H), 4.24 (q, J = 7.1 
Hz, 2H), 2.19 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.3 (Cq), 166.4 (Cq), 160.2 (d, 
1
JC–F = 247 Hz, Cq), 138.3 (d, 
4
JC–F = 2 Hz, CH), 131.9 (d, 
4
JC–F = 3 Hz, Cq), 130.2 (d, 
3
JC–F = 8 Hz, Cq), 127.9 (d, 
3
JC–F = 8 Hz, 
CH), 121.4 (CH), 117.7 (d, 
2
JC–F = 23 Hz, CH), 113.1 (d, 
2
JC–F = 23 Hz, CH), 60.8 (CH2), 23.8 
(CH3), 14.2 (CH3).  
19
F-NMR (CDCl3, 283 MHz): δ = −(111.3−111.5) (m).  
IR (ATR): ṽ = 3249, 1717, 1656, 1636, 1527, 1486, 1419, 1264, 1177, 971, 852 cm–1.  
MS (EI) m/z (relative intensity): 251 (20) [M
+
], 207 (32), 164 (100), 146 (22), 136 (70), 108 (16).  
HR-MS (EI) m/z calcd for C13H14FNO3
+
 251.0958, found 251.0956. 
Synthesis of (E)-(n)-butyl 3-(2-acetamido-5-fluorophenyl)acrylate (213hb) 
The general procedure D was followed using acetanilide 212h (76.5 mg, 
0.50 mmol), n-butyl acrylate (76b) (96.0 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). 
After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 1/1) yielded 213hb (74 mg, 53%) as a white solid.  
M.p. = 138−139 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.71 (s, 1H), 7.68 (d, J = 15.8 Hz, 1H), 7.51 (dd, J = 8.8, 5.4 Hz, 
1H), 7.18 (d, J = 8.8 Hz, 1H), 7.01 (dd, J = 8.2, 2.9 Hz, 1H), 6.30 (d, J = 15.8 Hz, 1H), 4.14 (t, J = 
6.5 Hz, 2H), 2.15 (s, 3H), 1.70−1.56 (m, 2H), 1.46−1.31 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.3 (Cq), 166.5 (Cq), 160.3 (d, 
1
JC–F = 246 Hz, Cq), 138.3 (CH), 
131.8 (d, 
4
JC–F = 2 Hz, Cq), 130.3 (d, 
3
JC–F = 8 Hz, Cq), 128.0 (d, 
3
JC–F = 8 Hz, CH), 121.2 (CH), 
117.6 (d, 
2
JC–F = 22 Hz, CH), 113.0 (d, 
2
JC–F = 22 Hz, CH), 64.7 (CH2), 30.6 (CH2), 23.7 (CH3), 
19.1 (CH2), 13.6 (CH3).  
19
F-NMR (CDCl3, 283 MHz): δ = −111.4 (m).  
IR (ATR): ṽ = 3255, 2955, 1717, 1656, 1636, 1527, 1486, 1174, 1015, 852 cm–1.  
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MS (EI) m/z (relative intensity): 279 (11) [M
+
], 237 (16), 164 (100), 136 (55), 108 (10).  
HR-MS (EI) m/z calcd for C15H18FNO3
+
 279.1271, found 279.1268.  
The spectral data were in accordance with those reported in the literature.
178
 
Synthesis of (E)-ethyl 3-{2-acetamido-5-(trifluoromethyl)phenyl}acrylate (213ia) 
The general procedure D was followed using acetanilide 212i (101.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 3/1) yielded 
213ia (69 mg, 46%) as a white solid.  
M.p. = 168−169 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.01 (sbr, 1H), 7.78 (d, J = 16.3 Hz, 1H), 7.77 (d, J = 8.4 Hz, 
1H), 7.73 (s, 1H), 7.57 (d, J = 8.4 Hz, 1H), 6.43 (d, J = 16.3 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 
2.23 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.0 (Cq), 166.3 (Cq), 138.8 (Cq), 137.8 (CH), 127.2 (q, 
3
JC–F = 
10 Hz, CH), 127.0 (q, 
2
JC–F = 33 Hz, Cq), 124.4 (q, 
4
JC–F = 4 Hz, CH), 124.2 (q, 
3
JC–F = 11 Hz, 
CH), 123.6 (q, 
1
JC–F = 273 Hz, Cq), 122.4 (CH), 121.8 (Cq), 61.0 (CH2), 24.2 (CH3), 14.2 (CH3).  
19
F-NMR (CDCl3, 283 MHz): δ = −62.6 (s). 
IR (ATR): ṽ = 3269, 1719, 1661, 1585, 1527, 1369, 1278, 1108, 1039, 834 cm–1.  
MS (EI) m/z (relative intensity): 301 (12) [M
+
], 259 (20), 212 (100), 196 (20), 186 (55), 166 (21), 
43 (38).  
HR-MS (EI) m/z calcd for C14H14F3NO3
+
 301.0926, found 301.0920. 
Synthesis of (E)-(n)-butyl 3-(2-acetamido-4-methylphenyl)acrylate (213ab) 
The general procedure D was followed using acetanilide 212a (74.5 mg, 
0.50 mmol), n-butyl acrylate (76b) (96.0 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). 
After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 3/1) yielded 213ab (77 mg, 56%) as a white solid.  
M.p. = 138−139 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.77 (d, J = 16.0 Hz, 1H), 7.51 (sbr, 1H), 7.51 (s, 1H), 7.44 (d, 
J = 8.0 Hz, 1H), 6.99 (d, J = 8.0 Hz, 1H), 6.33 (d, J = 16.0 Hz, 1H), 4.17 (t, J = 6.7 Hz, 2H), 2.38 
(s, 3H), 2.20 (s, 3H), 1.72−1.59 (m, 2H), 1.48−1.33 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 168.9 (Cq), 167.0 (Cq), 141.4 (Cq), 139.2 (CH), 135.7 (Cq), 126.9 
(CH), 126.8 (CH), 125.9 (Cq), 124.9 (CH), 119.3 (CH), 64.5 (CH2), 30.7 (CH2), 24.1 (CH3), 
21.4 (CH3), 19.1 (CH2), 13.7 (CH3).  
IR (ATR): ṽ = 3267, 2958, 1708, 1656, 1569, 1532, 1251, 1067, 973, 813 cm–1.  
MS (EI) m/z (relative intensity): 275 (17) [M
+
], 233 (10), 160 (92), 138 (20), 132 (100), 117 (13).  
HR-MS (EI) m/z calcd for C14H17NO3
+
 275.1521, found 275.1525.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of (E)-ethyl 3-(2-acetamido-4-methoxyphenyl)acrylate (213ja) 
The general procedure D was followed using acetanilide 212j (82.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, 
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purification by column chromatography on silica gel (n-hexane/EtOAc: 2/1) yielded 213ja (77 mg, 
58%) as a white solid.  
M.p. = 132−133 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.75 (d. J = 15.7 Hz, 1H), 7.58 (sbr, 1H), 7.47 (d, J = 8.4 Hz, 
1H), 7.40 (s, 1H), 7.72 (d, J = 8.4 Hz, 1H), 6.26 (d, J = 15.7 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 
3.76 (s, 3H), 2.22 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ = 168.8 (Cq), 167.1 (Cq), 161.6 (Cq), 138.7 (CH), 137.4 (Cq), 128.2 
(CH), 119.3 (Cq), 117.8 (CH), 112.5 (CH), 109.2 (CH), 60.5 (CH2), 55.4 (CH3), 14.3 (CH3), 14.3 
(CH3).  
IR (ATR): ṽ = 3258, 2976, 1697, 1660, 1610, 1573, 1435, 1259, 1110, 768 cm–1.  
MS (EI) m/z (relative intensity): 263 (30) [M
+
], 218 (20), 176 (65), 148 (70), 132 (38), 104 (22).  
HR-MS (EI) m/z calcd for C14H17NO4
+
 263.1118, found 263.1114. 
Synthesis of (E)-(n)-butyl 3-(2-acetamido-4-methoxyphenyl)acrylate (213jb) 
The general procedure D was followed using acetanilide 212j (82.5 mg, 
0.50 mmol), n-butyl acrylate (76b) (96.0 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). 
After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 3/1) yielded 213jb (76 mg, 52%) as a white solid.  
M.p. = 138−139 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.75 (d, J = 16.4 Hz, 1H), 7.61 (sbr, 1H), 7.47 (d, J = 8.8 Hz, 
1H), 7.40 (s, 1H), 6.72 (d, J = 8.8 Hz, 1H), 6.27 (d, J = 16.4 Hz, 1H), 4.16 (t, J = 6.4 Hz, 2H), 3.76 
(s, 3H), 2.22 (s, 3H) 1.78−1.59 (m, 2H), 1.51−1.33 (m, 2H), 0.94 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.1 (Cq), 161.8 (Cq), 138.7 (CH), 137.6 (Cq), 137.6 (Cq), 128.4 
(CH), 118.2 (CH), 112.6 (CH), 112.6 (Cq), 109.3 (CH), 64.4 (CH2), 55.5 (CH3), 30.8 (CH2), 24.2 
(CH3), 19.2 (CH2), 13.6 (CH3).  
IR (ATR): ṽ = 3266, 2952, 1697, 1660, 1609, 1573, 1244, 1110, 972, 767 cm–1.  
MS (EI) m/z (relative intensity): 291 (25) [M
+
], 249 (20), 176 (65), 148 (100), 132 (26), 104 (13).  
HR-MS (EI) m/z calcd for C14H17NO3
+
 291.1471, found 291.1472.  
The spectral data were in accordance with those reported in the literature.
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Synthesis of (E)-ethyl 3-(2-acetamido-4-chlorophenyl)acrylate (213ka) 
The general procedure D was followed using acetanilide 212k (84.5 mg, 
0.50 mmol), ethyl acrylate (76a) (150 mg, 1.50 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 1/1) yielded 
213ka (88 mg, 66%) as a white solid.  
M.p. = 167−168 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.87 (s, 1H), 7.75 (sbr, 1H), 7.69 (d, J = 15.8 Hz, 1H), 7.39 (d, 
J = 8.6 Hz, 1H), 7.09 (d, J = 8.6 Hz, 1H), 6.30 (d, J = 15.8 Hz, 1H), 4.22 (q, J = 7.3 Hz, 2H), 2.19 
(s, 3H), 1.30 (t, J = 7.3 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.1 (Cq), 166.6 (Cq), 138.2 (CH), 136.8 (Cq), 136.3 (Cq), 127.8 
(CH), 125.8 (CH), 125.6 (Cq), 124.9 (CH), 120.6 (CH), 60.8 (CH2), 24.0 (CH3), 14.2 (CH3).  
IR (ATR): ṽ = 3249, 1712, 1665, 1568, 1521, 1474, 1266, 1244, 975, 810 cm–1.  
MS (EI) m/z (relative intensity): 267 (18) [M
+
], 225 (25), 176 (100), 152 (90), 117 (30), 89 (32).  
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HR-MS (EI) m/z calcd for C13H14ClNO3
+
 267.0662, found 267.0622. 
Synthesis of (E)-ethyl 3-{2-acetamido-4-(trifluoromethyl)phenyl}acrylate (213la) 
The general procedure D was followed using acetanilide 213l (102 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 4/1) yielded 
213la (76 mg, 53%) as a white solid.  
M.p. = 138−139  C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.98 (s, 1H), 7.96 (sbr, 1H), 7.73 (d, J = 15.8 Hz, 1H), 7.55 (d, 
J = 8.2 Hz, 1H), 7.36 (d, J = 8.2 Hz, 1H), 6.48 (d, J = 15.8 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 2.20 
(s, 3H), 1.31 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 169.3 (Cq), 166.2 (Cq), 138.0 (CH), 136.2 (Cq), 132.1 (q, 
2
JC–F = 
33 Hz, Cq), 130.6 (Cq), 127.4 (CH), 123.4 (q, 
1
JC–F = 273 Hz, Cq), 122.5 (CH), 122.1 (q, 
3
JC–F = 14 
Hz, CH), 121.7 (q, 
3
JC–F = 12 Hz, CH), 60.9 (CH2), 23.9 (CH3), 14.1 (CH3).  
19
F-NMR (CDCl3, 283 MHz): δ = −63.0 (s).  
IR (ATR): ṽ = 3255, 2984, 1712, 1661, 1531, 1387, 1328, 1110, 822, 553 cm–1.  
MS (EI) m/z (relative intensity): 301 (10) [M
+
], 259 (20), 212 (100), 196 (20), 186 (65), 166 (25).  
HR-MS (EI) m/z calcd for C14H14F3NO3
+
 301.0926, found 301.0918. 
Synthesis of (E)-ethyl 3-(2-acetamido-6-fluorophenyl)acrylate (213ma) 
The general procedure D was followed using acetanilide 212m (76.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75.0 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 2/1) yielded 213ma (88 
mg, 70%) as a white solid.  
M.p. = 138−143 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.65–7.52 (m, 2H), 7.60 (d, J = 16.9 Hz, 1H), 7.30 (dd, J = 9.6, 
9.6 Hz, 1H), 6.93 (dd, J = 9.6, 8.7 Hz, 1H), 6.57 (d, J = 16.9 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 
2.21 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 168.8 (Cq), 166.9 (Cq), 161.3 (d, 
1
JC–F = 252 Hz, Cq), 137.3 (d, 
4
JC–F = 4 Hz, Cq), 133.3 (CH), 130.8 (d, 
3
JC–F = 10 Hz, CH), 124.8 (d, 
3
JC–F = 11 Hz, CH), 120.5 
(CH), 116.1 (d, 
2
JC–F = 10 Hz, Cq), 112.8 (d, 
2
JC–F = 24 Hz, CH), 60.8 (CH2), 24.2 (CH3), 14.2 
(CH3).  
19
F-NMR (CDCl3, 283 MHz): δ = −110.4 (s).  
IR (ATR): ṽ = 3264, 1719, 1664, 1636, 1572, 1364, 1184, 1029, 751, 530 cm–1.  
MS (EI) m/z (relative intensity): 251 (10) [M
+
], 207 (8), 164 (58), 146 (15), 136 (38), 108 (10).  
HR-MS (EI) m/z calcd for C13H14FNO3
+
 251.0958, found 251.0959. 
Synthesis of N-{5-methyl-2-(3-oxobutyl)phenyl}acetamide (213ac) 
The general procedure D was followed using N-(m-tolyl)acetamide 212a 
(74.5 mg, 0.50 mmol), 3-buten-2-one (76c) (52.5 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). 
After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 3/1→2/1) yielded 213ac (34 mg, 31%) as a white solid.  
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M.p. = 132−133 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 9.00 (sbr, 1H), 7.62 (s, 1H), 6.99 (d, J = 8.0 Hz, 1H), 6.88 (d, J = 
8.0 Hz, 1H), 2.88 (t, J = 6.7 Hz, 2H), 2.76 (t, J = 6.7 Hz, 2H), 2.30 (s, 3H), 2.27 (s, 3H), 2.13 (s, 
3H).  
13
C-NMR (75 MHz, CDCl3): δ = 208.7 (Cq), 169.1 (Cq), 137.0 (Cq), 135.6 (Cq), 129.8 (CH), 129.7 
(Cq), 126.2 (CH), 125.0 (CH), 45.7 (CH2), 30.2 (CH3), 24.5 (CH3), 23.7 (CH2), 21.3 (CH3).  
IR (ATR): ṽ = 3276, 2949, 1708, 1650, 1576, 1531, 1370, 1284, 1161, 814, 553 cm–1.  
MS (EI) m/z (relative intensity): 217 (28) [M
+
], 176 (67), 158 (25), 134 (100), 120 (90), 107 (20).  
HR-MS (EI) m/z calcd for C13H17NO2
+
 217.1259, found 217.1257. 
Ruthenium-catalyzed oxidative alkenylations of anilide 212a in 5 mmol scale (Scheme 75) 
 
A mixture of acetanilide 212a (715 mg, 5.0 mmol), ethyl acrylate (76a) (750 mg, 7.5 mmol), 
[RuCl2(p-cymene)]2 (76.5 mg, 2.5 mol %), KPF6 (92.0 mg, 10 mol %) and Cu(OAc)2·H2O (1.0 g, 
5.0 mmol) in H2O (2.0 mL) was stirred at 105 °C under N2 for 20 h. At ambient temperature, the 
mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 100 mL) and extracted with EtOAc (2  100 
mL). The combined organic phase was dried over anhydrous Na2SO4 (50 g). After filtration and 
evaporation of the solvents under reduced pressure, the crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc/CH2Cl2: 9/5/1→6/4/1) to yield 213aa (901 mg, 
73%) as a white solid. 
Intermolecular competition experiment with anilides 212h and 212d (Scheme 76a) 
 
A mixture of N-(4-fluorophenyl)acetamide (212h) (153 mg, 1.00 mmol), N-phenylacetamide 
(212d) (135 mg, 1.00 mmol), ethyl acrylate (76a) (50.0 mg, 0.50 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %), KPF6 (18.4 mg, 20 mol%) and Cu(OAc)2·H2O (99.5 mg, 1.00 mmol) in 
H2O (2.0 mL) was stirred at 120 °C under N2 for 20 h. At ambient temperature, the mixture was 
diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic phase 
was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and evaporation 
of the solvents under reduced pressure, the conversion of the crude mixture was determined by GC 




- 129 - 
 
Intermolecular competition experiment with anilides 212o and 212d (Scheme 76b) 
 
A mixture of N-(4-methoxyphenyl)acetamide (212o) (165 mg, 1.00 mmol), N-phenylacetamide 
(212d) (135 mg, 1.00 mmol), ethyl acrylate (76a) (50.0 mg, 0.50 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %), KPF6 (18.4 mg, 20 mol %) and Cu(OAc)2·H2O (99.5 mg, 1.00 mmol) in 
H2O (2.0 mL) was stirred at 120 °C under N2 for 20 h. At ambient temperature, the mixture was 
diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). The combined organic phase 
was washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and evaporation 
of the solvents under reduced pressure, the crude product was purified by column chromatography 
on silica gel (n-hexane/EtOAc: 2/1) to yield a mixture of 213oa and 213da as a white solid. The 
ratio of products 213oa:213da was found to be 1.3:1.0 by 
1
H-NMR spectroscopy. 
Intermolecular competition experiment with anilides 212h and 212o (Scheme 76c) 
 
A mixture of N-(4-fluorophenyl)acetamide (212h) (153 mg, 1.00 mmol), 
N-(4-methoxyphenyl)acetamide (212o) (165 mg, 1.00 mmol), ethyl acrylate (76a) (50.0 mg, 
0.50 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), KPF6 (18.4 mg, 20 mol %) and 
Cu(OAc)2·H2O (99.5 mg, 1.00 mmol) in H2O (2.0 mL) was stirred at 120 °C under N2 for 20 h. At 
ambient temperature, the mixture was diluted with H2O (75 mL) and extracted with EtOAc 
(3  75 mL). The combined organic phase was washed with brine (50 mL) and dried over 
anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced pressure, the 
crude product was purified by column chromatography on silica gel (n-hexane/EtOAc: 2/1) to 
yield a mixture of 213ha and 213oa as a white solid. The ratio of products 213ha:213oa was 
found to be 1.0:1.1 by 
1
H-NMR spectroscopy. 
Ruthenium-catalyzed H/D exchange in D2O (Scheme 77b) 
 
A mixture of acetanilide (212a) (149 mg, 1.00 mmol), ethyl acylate (76a) (150 mg, 1.50 mmol), 
[RuCl2(p-cymene)]2 (30.6 mg, 5.0 mol %), KPF6 (36.8 mg, 20 mol %) and Cu(OAc)2 (181 mg, 
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1.00 mmol) in D2O (3.0 mL) was stirred at 120 °C under N2 for 45 min. At ambient temperature, 
the mixture was diluted with sat. aq. NH4Cl/NH3 (1:1, 50 mL) and extracted with EtOAc 
(3  50 mL). The combined organic phase was washed with brine (50 mL) and dried over 
anhydrous Na2SO4. After filtration and evaporation of the solvents under reduced pressure, the 
crude product was purified by column chromatography on silica gel (n-hexane/EtOAc: 2/1→1/1) 
to yield [D]n-212a (100 mg, 67%) as a white solid and [D]n-213aa (67 mg, 27%) as a white solid. 
The deuterium incorporation was estimated by 
1
H-NMR spectroscopy. 
Synthesis of (E)-ethyl 3-{1-methyl-3-(methylcarbamoyl)-1H-indol-2-yl}acrylate (215aa) 
The general procedure D was followed using indole 214a (94 mg, 
0.50 mmol), ethyl acrylate (76a) (75 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 1/1) 
yielded 215aa (75mg, 52%) as a white solid.  
M.p. = 193−194 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.08 (d, J = 16.3 Hz, 1H), 7.79 (d, J =8.0 Hz, 1H), 7.36−7.30 (m, 
2H), 7.21 (dd, J = 8.0, 5.1 Hz, 1H), 6.53 (d, J = 16.3 Hz, 1H), 6.00 (sbr, 1H), 4.28 (q, J = 7.1 Hz, 
2H), 3.78 (CH3), 3.05 (d, J = 5.0 Hz, 3H), 1.35 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.4 (Cq), 165.7 (Cq), 138.1 (Cq), 135.1 (Cq), 132.1 (CH), 125.2 
(Cq), 124.2 (CH), 123.4 (CH), 121.7 (CH), 120.2 (CH), 113.8 (Cq), 110.1 (CH), 60.8 (CH2), 31.4 
(CH3), 26.6 (CH3), 14.3 (CH3).  
IR (ATR): ṽ = 3264, 1698, 1628, 1543, 1467, 1400, 1237, 1173, 1027, 731 cm–1.  
MS (EI) m/z (relative intensity): 286 (30) [M
+
], 219 (100), 199 (40), 184 (25), 128 (10).  
HR-MS (EI) m/z calcd for C16H18N2O3
+
 286.1317, found 286.1321. 
Synthesis of (E)-ethyl 3-{1-methyl-2-(methylcarbamoyl)-1H-indol-3-yl}acrylate (215ba) 
The general procedure D was followed using indole 214b (94 mg, 
0.50 mmol), ethyl acrylate (76a) (75 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 1/1) yielded 
215ba (102 mg, 71%) as a white solid. 
M.p. = 173−174 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.97 (d, J = 16.0 Hz, 1H), 7.91 (d, J = 8.2 Hz, 1H), 7.46−7.32 
(m, 2H), 7.26 (dd, J = 8.8, 4.0 Hz, 1H), 6.48 (d, J = 16.0 Hz, 1H), 6.30 (sbr, 1H), 4.19 (q, J = 
7.1 Hz, 2H), 3.85 (s, 3H), 3.10 (d, J = 5.1 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.9 (Cq), 162.2 (Cq), 138.1 (Cq), 136.4 (Cq), 136.3 (CH), 124.6 
(Cq), 124.5 (CH), 122.0 (CH), 121.4 (CH), 116.1 (CH), 111.3 (CH), 110.4 (Cq), 60.3 (CH2), 31.3 
(CH3), 26.9 (CH3), 14.3 (CH3).  
IR (ATR): ṽ = 3271, 2981, 1709, 1623, 1547, 1469, 1368, 1131, 977, 730 cm–1.  
MS (EI) m/z (relative intensity): 286 (40) [M
+
], 228 (26), 219 (100), 200 (32), 184 (25), 111 (15).  
HR-MS (EI) m/z calcd for C16H18N2O3
+
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Synthesis of (E)-ethyl 3-{2-(methylcarbamoyl)benzofuran-3-yl}acrylate (215da) 
The general procedure D was followed using benzofurane 214d (87.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %) in H2O (2.0 mL). After 
20 h, purification by column chromatography on silica gel (n-hexane/EtOAc: 
2/1) yielded 215da as a white solid (49 mg, 36%). 
The general procedure D was followed using benzofurane 214d (87.5 mg, 0.50 mmol), ethyl 
acrylate (76a) (75 mg, 0.75 mmol), [RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 
20 mol %) in t-AmOH (2.0 mL). After 20 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 2/1) yielded 215da as a white solid (87 mg, 64%). 
M.p. = 141−138 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.66 (d, J = 16.0 Hz, 1H), 7.88 (d, J = 7.9 Hz, 1H), 7.52−7.30 
(m, 3H), 6.86 (sbr, 1H), 6.69 (d, J = 16.0 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.04 (d, J = 5.1 Hz,  
3H), 1.34 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.5 (Cq), 159.6 (Cq), 153.5 (Cq), 145.5 (Cq), 124.8 (CH), 127.4 
(CH), 125.7 (Cq), 124.4 (CH), 122.7 (CH), 122.3 (CH), 120.1 (Cq), 111.9 (CH), 60.6 (CH2), 26.0 
(CH3), 14.3 (CH3).  
IR (ATR): ṽ = 3308, 1714, 1649, 1569, 1523, 1269, 1170, 1146, 743, 692 cm–1.  
MS (EI) m/z (relative intensity): 273 (5) [M
+
], 200 (100), 187 (9), 111 (10).  
HR-MS (EI) m/z calcd for C15H15NO4
+
 273.1001, found 273.0997. 
Synthesis of (E)-ethyl 3-{2-(methylcarbamoyl)thiophen-3-yl}acrylate (215ea) 
The general procedure D was followed using thiophene 214e (70.5 mg, 
0.50 mmol), ethyl acrylate (76a) (75 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 1/1) yielded 215ea 
(92 mg, 76%) as a white solid.  
M.p. = 92−93 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.25 (d, J = 16.0 Hz, 1H), 7.31 (dd, J = 6.1, 5.4 Hz, 1H), 7.29 
(dd, J = 6.1, 5.4 Hz, 1H), 6.32 (d, J = 16.0 Hz, 1H), 5.94 (sbr, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.00 
(d, J = 4.9 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.7 (Cq), 162.2 (Cq), 138.4 (Cq), 136.4 (CH), 136.0 (Cq), 127.0 
(CH), 126.7 (CH), 121.4 (CH), 60.6 (CH2), 27.0 (CH3), 14.3 (CH3).  
IR (ATR): ṽ = 3266, 2976, 1707, 1624, 1539, 1247, 1119, 1036, 981, 613 cm–1.  
MS (EI) m/z (relative intensity): 239 (25) [M
+
], 166 (76), 152 (100), 137 (23), 125 (22), 97 (25).  
HR-MS (EI) m/z calcd for C11H13NO3S
+
 239.0616, found 239.0615. 
Synthesis of (E)-(n)-butyl 3-{2-(methylcarbamoyl)thiophen-3-yl}acrylate (215eb) 
The general procedure D was followed using thiophene 214e (70.5 mg, 
0.50 mmol), n-butyl acrylate (76b) (96 mg, 0.75 mmol), [RuCl2(p-cymene)]2 
(15.3 mg, 5.0 mol %) and KPF6 (18.4 mg, 20 mol %). After 20 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 2/1) yielded 215eb 
(96 mg, 72%) as a white solid.  
M.p. = 93−94 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.18 (d, J = 16.1 Hz, 1H), 7.26 (d, J = 5.2 Hz, 1H), 7.22 (d, J = 
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5.2 Hz, 1H), 6.25 (d, J = 16.1 Hz, 1H), 6.20 (sbr, 1H), 4.14 (q, J = 6.4 Hz, 2H), 2.93 (d, J = 5.0 Hz, 
1H), 1.69−1.57 (m, 2H), 1.44−1.29 (m, 2H), 0.90 (t, J = 7.3 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.8 (Cq), 162.6 (Cq), 138.2 (Cq), 136.4 (CH), 126.9 (CH), 
126.5 (CH), 121.0 (CH), 109.1 (Cq), 64.3 (CH2), 30.7 (CH2), 26.9 (CH3), 18.8 (CH2), 13.7 (CH3).  
IR (ATR): ṽ = 3272, 2952, 1706, 1625, 1541, 1270, 1227, 1066, 987, 737 cm–1.  
MS (EI) m/z (relative intensity): 267 (25) [M
+
], 208 (10), 166 (100), 152 (16).  
HR-MS (EI) m/z calcd for C13H17NO3S
+
 267.0929, found 267.0922. 
Intramolecular competition experiments with amide 214f (Scheme 81) 
A mixture of thiophene 214f (70.5 mg, 0.50 mmol), ethyl acrylate (76a) (75 mg, 0.75 mmol), 
[RuCl2(p-cymene)]2 (15.3 mg, 5.0 mol %), KPF6 (18.4 mg, 20 mol %) and Cu(OAc)2·H2O 
(99.5 mg, 1.00 mmol) in H2O (2.0 mL) was stirred under N2 for 20 h at 120 °C. At ambient 
temperature, the mixture was diluted with H2O (75 mL) and extracted with EtOAc (3  75 mL). 
The combined organic phase was washed with brine (50 mL) and dried over anhydrous Na2SO4. 
After filtration and evaporation of the solvents under reduced pressure, the crude product was 
purified by column chromatography on silica gel (n-hexane/EtOAc: 1/1) to yield a mixture of 
215fa and 215'fa (59 mg, 49%, 12:1 mixture of regioisomers according to 
1
H-NMR) as a white 
solid. Recrystallization (n-hexane/CH2Cl2: 2/1) gave the major regioisomer 215fa (44 mg, 37%) as 
a white solid.  
(E)-Ethyl 3-{3-(methylcarbamoyl)thiophen-2-yl}acrylate (215fa) 
M.p. = 128−129 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.32 (d, J = 15.9 Hz, 1H), 7.25 (d, J = 5.1 Hz, 
1H), 7.14 (d, J = 5.1 Hz, 1H), 6.26 (d, J = 15.9 Hz, 1H), 6.03 (sbr, 1H), 4.21 (q, 
J = 7.1 Hz, 2H), 2.96 (d, J = 4.5 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.2 (Cq), 164.3 (Cq), 141.0 (Cq), 137.3 (Cq), 135.4 (CH), 127.6 
(CH), 126.9 (CH), 120.0 (CH), 60.6 (CH2), 26.7 (CH3), 14.3 (CH3).  
IR (ATR): ṽ = 3381, 3103, 1712, 1626, 1549, 1436, 1296, 1252, 982, 719 cm–1.  
MS (EI) m/z (relative intensity): 239 (13) [M
+
], 166 (100), 152 (20), 137 (20) 109 (10).  
HR-MS (EI) m/z calcd for C11H13NO3S
+
 239.0616, found 239.0611. 
8.4.4 Analytical Data for the Products of Ruthenium-Catalyzed C(sp
3
)−H 
α-Alkylation of Pyrrolidine 209 with Alkene 111 
Synthesis of 2-(2-n-decylpyrrolidin-1-yl)-3-methylpyridine (217ba) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-decene (111a) (70.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1→30/1) yielded 
217ba (138 mg, 94%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.06 (dd, J = 5.0, 2.0 Hz, 1H), 7.30–7.27 (m, 1H), 6.65 (dd, J = 
7.1, 5.0 Hz, 1H), 4.28–4.20 (m, 1H), 3.70–3.62 (m, 1H), 3.23–3.11 (m, 1H), 2.23 (s, 3H), 2.19–
2.09 (m, 1H), 1.95–1.54 (m, 4H), 1.29–1.17 (m, 17H), 0.89–0.85 (m, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 144.6 (CH), 139.1 (CH), 121.9 (Cq), 114.6 (CH), 
58.2 (CH), 51.7 (CH2), 34.2 (CH2), 31.9 (CH2), 31.2 (CH2), 29.9 (CH2), 29.6 (CH2), 29.6 (CH2), 
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29.6 (CH2), 29.3 (CH2), 25.9 (CH2), 24.9 (CH2), 22.7 (CH2), 20.1 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2922, 2853, 1588, 1564, 1384, 1346, 1186, 993, 775 cm–1.  
MS (EI) m/z (relative intensity): 302 (5) [M
+
], 287 (3), 208 (5), 161 (100), 133 (10), 107 (9), 92 
(14), 43 (10).  
HR-MS (EI) m/z calcd for C20H34N2
+
 302.2722, found 302.2724. 
Synthesis of 2-(2-n-decylpyrrolidin-1-yl)-3-(trifluoromethyl)pyridine (217ca) 
The general procedure E was followed using 
2-(pyrrolidin-1-yl)-3-(trifluoromethyl)pyridine (216c) (324 mg, 1.5 mmol) 
and 1-decene (2a) (70.1 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 100/1) yielded 
217ca (128 mg, 72%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.25 (dd, J = 4.9, 1.8 Hz, 1H), 7.75 (d, J = 7.4 Hz, 1H), 6.61 (dd, 
J = 7.4, 4.9 Hz, 1H), 4.47−4.36 (m, 1H), 3.65−3.53 (m, 1H), 3.41−3.31 (m, 1H), 2.14−2.04 (m, 
1H), 1.97−1.87 (m, 1H), 1.82−1.56 (m, 3H), 1.35−1.16 (m, 17H), 0.85 (t, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 155.7 (Cq), 150.4 (CH), 137.0 (q, 
3
JC–F = 6 Hz, CH), 124.6 (q, 
1
JC–F = 272 Hz, Cq), 111.8 (CH), 110.7 (q, 
2
JC–F = 32 Hz, Cq), 58.9 (CH), 51.6 (q, JC–F = 5 Hz, 
CH2), 33.6 (CH2), 31.9 (CH2), 30.5 (CH2), 29.8 (CH2), 29.6 (CH2), 29.6 (CH2), 29.6 (CH2), 29.3 
(CH2), 25.6 (CH2), 25.5 (CH2), 22.7 (CH2), 14.1 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −56.6 (s).  
IR (ATR): ṽ = 2923, 2854, 1596, 1556, 1449, 1369, 1302, 1097, 1019, 767 cm–1.  
MS (EI) m/z (relative intensity): 356 (4) [M
+
], 213 (100), 175 (4), 146 (5).  
HR-MS (EI) m/z calcd for C20H31F3N2
+
 356.2439, found 356.2432. 
Synthesis of 3-methyl-2-(2-n-nonylpyrrolidin-1-yl)pyridine (217da) 
The general procedure E was followed using 
4-methyl-2-(pyrrolidin-1-yl)pyridine (216d) (243 mg, 1.5 mmol) and 
1-decene (111a) (70.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) yielded 
217da (97 mg, 64%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.99 (d, J = 5.2 Hz, 1H), 6.32 (dd, J = 5.2, 1.2 Hz, 1H), 6.12 (s, 
1H), 3.93−3.82 (m, 1H), 3.56−3.46 (m, 1H), 3.41−3.29 (m, 1H), 2.22 (s, 3H), 2.04−1.65 (m, 5H), 
1.38−1.12 (m, 17H), 0.86 (t, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 157.4 (Cq), 147.9 (CH), 147.4 (Cq), 112.5 (CH), 106.8 (CH), 
57.6 (CH), 47.4 (CH2), 33.0 (CH2), 31.9 (CH2), 30.1 (CH2), 29.8 (CH2), 29.7 (CH2), 29.6 (CH2), 
29.6 (CH2), 29.3 (CH2), 26.4 (CH2), 23.4 (CH2), 22.7 (CH2), 21.3 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2921, 2852, 1708, 1604, 1553, 1453, 1297, 1176, 792, 447 cm–1.  
MS (EI) m/z (relative intensity): 302 (5) [M
+
], 161 (100), 133 (7), 92 (9), 41 (7).  
HR-MS (EI) m/z calcd for C20H34N2
+
 302.2722, found 302.2722. 
Synthesis of 2-(2-n-decylpyrrolidin-1-yl)-5-fluoropyridine (217ea) 
The general procedure E was followed using 
5-fluoro-2-(pyrrolidin-1-yl)pyridine (216e) (249 mg, 1.5 mmol) and 1-decene 
(111a) (70.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 217ea (116 mg, 
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76%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.99 (d, J = 3.0 Hz, 1H), 7.17 (ddd, J = 8.8, 3.0, 1.1 Hz, 1H), 
6.24 (dd, J = 8.8, 3.0 Hz, 1H), 3.87−3.78 (m, 1H), 3.52−3.43 (m, 1H), 3.35−3.25 (m, 1H), 
2.04−1.65 (m, 5H), 1.34−1.16 (m, 17H), 0.86 (t, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 154.1 (Cq), 152.4 (d, 
1
JC–F = 240 Hz, Cq), 134.6 (d, 
2
JC–F = 24 Hz, 
CH), 124.6 (d, 
2
JC–F = 20 Hz, CH), 106.4 (d, 
3
JC–F = 4 Hz, CH), 58.2 (CH), 47.4 (CH2), 33.1 (CH2), 
31.9 (CH2), 30.2 (CH2), 29.8 (CH2), 29.7 (CH2), 29.6 (CH2), 29.6 (CH2), 29.3 (CH2), 26.5 (CH2), 
23.5 (CH2), 22.7 (CH2), 14.1 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(146.91−146.95) (m).  
IR (ATR): ṽ = 2922, 2852, 1613, 1492, 1407, 1224, 762 cm–1.  
MS (EI) m/z (relative intensity): 306 (22) [M
+
], 305 (100) [(M−H)
+
], 165 (18).  
HR-MS (EI) m/z calcd for C19H31FN2
+
 306.2471, found 306.2387. 
Synthesis of 1-(2-n-decylpyrrolidin-1-yl)isoquinoline (217ga) 
The general procedure E was followed using 
1-(pyrrolidin-1-yl)isoquinoline (216g) (297 mg, 1.5 mmol) and 1-decene 
(111a) (70.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 217ga (113 
mg, 67%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 8.6 Hz, 1H), 8.03 (d, J = 5.7 Hz, 1H), 7.65 (d, J = 
8.2 Hz, 1H), 7.52 (ddd, J = 8.2, 8.2, 1.2 Hz, 1H), 7.38 (ddd, J = 8.6, 8.2, 1.2 Hz, 1H), 7.01 (d, J = 
5.7 Hz, 1H), 4.61−4.50 (m, 1H), 4.02−3.92 (m, 1H), 3.65−3.56 (m, 1H), 2.26−2.13 (m, 1H), 
1.99−1.81 (m, 2H), 1.81−1.61 (m, 2H), 1.43−1.16 (m, 17H), 0.87 (t, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 158.8 (Cq), 140.9 (CH), 138.6 (Cq), 129.0 (CH), 126.5 (CH), 
126.3 (CH), 124.4 (CH), 121.4 (Cq), 112.4 (CH), 58.9 (CH), 54.8 (CH2), 34.0 (CH2), 31.9 (CH2), 
31.2 (CH2), 29.9 (CH2), 29.6 (CH2), 29.6 (CH2), 29.6 (CH2), 29.3 (CH2), 25.9 (CH2), 25.9 (CH2), 
22.7 (CH2), 14.1 (CH3).  
IR (ATR): ṽ = 2921, 2852, 1585, 1551, 1503, 1408, 1346, 761, 743, 681 cm–1.  
MS (EI) m/z (relative intensity): 338 (14) [M
+
], 255 (7), 225 (6), 197 (100), 183 (15), 169 (22), 
143 (33), 128 (27).  
HR-MS (EI) m/z calcd for C23H34N2
+
 338.2722, found 338.2730. 
Synthesis of 2-(2-n-hexylpyrrolidin-1-yl)-3-methylpyridine (217bb) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-hexene (111b) (38.0 mg, 0.5 mmol) at 80 °C. After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 
217bb (90 mg, 73%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 5.0, 1.8 Hz, 1H), 7.26 (dd, J = 7.4, 1.8 Hz, 1H), 
6.62 (dd, J = 7.4, 5.0 Hz, 1H), 4.29−4.16 (m, 1H), 3.70−3.58 (m, 1H), 3.21−3.09 (m, 1H), 2.20 (s, 
3H), 2.17−2.05 (m, 1H), 1.93−1.52 (m, 4H), 1.29−1.14 (m, 9H), 0.83 (t, J = 6.3 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.9 (Cq), 114.7 (CH), 
58.1 (CH), 51.7 (CH2), 34.3 (CH2), 31.9 (CH2), 31.2 (CH2), 29.6 (CH2), 25.9 (CH2), 24.9 (CH2), 
22.6 (CH2), 20.0 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2922, 2856, 1588, 1563, 1383, 1345, 975, 774 cm–1. MS (EI) m/z (relative 
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intensity): 246 (7) [M
+
], 161 (100), 154 (8), 133 (12), 92 (17).  
HR-MS (EI) m/z calcd for C16H26N2
+
 246.2076, found 226.2068.  
Synthesis of 2-(2-n-heptylpyrrolidin-1-yl)-3-methylpyridine (217bc) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-heptene (111c) (49.0 mg, 0.5 mmol) at 80 °C. After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 
217bc (103 mg, 78%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.8 Hz, 1H), 7.26 (dd, J = 7.4, 1.8 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.28−4.15 (m, 1H), 3.70−3.57 (m, 1H), 3.21−3.09 (m, 1H), 2.21 (s, 
3H), 2.17−2.05 (m, 1H), 1.95−1.52 (m, 5H), 1.35−1.11 (m, 10H), 0.84 (t, J = 6.1 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
58.1 (CH), 51.7 (CH2), 34.2 (CH2), 31.8 (CH2), 31.2 (CH2), 29.8 (CH2), 29.3 (CH2), 25.9 (CH2), 
24.9 (CH2), 22.6 (CH2), 20.0 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2922, 2854, 1588, 1564, 1383, 1346, 774 cm–1.  
MS (EI) m/z (relative intensity): 260 (5) [M
+
], 168 (5), 161 (100), 133 (10), 92 (16).  
HR-MS (EI) m/z calcd for C17H28N2
+
 260.2252, found 260.2244.  
Synthesis of 3-methyl-2-(2-n-octylpyrrolidin-1-yl)pyridine (217bd) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-octene (111d) (56.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1→30/1) yielded 
217bd (123 mg, 90%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.8 Hz, 1H), 7.26 (dd, J = 7.4, 1.8 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.28−4.16 (m, 1H), 3.69−3.58 (m, 1H), 3.20−3.10 (m, 1H), 2.20 (s, 
3H), 2.17−2.06 (m, 1H), 1.95−1.50 (m, 5H), 1.34−1.11 (m, 12H), 0.84 (t, J = 6.1 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
58.1 (CH), 51.7 (CH2), 34.2 (CH2), 31.9 (CH2), 31.2 (CH2), 29.9 (CH2), 29.6 (CH2), 29.2 (CH2), 
25.9 (CH2), 24.9 (CH2), 22.6 (CH2), 20.0 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2921, 2853, 1588, 1383, 1346, 775 cm–1.  
MS (EI) m/z (relative intensity): 274 (5) [M
+
], 182 (6), 161 (100), 133 (7), 84 (17).  
HR-MS (EI) m/z calcd for C18H30N2
+
 274.2409, found 274.2405.  
Synthesis of 3-methyl-2-(2-n-nonylpyrrolidin-1-yl)pyridine (217be) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-nonene (111e) (63.0 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1→30/1) yielded 
217be (129 mg, 89%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.8 Hz, 1H), 7.26 (dd, J = 7.4, 1.8 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.28−4.15 (m, 1H), 3.69−3.58 (m, 1H), 3.20−3.10 (m, 1H), 2.21 (s, 
3H), 2.17−2.06 (m, 1H), 1.95−1.51 (m, 5H), 1.32−1.12 (m, 14H), 0.85 (t, J = 6.1 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 139.0 (CH), 121.9 (Cq), 114.7 (CH), 
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58.2 (CH), 51.7 (CH2), 34.2 (CH2), 31.9 (CH2), 31.2 (CH2), 29.9 (CH2), 29.6 (CH2), 29.6 (CH2), 
29.3 (CH2), 25.9 (CH2), 24.9 (CH2), 22.7 (CH2), 20.0 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2921, 2853, 1588, 1564, 1383, 1345, 775 cm–1.  
MS (EI) m/z (relative intensity): 288 (5) [M
+
], 196 (5), 161 (100), 133 (7), 92 (7).  
HR-MS (EI) m/z calcd for C19H32N2
+
 288.2565, found 288.2562.  
Synthesis of 3-methyl-2-(2-n-pentadecylpyrrolidin-1-yl)pyridine (217bf) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-pentadecene (111f) (105 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 
217bf (159 mg, 85%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 2.0 Hz, 1H), 7.26 (dd, J = 7.4, 2.0 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.27−4.16 (m, 1H), 3.69−3.59 (m, 1H), 3.20−3.11 (m, 1H), 2.21 (s, 
3H), 2.17−2.06 (m, 1H), 1.95−1.51 (m, 5H), 1.35−1.10 (m, 26H), 0.86 (t, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 144.6 (CH), 138.9 (CH), 121.8 (Cq), 114.6 (CH), 
58.2 (CH), 51.7 (CH2), 34.3 (CH2), 32.0 (CH2), 31.3 (CH2), 30.0 (CH2), 29.8 (CH2), 29.8 (CH2), 
29.8 (CH2), 29.8 (CH2), 29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.4 (CH2), 26.0 (CH2), 
25.0 (CH2), 22.8 (CH2), 20.1 (CH3), 14.2 (CH3).  
IR (ATR): ṽ = 2920, 2851, 1588, 1384, 1346, 1186, 992, 775 cm–1.  
MS (EI) m/z (relative intensity): 372 (4) [M
+
], 276 (6), 161 (100), 133 (7), 107 (7), 92 (8).  
HR-MS (EI) m/z calcd for C25H44N2
+
 372.3504.0572, found 372.3510.  
Synthesis of 2-(2-n-hexadecylpyrrolidin-1-yl)-3-methylpyridine (217bg) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-hexadecene (111g) (112 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 
217bg (168 mg, 87%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.9 Hz, 1H), 7.26 (dd, J = 7.4, 1.9 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.27−4.16 (m, 1H), 3.68−3.58 (m, 1H), 3.20−3.11 (m, 1H), 2.21 (s, 
3H), 2.17−2.06 (m, 1H), 1.98−1.50 (m, 5H), 1.30−1.15 (m, 28H), 0.86 (t, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 139.0 (CH), 121.9 (Cq), 114.7 (CH), 
58.2 (CH), 51.7 (CH2), 34.3 (CH2), 31.9 (CH2), 31.2 (CH2), 29.9 (CH2), 29.7 (CH2), 29.7 (CH2), 
29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.7 (CH2), 29.6 (CH2), 29.4 (CH2), 
25.9 (CH2), 24.9 (CH2), 22.7 (CH2), 20.0 (CH3), 14.1 (CH3).  
IR (ATR): ṽ = 2920, 2851, 1588, 1384, 1346, 992, 775 cm–1.  
MS (EI) m/z (relative intensity): 386 (5) [M
+
], 371 (4), 294 (7), 161 (100), 133 (7), 107 (8), 92 (7).  
HR-MS (EI) m/z calcd for C26H46N2
+
 386.3661, found 386.3662.  
Synthesis of 2-{2-(3,3-dimethylbutyl)pyrrolidin-1-yl}-3-methylpyridine (217bh) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (81.0 mg, 0.5 mmol) and 
3,3-dimethyl-1-butene (111h) (63.1 mg, 1.5 mmol) at 80 °C. After 18 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 30/1) 
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yielded 217bh (62 mg, 50%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 5.0, 1.9 Hz, 1H), 7.26 (dd, J = 7.2, 1.9 Hz, 1H), 
6.62 (dd, J = 7.2, 5.0 Hz, 1H), 4.22−4.12 (m, 1H), 3.69−3.59 (m, 1H), 3.22−3.13 (m, 1H), 2.21 (s, 
3H), 2.16−2.06 (m, 1H), 1.91−1.53 (m, 4H), 1.20−1.07 (m, 3H), 0.78 (s, 9H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.5 (Cq), 144.7 (CH), 139.0 (CH), 121.7 (Cq), 114.6 (CH), 
58.6 (CH), 51.7 (CH2), 39.8 (CH2), 31.2 (CH2), 30.1 (Cq), 29.3 (CH3), 29.0 (CH2), 24.9 (CH2), 
20.0 (CH3).  
IR (ATR): ṽ = 2951, 2864, 1588, 1383, 1343, 992, 775 cm–1.  
MS (EI) m/z (relative intensity): 246 (7) [M
+
], 161 (100), 143 (5), 92 (5).  
HR-MS (EI) m/z calcd for C16H26N2
+
 246.2076, found 246.2078.  
Synthesis of 3-methyl-2-{2-[2-(trimethylsilyl)ethyl]pyrrolidin-1-yl}pyridine (217bi) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
trimethyl(vinyl)silane (111i) (50.1 mg, 0.5 mmol) at 80 °C. After 18 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
40/1) yielded 217bi (78 mg, 59%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.03 (dd, J = 5.0, 1.9 Hz, 1H), 7.25 (dd, J = 7.2, 1.9 Hz, 1H), 
6.62 (dd, J = 7.2, 5.0 Hz, 1H), 4.25−4.13 (m, 1H), 3.71−3.60 (m, 1H), 3.24−3.15 (m, 1H), 2.21 (s, 
3H), 2.17−2.07 (m, 1H), 1.94−1.55 (m, 4H), 1.25−1.11 (m, 1H), 0.54−0.31 (m, 2H), −0.11 (s, 9H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.5 (Cq), 144.7 (CH), 139.0 (CH), 121.5 (Cq), 114.5 (CH), 
60.4 (CH), 52.0 (CH2), 30.7 (CH2), 27.9 (CH2), 24.8 (CH2), 20.1 (CH3), 12.1 (CH2), −1.8 (CH3).  
IR (ATR): ṽ = 2952, 2870, 1588, 1384, 1348, 1245, 1186, 832, 774, 691 cm–1.  
MS (EI) m/z (relative intensity): 262 (6) [M
+
], 261 (10) [(M−H)
+
], 161 (100), 92 (18), 73 (20).  
HR-MS (ESI) m/z calcd for [(C15H26N2Si)H]
+
 263.1938, found 263.1940.  
Synthesis of 3-methyl-2-{2-[2-(triethylsilyl)ethyl]pyrrolidin-1-yl}pyridine (217bj) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
triethyl(vinyl)silane (111j) (71.2 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 40/1) yielded 217bj 
(131 mg, 86%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.03 (dd, J = 4.9, 1.9 Hz, 1H), 7.24 (dd, J = 7.2, 1.9 Hz, 1H), 
6.60 (dd, J = 7.2, 4.9 Hz, 1H), 4.25−4.13 (m, 1H), 3.71−3.60 (m, 1H), 3.25−3.15 (m, 1H), 2.20 (s, 




C-NMR (75 MHz, CDCl3): δ = 159.4 (Cq), 144.7 (CH), 138.9 (CH), 121.5 (Cq), 114.5 (CH), 
60.6 (CH), 51.9 (CH2), 30.6 (CH2), 27.6 (CH2), 24.8 (CH2), 20.1 (CH3), 7.3 (CH3), 6.4 (CH2), 3.2 
(CH2). IR (ATR): ṽ = 2950, 2872, 1588, 1385, 1347, 1186, 1014, 772, 725 cm
–1
.  
MS (EI) m/z (relative intensity): 304 (3) [M
+
], 275 (4), 161 (100), 92 (5).  
HR-MS (EI) m/z calcd for C18H32N2Si
+
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Synthesis of 2-{2-(10-methoxy-n-decyl)pyrrolidin-1-yl}-3-methylpyridine (217bk) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
10-methoxy-1-decene (111k) (79.1 mg, 0.5 mmol) in DCE. After 18 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
30/1→20/1) yielded 217bk (104 mg, 65%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.03 (dd, J = 4.9, 2.0 Hz, 1H), 7.25 (dd, J = 7.4, 2.0 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.27−4.16 (m, 1H), 3.68−3.58 (m, 1H), 3.33 (t, J = 6.76 Hz, 2H), 




C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.6 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
72.9 (CH2), 58.5 (CH), 58.1 (CH3), 51.7 (CH2), 34.2 (CH2), 31.2 (CH2), 29.9 (CH2), 29.6 (CH2), 
29.6 (CH2), 29.5 (CH2), 29.5 (CH2), 29.4 (CH2), 26.1 (CH2), 25.9 (CH2), 24.9 (CH2), 20.0 (CH3).  
IR (ATR): ṽ = 2922, 2853, 1588, 1384, 1346, 1116, 992, 775 cm–1.  
MS (ESI) m/z (relative intensity): 332 (5) [M
+
], 240 (7), 161 (100), 133 (12), 92 (13).  
HR-MS (ESI) m/z calcd for C21H26N2O
+
 332.2828, found 332.2826.  
Synthesis of 2-{2-(10-chloro-n-decyl)pyrrolidin-1-yl}-3-methylpyridine (217bl) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
10-chloro-1-decene (111l) (87.3 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 30/1) yielded 217bl 
(138 mg, 82%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.9 Hz, 1H), 7.26 (dd, J = 7.4, 1.9 Hz, 1H), 
6.62 (dd, J = 7.4, 4.9 Hz, 1H), 4.27−4.16 (m, 1H), 3.68−3.59 (m, 1H), 3.50 (t, J = 7.4 Hz, 2H), 
3.19−3.10 (m, 1H), 2.21 (s, 3H), 2.17−2.06 (m, 1H), 1.93−1.54 (m, 6H), 1.44−1.14 (m, 15H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
58.1 (CH), 51.7 (CH2), 45.2 (CH2), 34.2 (CH2), 32.6 (CH2), 31.2 (CH2), 29.8 (CH2), 29.5 (CH2), 
29.4 (CH2), 29.4 (CH2), 28.8 (CH2), 26.8 (CH2), 25.9 (CH2), 24.9 (CH2), 20.0 (CH3).  
IR (ATR): ṽ = 2923, 2853, 1588, 1383, 1346, 992, 776, 650 cm–1.  
MS (EI) m/z (relative intensity): 336 (4) [M
+
], 244 (4), 161 (100), 133 (8), 92 (11).  
HR-MS (EI) m/z calcd for C20H33ClN2
+
 336.2332, found 336.2336. 
Synthesis of 2-{2-(10-bromo-n-decyl)pyrrolidin-1-yl}-3-methylpyridine (217bm) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
10-bromo-1-decene (111m) (110 mg, 0.5 mmol) in DCE. After 18 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 30/1) 
yielded 217bm (114 mg, 60%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 1.9 Hz, 1H), 7.25 (dd, J = 7.2, 1.9 Hz, 1H), 
6.62 (dd, J = 7.2, 4.9 Hz, 1H), 4.28−4.17 (m, 1H), 3.69−3.58 (m, 1H), 3.50 (t, J = 7.2 Hz, 2H), 
3.19−3.10 (m, 1H), 2.20 (s, 3H), 2.16−2.05 (m, 1H), 1.94−1.52 (m, 6H), 1.43−1.12 (m, 15H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
58.1 (CH), 51.7 (CH2), 45.1 (CH2), 34.2 (CH2), 32.6 (CH2), 31.2 (CH2), 29.8 (CH2), 29.5 (CH2), 
29.4 (CH2), 29.4 (CH2), 28.8 (CH2), 26.8 (CH2), 25.9 (CH2), 24.9 (CH2), 20.0 (CH3).  
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IR (ATR): ṽ = 2923, 2853, 1707, 1588, 1384, 1346, 992, 775, 650 cm–1.  









HR-MS (ESI) m/z calcd for [(C20H33BrN2)H]
+
 381.1900, found 381.1897. 
Synthesis of 2-{2-[4-(2-bromophenyl)butyl]pyrrolidin-1-yl}-3-methylpyridine (217bn) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
1-bromo-2-(but-3-en-1-yl)benzene (111n) (105 mg, 0.5 mmol). After 
18 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1) yielded 217bn (152 mg, 82%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.05 (dd, J = 4.9, 1.9 Hz, 1H), 7.48 (dd, J = 8.1, 1.1 Hz, 1H), 
7.26 (dd, J = 7.4, 1.9 Hz, 1H), 7.21−7.11 (m, 2H), 7.00 (ddd, J = 7.4, 7.4, 2.6 Hz, 1H), 6.62 (dd, 
J = 7.4, 4.9 Hz, 1H), 4.34−4.23 (m, 1H), 3.70−3.60 (m, 1H), 3.19−3.10 (m, 1H), 3.50 (td, J = 7.4, 
2.1 Hz, 2H), 2.21 (s, 3H), 2.18−2.07 (m, 1H), 1.96−1.83 (m, 1H), 1.82−1.67 (m, 2H), 1.65−1.49 
(m, 3H), 1.46−1.21 (m, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.6 (CH), 138.0 (Cq), 139.0 (CH), 132.6 (CH), 
130.2 (CH), 127.2 (CH), 127.2 (CH), 124.4 (Cq), 121.9 (Cq), 114.8 (CH), 58.0 (CH), 51.9 (CH2), 
36.0 (CH2), 33.9 (CH2), 31.1 (CH2), 30.0 (CH2), 25.6 (CH2), 25.0 (CH2), 20.0 (CH3).  
IR (ATR): ṽ = 2930, 2858, 1587, 1382, 1346, 1020, 776, 746 cm–1.  








Br), 317 (6), 265 (13), 
171 (35), 161 (40), 33 (22), 92 (17).  
HR-MS (ESI) m/z calcd for [(C20H25BrN2)H]
+
 373.1274, found 373.1274.  
Synthesis of 3-methyl-2-(2-phenethylpyrrolidin-1-yl)pyridine (217bo) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and styrene 
(111o) (52.1 mg, 0.5 mmol). After 18 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 25/1) yielded 217bo (98 mg, 
73%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.06 (dd, J = 4.9, 1.9 Hz, 1H), 7.30−7.18 (m, 3H), 7.17−7.09 (m, 
3H), 6.65 (dd, J = 7.2, 4.9 Hz, 1H), 4.41−4.31 (m, 1H), 3.73−3.64 (m, 1H), 3.22−3.14 (m, 1H), 
2.68−2.56 (m, 2H), 2.25−2.14 (m, 1H), 2.19 (s, 3H), 2.06−1.90 (m, 2H), 1.84−1.54 (m, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.8 (CH), 138.8 (Cq), 139.1 (CH), 128.3 (CH), 
128.2 (CH), 125.5 (CH), 122.1 (Cq), 111.0 (CH), 57.8 (CH), 51.7 (CH2), 35.9 (CH2), 32.2 (CH2), 
31.1 (CH2), 24.9 (CH2), 19.8 (CH3).  
IR (ATR): ṽ = 2956, 2862, 1587, 1382, 1346, 1186, 1099, 776, 696 cm–1.  
MS (EI) m/z (relative intensity): 266 (5) [M
+
], 175 (26), 161 (100), 133 (7), 92 (17).  
HR-MS (EI) m/z calcd for C18H22N2
+
 266.1783, found 266.1792.  
Synthesis of 2-{2-(4-methoxyphenethyl)pyrrolidin-1-yl}-3-methylpyridine (217bp) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
4-methoxystyrene (111p) (67.1 mg, 0.5 mmol). After 18 h, 
purification by column chromatography on silica gel 
(n-hexane/EtOAc: 30/1→20/1) yielded 217bp (104 mg, 70%) as a colorless oil.  
Experimental Section 
 
- 140 - 
 
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 5.0, 1.9 Hz, 1H), 7.26 (dd, J = 7.3, 1.9 Hz, 1H), 
7.04 (d, J = 8.6 Hz, 2H), 6.76 (d, J = 8.6 Hz, 2H), 6.65 (dd, J = 7.3, 5.0 Hz, 1H), 4.38−4.26 (m, 
1H), 3.75 (s, 3H), 3.70−3.61 (m, 1H), 3.20−3.12 (m, 1H), 2.61−2.47 (m, 2H), 2.24−2.11 (m, 1H), 
2.18 (s, 3H), 2.01−1.49 (m, 5H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 157.5 (Cq), 144.7 (CH), 139.0 (CH), 134.8 (Cq), 
129.1 (CH), 122.1 (Cq), 114.9 (CH), 113.6 (CH), 57.8 (CH), 55.2 (CH3), 51.8 (CH2), 36.2 (CH2), 
31.3 (CH2), 31.2 (CH2), 25.0 (CH2), 19.9 (CH3).  
IR (ATR): ṽ = 2952, 2862, 1587, 1510, 1382, 1347, 1241, 1176, 1035, 820, 776 cm–1.  
MS (EI) m/z (relative intensity): 296 (10) [M
+
], 281 (10), 175 (35), 161 (100), 133 (13), 121 (25), 
92 (27).  
HR-MS (EI) m/z calcd for C19H24N2O
+
 296.1889, found 296.1887.  
Synthesis of 2-{2-(4-bromophenethyl)pyrrolidin-1-yl}-3-methylpyridine (217bq) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
4-bromostyrene (111q) (91.5 mg, 0.5 mmol). After 18 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 30/1) 
yielded 217bq (112 mg, 65%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.05 (dd, J = 4.9, 1.9 Hz, 1H), 7.32 (d, J = 8.6 Hz, 2H), 7.26 (dd, 
J = 7.4, 1.9 Hz, 1H), 6.99 (d, J = 8.6 Hz, 2H), 6.65 (dd, J = 7.4, 4.9 Hz, 1H), 4.40−4.29 (m, 1H), 




C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 144.6 (CH), 141.6 (Cq), 139.0 (CH), 131.1 (CH), 
130.0 (CH), 122.0 (Cq), 119.1 (Cq), 111.0 (CH), 57.7 (CH), 52.0 (CH2), 35.7 (CH2), 31.7 (CH2), 
31.1 (CH2), 25.0 (CH2), 19.8 (CH3).  
IR (ATR): ṽ = 2958, 2862, 1587, 1487, 1382, 1347, 1010, 776 cm–1.  








Br), 175 (38), 161 (100), 147 
(10), 133 (18), 92 (23).  
HR-MS (EI) m/z calcd for C18H21BrN2
+
 344.0888, found 344.0879.  
Synthesis of 2-{2-(4-fluorophenethyl)pyrrolidin-1-yl}-3-methylpyridine (217br) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
4-fluorostyrene (111r) (61.1 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 30/1→20/1) 
yielded 217br (91 mg, 64%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.05 (dd, J = 4.9, 1.9 Hz, 1H), 7.27 (dd, J = 7.3, 1.9 Hz, 1H), 
7.07 (ddd, J = 8.7, 8.7, 2.3 Hz, 2H), 6.76 (dd, J = 8.7, 8.7 Hz, 2H), 6.65 (dd, J = 7.3, 4.9 Hz, 1H), 
4.41−4.29 (m, 1H), 3.73−3.62 (m, 1H), 3.21−3.11 (m, 1H), 2.66−2.51 (m, 2H), 2.23−2.12 (m, 1H), 
2.19 (s, 3H), 2.03−1.51 (m, 5H).
  
13
C-NMR (75 MHz, CDCl3): δ = 161.1 (d, 
1
JC–F = 243 Hz, Cq), 159.7 (Cq), 144.6 (CH), 139.0 
(CH), 138.2 (d, 
4
JC–F = 3 Hz, Cq), 129.5 (d, 
3
JC–F = 8 Hz, CH), 122.0 (Cq), 111.0 (CH), 114.7 (d, 
2
JC–F = 21 Hz, CH), 57.7 (CH), 51.9 (CH2), 36.0 (CH2), 31.4 (CH2), 31.1 (CH2), 25.0 (CH2), 19.8 
(CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(118.2−118.3) (m).  
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IR (ATR): ṽ = 2955, 2864, 1587, 1508, 1382, 1348, 1216, 822, 776 cm–1.  
MS (EI) m/z (relative intensity): 284 (5) [M
+
], 175 (32), 161 (100), 133 (12), 109 (17), 92 (27).  
HR-MS (EI) m/z calcd for C18H21FN2
+
 284.1689, found 284.1692. 
Synthesis of 3-methyl-2-{2-[2-(naphthalen-2-yl)ethyl]pyrrolidin-1-yl}pyridine (217bs) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
2-vinylnaphthalene (111s) (77.1 mg, 0.5 mmol). After 18 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 25/1) 
yielded 217bs (91 mg, 57%) as a white solid.  
M.p. = 93−94 °C.
  
1
H-NMR (300 MHz, CDCl3): δ = 8.09 (dd, J = 4.9, 2.0 Hz, 1H), 7.79−7.69 (m, 3H), 7.58 (s, 1H), 
7.45−7.35 (m, 2H), 7.31−7.25 (m, 2H), 6.67 (dd, J = 7.4, 4.9 Hz, 1H), 4.48−4.36 (m, 1H), 




C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 140.2 (Cq), 139.0 (CH), 133.6 (Cq), 
131.8 (Cq), 127.6 (CH), 127.5 (CH), 127.4 (CH), 127.3 (CH), 126.0 (CH), 125.7 (CH), 124.9 
(CH), 122.0 (Cq), 111.0 (CH), 57.9 (CH), 51.9 (CH2), 35.7 (CH2), 32.4 (CH2), 31.2 (CH2), 25.0 
(CH2), 19.9 (CH3).  
IR (ATR): ṽ = 2963, 2919, 2858, 1588, 1563, 1382, 1320, 862, 815, 786, 475 cm–1.  
MS (EI) m/z (relative intensity): 316 (10) [M
+
], 175 (50), 161 (100), 141 (20), 111 (15), 92 (30).  
HR-MS (EI) m/z calcd for C22H24N2
+
 316.1939, found 316.1927.  
Synthesis of 2-{2-(10-isobutoxy-n-decyl)pyrrolidin-1-yl}-3-methylpyridine (217'bt) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
9-decen-1-yl 4-methylbenzenesulfonate (111t) (155 mg, 0.5 mmol). 
After 18 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 40/1→30/1) yielded 217'bt (144 mg, 77%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.04 (dd, J = 4.9, 2.0 Hz, 1H), 7.25 (dd, J = 7.4, 2.0 Hz, 1H), 
6.61 (dd, J = 7.4, 4.9 Hz, 1H), 4.27−4.16 (m, 1H), 3.68−3.58 (m, 1H), 3.35 (t, J = 6.7 Hz, 2H), 
3.31 (d, J = 6.7 Hz, 2H), 2.20 (s, 3H), 2.17−2.06 (m, 1H), 1.95−1.47 (m, 8H), 1.33−1.13 (m, 15H), 
0.87 (d, J = 7.0 Hz, 6H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.7 (Cq), 144.7 (CH), 138.9 (CH), 121.8 (Cq), 114.7 (CH), 
77.8 (CH2), 71.0 (CH2), 58.1 (CH), 51.7 (CH2), 34.2 (CH2), 31.2 (CH2), 29.9 (CH2), 29.7 (CH2), 
29.6 (CH2), 29.6 (CH2), 29.5 (CH2), 29.5 (CH2), 28.4 (CH), 26.2 (CH2), 25.9 (CH2), 24.9 (CH2), 
20.0 (CH3), 19.4 (CH3).  
IR (ATR): ṽ = 2923, 2852, 1588, 1565, 1384, 1346, 1110, 992, 775 cm–1.  
MS (EI) m/z (relative intensity): 374 (5) [M
+
], 331 (6), 282 (5), 161 (100), 133 (7), 107 (96), 92 
(6).  
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Synthesis of 10-{1-(3-methylpyridin-2-yl)pyrrolidin-2-yl}-n-decyl 4-methylbenzenesulfonate 
(217bt) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
9-decen-1-yl 4-methylbenzenesulfonate (111t) (155 mg, 0.5 mmol) in DCE. 
After 18 h, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 15/1→5/1) yielded 217bt (148 mg, 63%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.03 (dd, J = 4.9, 1.9 Hz, 1H), 7.75 (d, J = 8.3 Hz, 2H), 7.31 (d, 
J = 8.3 Hz, 2H), 7.25 (dd, J = 7.2, 1.9 Hz, 1H), 6.61 (dd, J = 7.2, 4.9 Hz, 1H), 4.28−4.15 (m, 1H), 
3.98 (t, J = 6.6 Hz, 2H), 3.69−3.58 (m, 1H), 3.21−3.08 (m, 1H), 2.41 (s, 3H), 2.20 (s, 3H), 
2.16−2.05 (m, 1H), 1.94−1.52 (m, 6H), 1.30−1.09 (m, 15H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 144.5 (CH), 144.5 (Cq), 139.0 (CH), 133.2 (Cq), 
129.7 (CH), 127.8 (CH), 121.9 (Cq), 114.6 (CH), 70.6 (CH2), 58.1 (CH), 51.7 (CH2), 34.2 (CH2), 
31.2 (CH2), 29.8 (CH2), 29.5 (CH2), 29.3 (CH2), 29.3 (CH2), 28.8 (CH2), 28.7 (CH2), 25.8 (CH2), 
25.2 (CH2), 24.9 (CH2), 21.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2923, 2851, 1588, 1385, 1356, 1174, 1097, 956, 775, 553 cm–1.  
MS (EI) m/z (relative intensity): 472 (3) [M
+
], 376 (3), 161 (100), 133 (10), 107 (14), 92 (13).  
HR-MS (EI) m/z calcd for C27H40N2O3S
+
 472.2760, found 472.2767. 
Synthesis of 12-{1-(3-methylpyridin-2-yl)pyrrolidin-2-yl}dodecan-2-one (217bu) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
11-dodecen-2-one (111u) (99.1 mg, 0.5 mmol) in DCE. After 18 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
10/1) yielded 217bu (69 mg, 38%) as a white solid.  
M.p. = 62−63 °C.
  
1
H-NMR (300 MHz, CDCl3): δ = 8.01 (dd, J = 4.9, 1.9 Hz, 1H), 7.23 (dd, J = 7.2, 1.9 Hz, 1H), 
6.60 (dd, J = 7.2, 4.9 Hz, 1H), 4.27−4.15 (m, 1H), 3.68−3.56 (m, 1H), 3.17−3.06 (m, 1H), 2.36 (t, 




C-NMR (75 MHz, CDCl3): δ = 207.1 (Cq), 159.7 (Cq), 144.6 (CH), 138.9 (CH), 121.8 (Cq), 
114.6 (CH), 58.1 (CH), 51.6 (CH2), 43.7 (CH2), 34.2 (CH2), 31.1 (CH2), 29.8 (CH2), 29.7 (CH3), 
29.5 (CH2), 29.4 (CH2), 29.4 (CH2), 29.3 (CH2), 29.1 (CH2), 25.8 (CH2), 24.8 (CH2), 23.8 (CH2), 
19.9 (CH3).  
IR (ATR): ṽ = 2922, 2853, 1714, 1588, 1384, 1347, 1164, 776, 731 cm–1.  
MS (EI) m/z (relative intensity): 344 (4) [M
+
], 252 (6), 161 (100), 133 (12), 92 (16).  
HR-MS (ESI) m/z calcd for [(C22H36N2O)H]
+
 345.2900, found 345.2900. 
Synthesis of 9-{1-(3-methylpyridin-2-yl)pyrrolidin-2-yl}nonan-2-ol (217bv) 
The general procedure E was followed using 
3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
8-nonen-2-one (111v) (70.0 mg, 0.5 mmol). After 18 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1→5/1) 
yielded 217bv (77 mg, 51%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 8.02 (dd, J = 4.9, 1.8 Hz, 1H), 7.26 (dd, J = 7.2, 1.8 Hz, 1H), 
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6.62 (dd, J = 7.2, 4.9 Hz, 1H), 4.27−4.15 (m, 1H), 3.76−3.68 (m, 1H), 3.68−3.58 (m, 1H), 
3.19−3.09 (m, 1H), 2.20 (s, 3H), 2.16−2.05 (m, 1H), 1.94−1.50 (m, 5H), 1.44−1.14 (m, 13H), 1.13 
(d, J = 6.4 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 144.6 (CH), 139.0 (CH), 121.9 (Cq), 114.6 (CH), 
68.0 (CH), 58.1 (CH), 51.7 (CH2), 39.3 (CH2), 34.2 (CH2), 31.2 (CH2), 29.8 (CH2), 29.5 (CH2), 
29.5 (CH2), 25.8 (CH2), 25.7 (CH2), 24.9 (CH2), 23.4 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 3364, 2924, 2854, 1588, 1384, 1346, 1102, 776, 730 cm–1.  
MS (EI) m/z (relative intensity): 304 (5) [M
+
], 289 (5), 161 (100), 133 (12), 92 (18).  
HR-MS (EI) m/z calcd for C19H32N2O
+
 304.2515, found 304.2519. 
Mechanistic studies with TEMPO (Scheme 82) 
 
A suspension of [RuCl2(PPh3)3] (24.0 mg, 5.0 mol %), rac-BINAP (18.7 mg, 6.0 mol %), AgOTf 
(15.4 mg, 12 mol %), TEMPO (234 mg, 1.5 mmol), 3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) 
(243 mg, 1.5 mmol) and 1-decene (111a) (70.1 mg, 0.5 mmol) in i-BuOH (1.0 mL) was stirred at 
120 °C under N2 for 18 h. At ambient temperature, EtOAc (5 mL) and silica (1.5 g) were added to 
the reaction mixture and the solvents were evaporated in reduced pressure. Purification by column 
chromatography on silica gel (n-hexane/EtOAc: 40/1→30/1) yielded 217ba (106 mg, 70%) as a 
colorless oil.  
Studies with isotopically labelled [D]4-MeOH (Scheme 83a) 
 
A suspension of [RuCl2(PPh3)3] (24.0 mg, 5.0 mol %), rac-BINAP (18.7 mg, 6.0 mol %), AgOTf 
(15.4 mg, 12 mol %), 3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (243 mg, 1.5 mmol) and 
styrene (111o) (52.1 mg, 0.5 mmol) in [D]4-MeOH (1.0 mL) was stirred at 120 °C under N2 for 
18 h. CuCl (50 mg), EtOAc (5 mL) and silica (1.5 g) were added to the cold reaction mixture and 
the solvents were evaporated in vacuo. Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1→10/1) to give [D]n-217bo (104 mg, 78%) as a colorless oil and [D]n-216b 
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Studies with isotopically labelled [D]4-MeOH (Scheme 83b) 
 
A suspension of [RuCl2(PPh3)3] (24.0 mg, 5.0 mol %), rac-BINAP (18.7 mg, 6.0 mol %), AgOTf 
(15.4 mg, 12 mol %) and 3-methyl-2-(pyrrolidin-1-yl)pyridine (216b) (81.0 mg, 0.5 mmol) in 
[D]4-MeOH (1.0 mL) was stirred at 120 °C under N2 for 18 h. EtOAc (5 mL) and silica (1.5 g) 
were added to the cold reaction mixture and the solvents were evaporated in vacuo. Purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) yielded compound 
[D]n-216b (65 mg, 76%) as a colorless oil. The deuterium incorporation was estimated by 
1
H-NMR spectroscopy.  
Studies with isotopically labelled compounds (Scheme 84) 
 
A suspension of [RuCl2(PPh3)3] (24.0 mg, 5.0 mol %), rac-BINAP (18.7 mg, 6.0 mol %), AgOTf 
(15.4 mg, 12 mol %), [D]n-216b (243 mg, 1.5 mmol) and 111o (52.1 mg, 0.5 mmol) in DCE 
(1.0 mL) was stirred at 120 °C under N2 for 18 h. CuCl (50 mg), EtOAc (5 mL) and silica (1.5 g) 
were added to the cold reaction mixture and the solvents were evaporated in vacuo. Purification by 
column chromatography on silica gel (n-hexane/EtOAc: 25/1→10/1) to give [D]n-217bo (116 mg, 
87%) as a colorless oil and [D]n-216b (120 mg, 49%) as a colorless oil. The deuterium 
incorporation was estimated by 
1
H-NMR spectroscopy.  
Synthesis of 2-decylpyrrolidine (218ba) 
The general procedure F was followed using 
2-(2-decylpyrrolidin-1-yl)-3-methylpyridine (217ba) (151 mg, 0.5 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH: 20/1→10/1) yielded 218ba 
(74 mg, 70%) as a white solid.  
M.p. = 88−89 °C.
  
1
H-NMR (300 MHz, [d]6-DMSO): δ = 9.34 (sbr, 1H), 3.38−3.24 (m, 1H), 3.19−3.00 (m, 2H), 
2.11−1.98 (m, 1H), 1.96−1.38 (m, 6H), 1.39−1.18 (m, 16H), 0.85 (t, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, [d]6-DMSO): δ = 59.3 (CH), 43.7 (CH2), 31.3 (CH2), 31.2 (CH2), 29.7 (CH2), 
28.9 (CH2), 28.8 (CH2), 28.7 (CH2), 28.6 (CH2), 28.6 (CH2), 26.1 (CH2), 22.9 (CH2), 22.0 (CH2), 
13.8 (CH3).  
IR (ATR): ṽ = 2919, 2850, 2744, 1461, 1385, 1030, 730 cm–1.  
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HR-MS (ESI) m/z calcd for [(C14H29N)H]
+
 210.2373, found 210.2375. 
Synthesis of 2-{2-(triethylsilyl)ethyl}pyrrolidine (218bj) 
The general procedure F was followed using 
3-methyl-2-{2-[2-(triethylsilyl)ethyl]pyrrolidin-1-yl}pyridine (217bj) (152 mg, 
0.5 mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH: 
20/1→10/1→5/1) yielded 218bj (65 mg, 61%) as a white solid.  
M.p. = 52−53 °C.
  
1
H-NMR (300 MHz, CDCl3): δ = 7.52 (sbr, 1H), 3.35−3.09 (m, 3H), 2.16−2.00 (m, 1H), 2.00−1.69 
(m, 3H), 1.64−1.43 (m, 2H), 0.91 (t, J = 7.8 Hz, 9H), 0.67−0.38 (m, 8H).
  
13
C-NMR (75 MHz, [d]6-DMSO): δ = 62.1 (CH), 44.1 (CH2), 29.4 (CH2), 26.3 (CH2), 23.1 (CH2), 
8.0 (CH2), 7.2 (CH3), 2.7 (CH2).  
IR (ATR): ṽ = 2950, 2873, 2730, 1459, 1414, 1015, 758, 720 cm–1.  
MS (ESI) m/z (relative intensity): 212 (100) [(M+H)
+
].  
HR-MS (ESI) m/z calcd for [(C12H27NSi)H]
+
 212.1986, found 212.1987. 
Synthesis of 2-(2-cyclohexylethyl)pyrrolidine (218bo) 
The general procedure F was followed using 
3-methyl-2-(2-phenethylpyrrolidin-1-yl)pyridine (217bo) (195 mg, 0.5 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH: 
10/1→5/1→3/1) yielded 218bo (53 mg, 58%) as a white solid.  
M.p. = 99−100 °C.
  
1
H-NMR (300 MHz [D]6-DMSO): δ = 6.93 (sbr, 1H), 3.33−3.18 (m, 1H), 3.17−2.95 (m, 2H), 
2.12−1.96 (m, 1H), 1.95−1.37 (m, 10H), 1.33−1.00 (m, 6H), 0.96−0.75 (m, 2H).
  
13
C-NMR (75 MHz, [d]6-DMSO): δ = 59.5 (CH), 43.8 (CH2), 36.7 (CH), 33.7 (CH2), 32.6 (CH2), 
29.8 (CH2), 28.9 (CH2), 26.0 (CH2), 25.6 (CH2), 23.0 (CH2).  
IR (ATR): ṽ = 1917, 1851, 1575, 1588, 1448, 1412, 1027, 387 cm–1.  
MS (ESI) m/z (relative intensity): 182 (100) [(M+H)
+
].  
HR-MS (ESI) m/z calcd for [(C12H23N)H]
+
 182.1903, found 182.1905. 
8.3.5 Analytical Data for the Products of Ruthenium-Catalyzed ortho-C−H 
Halogenation of Benzamide 219 
Synthesis of 2-bromo-N,N-diisopropylbenzamide (220a) 
The general procedure G was followed using N,N-diisopropylbenzamide (219a) 
(103 mg, 0.5 mmol) and NBS (178 mg, 1.0 mmol). After 16 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1→5/1) yielded 220a (86 
mg, 60%) as a white solid.  
M.p. = 73−74 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.57 (d, J = 7.6 Hz, 1H), 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 
7.22−7.12 (m, 2H), 3.65−3.43 (m, 2H), 1.56 (d, J = 6.7 Hz, 3H), 1.55 (d, J = 6.7 Hz, 3H), 1.22 (d, 
J = 6.7 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.0 (Cq), 140.1 (Cq), 132.7 (CH), 129.3 (CH), 127.4 (CH), 
126.5 (CH), 118.8 (Cq), 51.1 (CH), 45.9 (CH), 20.7 (CH3), 20.6 (CH3), 20.5 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2975, 2930, 1626, 1438, 1339, 1019, 770 cm–1.  
Experimental Section 
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Br), 238 (25), 240 (26), 
185 (98), 185 (100).  
HR-MS (EI) m/z calcd for C13H18BrNO
+
 283.0572, found 283.0567.  
The spectral data were in accordance with those reported in the literature.
113a
 
Synthesis of 2-bromo-N,N,3,5-tetramethylbenzamide (220b) 
The general procedure G was followed using N,N,3,5-tetramethylbenzamide (219b) 
(177 mg, 1.0 mmol) and NBS (356 mg, 2.0 mmol). After 16 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 3/1→2/1) yielded 220b 
(175 mg, 68%) as a yellow solid.  
M.p. = 103−104 °C. 
1




C-NMR (75 MHz, CDCl3): δ = 169.8 (Cq), 138.9 (Cq), 138.5 (Cq), 137.6 (Cq), 131.7 (CH), 125.5 
(CH), 117.9 (Cq), 38.2 (CH3), 34.5 (CH3), 23.0 (CH3), 20.7 (CH3).  
IR (ATR): ṽ = 2918, 2871, 1626, 1508, 1441, 1392, 1257, 1130, 1020, 865, 665 cm–1.  








Br), 219 (97), 209 (100), 
104 (35).  
HR-MS (EI) m/z calcd for C11H14BrNO
+
 255.0259, found 255.0249. 
Synthesis of 2-iodo-N,N,3,5-tetramethylbenzamide (221b) 
The general procedure G was followed using N,N,3,5-tetramethylbenzamide (219b) 
(177 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 16 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 3/1) yielded 221b (224 mg, 
74%) as a yellow solid. 
The general procedure H was followed using N,N,3,5-tetramethylbenzamide (219b) (177 mg, 
1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 3/1) yielded 221b (237 mg, 78%) as a yellow solid.  
M.p. = 82−83 °C.  
1




C-NMR (75 MHz, CDCl3): δ = 171.3 (Cq), 143.5 (Cq), 138.0 (Cq), 138.4 (Cq), 130.3 (CH), 124.8 
(CH), 94.9 (Cq), 38.3 (CH3), 34.5 (CH3), 28.4 (CH3), 20.6 (CH3).  
IR (ATR): ṽ = 2913, 2853, 1626, 1505, 1441, 1399, 1125, 1003, 863, 663 cm–1.  
MS (EI) m/z (relative intensity): 303 (38) [M
+
], 259 (100), 231 (24), 104 (20).  
HR-MS (EI) m/z calcd for C11H14INO
+
 303.0120, found 303.0118. 
Synthesis of 2-bromo-N,N-diethyl-3,5-dimethylbenzamide (220c) 
The general procedure G was followed using N,N-diethyl-3,5-dimethylbenzamide 
(219c) (205 mg, 1.0 mmol) and NBS (356 mg, 2.0 mmol). After 16 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 220c 
(159 mg, 56%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.02 (s, 1H), 6.85 (s, 1H), 3.79 (hex, J = 6.9 Hz, 1H), 3.31 (hex, 
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13
C-NMR (75 MHz, CDCl3): δ = 169.0 (Cq), 139.0 (Cq), 138.4 (Cq), 137.2 (Cq), 131.4 (CH), 125.3 
(CH), 117.9 (Cq), 38.5 (CH2), 38.6 (CH2), 23.0 (CH3), 20.6 (CH3), 13.8 (CH3), 12.4 (CH3).  
IR (ATR): ṽ = 2973, 2932, 1631, 1433, 1132, 1023, 767, 649 cm–1.  








Br), 219 (98), 209 (100), 
133 (22), 104 (48).  
HR-MS (ESI) m/z calcd for [(C13H18BrNO)H]
+
 284.0645, found 284.0645. 
Synthesis of N,N-diethyl-2-iodo-3,5-dimethylbenzamide (221c) 
The general procedure G was followed using N,N-diethyl-3,5-dimethylbenzamide 
(219c) (205 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 16 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 10/1→5/1) and normal 
phase HPLC (n-hexane/EtOAc: 15/1→7/1) yielded 221c (179 mg, 54%) as a 
colorless oil. 
The general procedure H was followed using N,N-diethyl-3,5-dimethylbenzamide (219c) (205 mg, 
1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 10/1→5/1) and normal phase HPLC (n-hexane/EtOAc: 15/1→7/1) 
yielded 221c (235 mg, 71%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.02 (s, 1H), 6.79 (s, 1H), 3.84 (hex, J = 6.9 Hz, 1H), 3.28 (hex, 




C-NMR (75 MHz, CDCl3): δ = 170.7 (Cq), 143.6 (Cq), 138.1 (Cq), 138.2 (Cq), 130.2 (CH), 124.8 
(CH), 95.4 (Cq), 38.6 (CH2), 38.7 (CH2), 28.5 (CH3), 20.7 (CH3), 13.8 (CH3), 12.3 (CH3).  
IR (ATR): ṽ = 2972, 2932, 1628, 1432, 1317, 1129, 1008, 857, 766, 648 cm–1.  
MS (EI) m/z (relative intensity): 331 (57) [M
+
], 259 (100), 231 (32), 204 (50), 135 (33), 104 (37).  
HR-MS (EI) m/z calcd for C13H18INO
+
 331.0433, found 331.0432. 
Synthesis of 2-bromo-N,N-diisopropyl-3,5-dimethylbenzamide (220d) 
The general procedure G was followed using 
N,N-diisopropyl-3,5-dimethylbenzamide (219d) (233 mg, 1.0 mmol) and NBS 
(356 mg, 2.0 mmol) at 80 °C. After 16 h, purification by column chromatography 
on silica gel (n-hexane/EtOAc: 10/1) yielded 220d (277 mg, 89%) as a white 
solid.  
M.p. = 200−201 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.00 (s, 1H), 6.76 (s, 1H), 3.63 (sept, J = 6.7 Hz, 1H), 3.50 (sept, 
J = 6.7 Hz, 1H), 2.36 (s, 3H), 2.25 (s, 3H), 1.57 (d, J = 6.7 Hz, 3H), 1.55 (d, J = 6.7 Hz, 3H), 1.22 
(d, J = 6.7 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.7 (Cq), 140.4 (Cq), 138.4 (Cq), 137.2 (Cq), 130.9 (CH), 124.4 
(CH), 117.7 (Cq), 51.0 (CH), 45.7 (CH), 23.0 (CH3), 20.7 (CH3), 20.6 (CH3), 20.6 (CH3), 20.5 
(CH3), 19.9 (CH3).  
IR (ATR): ṽ = 2960, 2928, 1626, 1438, 1368, 1346, 1207, 1026, 865, 778 cm–1.  








Br), 270 (28), 268 (28), 
219 (98), 209 (100), 104 (17).  
HR-MS (EI) m/z calcd for C15H22BrNO
+
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Synthesis of 2-iodo-N,N-diisopropyl-3,5-dimethylbenzamide (221d) 
The general procedure G was followed using 
N,N-diisopropyl-3,5-dimethylbenzamide (219d) (233 mg, 1.0 mmol) and NIS 
(450 mg, 2.0 mmol). After 16 h, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 221d (251 mg, 70%) as a white solid.  
The general procedure H was followed using N,N-diisopropyl-3,5-dimethylbenzamide (219d) 
(233 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 221d (305 mg, 85%) as a white 
solid.  
M.p. = 195−196 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 6.98 (s, 1H), 6.71 (s, 1H), 3.59 (hept, J = 6.8 Hz, 1H), 3.48 (hept, 
J = 6.8 Hz, 1H), 2.39 (s, 3H), 2.23 (s, 3H), 1.60 (d, J = 6.8 Hz, 3H), 1.54 (d, J = 6.8 Hz, 3H), 1.24 
(d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 170.5 (Cq), 145.0 (Cq), 138.2 (Cq), 138.2 (Cq), 129.9 (CH), 123.8 
(CH), 95.0 (Cq), 51.1 (CH), 45.8 (CH), 28.5 (CH3), 20.7 (CH3), 20.7 (CH3), 20.7 (CH3), 20.6 
(CH3), 19.9 (CH3).  
IR (ATR): ṽ = 2958, 2926, 1625, 1438, 1368, 1344, 1206, 864, 777, 630 cm–1.  
MS (EI) m/z (relative intensity): 359 (40) [M
+
], 316 (48), 259 (100), 232 (40), 133 (32), 104 (32).  
HR-MS (ESI) m/z calcd for [(C15H22INO)H]
+
 360.0824, found 360.0817. 
Synthesis of (2-bromo-3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone (220e) 
The general procedure G was followed using 
(3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone (219e) (203 mg, 1.0 mmol) and 
NBS (356 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 2/1→1/1) and normal phase HPLC (n-hexane/EtOAc: 
3/1→2/1) yielded 220e (102 mg, 36%) as a white solid. 
The general procedure H was followed using (3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone 
(219e) (203 mg, 1.0 mmol) and NBS (356 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 2/1→1/1) and normal phase HPLC 
(n-hexane/EtOAc: 3/1→2/1) yielded 220e (102 mg, 36%) as a white solid.  
M.p. = 68−69 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.03 (s, 1H), 6.90 (s, 1H), 3.64 (t, J = 6.7 Hz, 2H), 3.31−3.08 (m, 
2H), 2.36 (s, 3H), 2.26 (s, 3H), 2.00−1.83 (m, 4H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.0 (Cq), 139.9 (Cq), 138.5 (Cq), 137.6 (Cq), 131.6 (CH), 125.3 
(CH), 117.5 (Cq), 43.0 (CH2), 45.3 (CH2), 25.8 (CH3), 24.6 (CH2), 23.0 (CH2), 20.7 (CH3).  
IR (ATR): ṽ = 2971, 2874, 1629, 1433, 1023, 859, 706, 621 cm–1.  








Br), 219 (98), 209 (100), 
202 (37), 104 (38).  
HR-MS (EI) m/z calcd for C13H16BrNO
+
 281.0415, found 281.0405. 
Synthesis of (2-iodo-3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone (221e) 
The general procedure G was followed using 
(3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone (219e) (203 mg, 1.0 mmol) and 
NIS (450 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 10/1) yielded 221e (238 mg, 72%) as a white solid.  
Experimental Section 
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The general procedure H was followed using (3,5-dimethylphenyl)(pyrrolidin-1-yl)methanone 
(219e) (203 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 10/1) yielded 221e (250 mg, 76%) as a white 
solid.  
M.p. = 107−108 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.00 (s, 1H), 6.76 (s, 1H), 3.61 (t, J = 6.7 Hz, 2H), 3.25−3.01 (m, 
2H), 2.38 (s, 3H), 2.23 (s, 3H), 1.99−1.76 (m, 4H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.5 (Cq), 144.7 (Cq), 138.1 (Cq), 138.5 (Cq), 130.4 (CH), 124.6 
(CH), 94.7 (Cq), 48.3 (CH2), 45.4 (CH2), 28.4 (CH3), 25.9 (CH2), 24.5 (CH2), 20.7 (CH3).  
IR (ATR): ṽ = 2963, 2930, 1626, 1434, 1364, 1322, 1148, 1036, 816, 608 cm–1.  
MS (EI) m/z (relative intensity): 329 (67) [M
+
], 259 (100), 231 (34), 202 (49), 133 (37), 104 (38).  
HR-MS (EI) m/z calcd for C13H16INO 329.0277, found 329.0275. 
Synthesis of (2-bromo-3,5-dimethylphenyl)(piperidin-1-yl)methanone (220f) 
The general procedure D was followed using 
(3,5-dimethylphenyl)(piperidin-1-yl)methanone (219f) (215 mg, 1.0 mmol) and 
NBS (356 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 5/1→4/1) and normal phase HPLC (n-hexane/EtOAc: 
10/1→5/1) yielded 220f (198 mg, 67%) as a white solid.  
M.p. = 107−108 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 6.99 (s, 1H), 6.76 (s, 1H), 3.76−3.58 (m, 2H), 3.22−3.05 (m, 
2H), 2.32 (s, 3H), 2.22 (s, 3H), 1.71−1.50 (m, 5H), 1.48−1.31 (m, 1H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.0 (Cq), 138.8 (Cq), 138.4 (Cq), 137.3 (Cq), 131.4 (CH), 125.2 
(CH), 117.8 (Cq), 47.7 (CH2), 38.2 (CH2), 26.1 (CH3), 25.3 (CH2), 24.4 (CH2), 23.0 (CH2), 20.6 
(CH3).  
IR (ATR): ṽ = 2937, 2855, 1624, 1439, 1217, 1021, 792, 659 cm–1.  








Br), 219 (98), 209 (100), 
135 (27), 104 (38).  
HR-MS (EI) m/z calcd for C14H18BrNO
+
 295.0572, found 295.0576. 
Synthesis of (2-iodo-3,5-dimethylphenyl)(piperidin-1-yl)methanone (221f) 
The general procedure G was followed using 
(3,5-dimethylphenyl)(piperidin-1-yl)methanone (219f) (215 mg, 1.0 mmol) and 
NIS (450 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 5/1→4/1) yielded 221f (219 mg, 62%) as a white 
solid. 
The general procedure H was followed using (3,5-dimethylphenyl)(piperidin-1-yl)methanone 
(219f) (215 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 5/1→4/1) yielded 221f (275 mg, 76%) as a white 
solid.  
M.p. = 77−78 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.01 (s, 1H), 6.77 (s, 1H), 3.84−3.74 (m, 1H), 3.70−3.60 (m, 
1H), 3.25−3.07 (m, 2H), 2.41 (s, 3H), 2.25 (s, 3H), 1.76−1.54 (m, 5H), 1.53−1.35 (m, 1H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.8 (Cq), 143.6 (Cq), 138.2 (Cq), 138.4 (Cq), 130.3 (CH), 124.7 
(CH), 95.1 (Cq), 47.8 (CH2), 38.3 (CH2), 28.5 (CH3), 26.1 (CH2), 25.3 (CH2), 24.5 (CH2), 20.7 
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(CH3).  
IR (ATR): ṽ = 2936, 2852, 1625, 1435, 1215, 1006, 855, 658 cm–1.  
MS (EI) m/z (relative intensity): 343 (52) [M
+
], 338 (100), 259 (93), 231 (23), 214 (43), 104 (28).  
HR-MS (EI) m/z calcd for C14H18INO
+
 343.0433, found 343.0438. 
Synthesis of (2-bromo-3,5-dimethylphenyl)(morpholino)methanone (220g) 
The general procedure G was followed using 
(3,5-dimethylphenyl)(morpholino)methanone (219g) (217 mg, 1.0 mmol) and 
NBS (356 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 3/1→2/1) and normal phase HPLC (n-hexane/EtOAc: 
5/1→3/1) yielded 220g (155 mg, 52%) as a white solid.  
M.p. = 118−119 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.05 (s, 1H), 6.85 (s, 1H), 3.92−3.63 (m, 5H), 3.33−3.13 (m, 
1H), 3.32−3.11 (m, 2H), 2.34 (s, 3H), 2.25 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.3 (Cq), 138.7 (Cq), 137.8 (Cq), 137.7 (Cq), 132.0 (CH), 125.5 
(CH), 117.9 (Cq), 66.7 (CH2), 66.6 (CH2), 47.1 (CH2), 41.9 (CH2), 23.0 (CH3), 20.7 (CH3).  
IR (ATR): ṽ = 2913, 2848, 1630, 1436, 1112, 1020, 860, 618 cm–1.  








Br), 219 (100), 209 (98), 
104 (33).  
HR-MS (ESI) m/z calcd for [(C13H16INO2)H]
+
 298.0437, found 298.0445. 
Synthesis of (2-iodo-3,5-dimethylphenyl)(morpholino)methanone (221g) 
The general procedure G was followed using 
(3,5-dimethylphenyl)(morpholino)methanone (219g) (217 mg, 1.0 mmol) and 
NIS (450 mg, 2.0 mmol). After 16 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 3/1→2/1) and normal phase HPLC (n-hexane/EtOAc: 
7/1→3/1) yielded 221g (186 mg, 54%) as a white solid. 
The general procedure H was followed using (3,5-dimethylphenyl)(morpholino)methanone (219g) 
(217 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 3/1→2/1) and normal phase HPLC 
(n-hexane/EtOAc: 7/1→3/1) yielded 221g (248 mg, 72%) as a white solid.  
M.p. = 135−136 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.03 (s, 1H), 6.77 (s, 1H), 3.86−3.68 (m, 5H), 3.60−3.50 (m, 
1H), 3.32−3.11 (m, 2H), 2.40 (s, 3H), 2.25 (s, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 170.0 (Cq), 138.5 (Cq), 138.2 (Cq), 138.6 (Cq), 130.8 (CH), 124.9 
(CH), 95.0 (Cq), 66.6 (CH2), 66.5 (CH2), 47.1 (CH2), 41.8 (CH2), 28.5 (CH3), 20.7 (CH3).  
IR (ATR): ṽ = 2901, 2856, 1627, 1460, 1434, 1106, 1007, 860, 662 cm–1.  
MS (EI) m/z (relative intensity): 345 (30) [M
+
], 359 (100), 2313 (17), 104 (20).  
HR-MS (EI) m/z calcd for C13H16INO2
+
 345.0226, found 345.0209. 
Synthesis of 2-bromo-N,N-diisopropyl-5-methylbenzamide (220h) 
The general procedure G was followed using 
N,N-diisopropyl-3-methylbenzamide (219h) (110 mg, 0.5 mmol) and NBS 
(178 mg, 1.0 mmol). After 16 h, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1→5/1) yielded 220h (95 mg, 64%) as a white solid.  
Experimental Section 
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M.p. = 162−163 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.40 (d, J = 8.2 Hz, 1H), 7.03−6.94 (m, 2H), 3.61 (sept, J = 
6.7 Hz, 1H), 3.51 (sept, J = 6.7 Hz, 1H), 2.29 (s, 3H), 1.57 (d, J = 6.7 Hz, 3H), 1.55 (d, J = 6.7 Hz, 
3H), 1.23 (d, J = 6.7 Hz, 3H), 1.06 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.3 (Cq), 139.9 (Cq), 137.6 (Cq), 132.5 (CH), 130.2 (CH), 
127.1 (CH), 111.4 (Cq), 51.1 (CH), 45.9 (CH), 20.8 (CH3), 20.8 (CH3), 20.6 (CH3), 20.6 (CH3), 
20.1 (CH3).  
IR (ATR): ṽ = 2960, 2928, 1626, 1441, 1337, 1044, 831, 764, 622, 459 cm–1.  








Br), 256 (25), 254 (25), 199 
(97), 197 (100).  
HR-MS (EI) m/z calcd for C14H20BrNO
+
 297.0728, found 297.0721.  
The spectral data were in accordance with those reported in the literature.
113a
 
Synthesis of 2-bromo-3-fluoro-N,N-diisopropylbenzamide (220i) 
The general procedure H was followed using 3-fluoro-N,N-diisopropylbenzamide 
(219i) (219 mg, 1.0 mmol) and NBS (356 mg, 2.0 mmol). After 22 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 220i 
(165 mg, 55%) as a white solid.  
M.p. = 134−135 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.28 (dddd, J = 8.2, 7.8, 4.9, 0.8 Hz, 1H), 7.06 (ddd, J = 8.2, 8.2, 
1.5 Hz, 1H), 6.95 (dq, J = 7.8, 0.8 Hz, 1H), 3.63−3.43 (m, 2H), 1.56 (d, J = 6.7 Hz, 3H), 1.54 (d, 
J = 6.7 Hz, 3H), 1.21 (d, J = 6.7 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 166.9 (d, 
4
JC–F = 2 Hz, Cq), 159.2 (d, 
1
JC–F = 249 Hz, Cq), 138.2 
(Cq), 129.2 (d, 
3
JC–F = 8 Hz, CH), 121.8 (d, 
4
JC–F = 4 Hz, CH), 111.8 (d, 
2
JC–F = 22 Hz, CH), 106.4 
(d, 
2
JC–F = 22 Hz, Cq), 51.2 (CH), 46.1 (CH), 20.7 (CH3), 20.6 (CH3), 20.6 (CH3), 20.1 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(105.1−105.2) (m).  
IR (ATR): ṽ = 2970, 2932, 2874, 1625, 1437, 1339, 1205, 1041, 790, 603 cm–1.  








Br), 202 (90), 200 (100), 174 
(16), 172 (18), 57 (48).  
HR-MS (ESI) m/z calcd for [(C13H17FBrNO)H]
+
 302.0556, found 302.0551.
 
Synthesis of 3-bromo-N,N-diisopropyl-[1,1'-biphenyl]-4-carboxamide (220j) 
The general procedure H was followed using 
3-bromo-N,N-diisopropyl-[1,1'-biphenyl]-4-carboxamide (219j) (281 mg, 1.0 mmol) 
and NBS (712 mg, 4.0 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 5/1) and normal phase HPLC (n-hexane/EtOAc: 
15/1→1/9) yielded 220j (173 mg, 48%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 1.6 Hz, 1H), 7.57−7.49 (m, 3H), 7.47−7.39 (m 2H), 
7.39−7.32 (m, 1H), 7.22 (d, J = 7.8 Hz, 1H), 3.68 (sept, J = 6.7 Hz, 1H), 3.53 (sept, J = 6.7 Hz, 




C-NMR (75 MHz, CDCl3): δ = 168.1 (Cq), 138.6 (Cq), 139.0 (Cq), 138.7 (Cq), 131.3 (CH), 128.9 
(CH), 128.0 (CH), 127.0 (CH), 126.8 (CH), 126.3 (CH), 119.3 (Cq), 51.2 (CH), 46.0 (CH), 20.8 
(CH3), 20.7 (CH3), 20.6 (CH3), 20.1 (CH3).  
IR (ATR): ṽ = 2968, 2931, 1631, 1437, 1336, 1044, 754, 696 cm–1.  
Experimental Section 
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Br), 318 (32), 316 (33), 
261 (99), 259 (100), 152 (70).  
HR-MS (EI) m/z calcd for C19H22BrNO
+
 359.0885, found 359.0885. 
Synthesis of 4-bromo-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (220k) 
The general procedure H was followed using 
N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (219k) (141 mg, 0.5 mmol) and 
NBS (267 mg, 1.5 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1→10/1) yielded 220k (117 mg, 65%) as a white 
solid.  
M.p. = 151−152 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.61 (d, J = 8.2 Hz, 1H), 7.55 (d, J = 7.8 Hz, 2H), 7.51−7.37 (m, 
4H), 7.36 (d, J = 2.2 Hz, 1H), 3.69 (sept, J = 6.6 Hz, 1H), 3.55 (sept, J = 6.6 Hz, 1H), 1.61 (d, J = 
6.6 Hz, 3H), 1.59 (d, J = 6.6 Hz, 3H), 1.26 (d, J = 6.6 Hz, 3H), 1.08 (d, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.0 (Cq), 140.8 (Cq), 140.5 (Cq), 139.4 (Cq), 133.2 (CH), 128.9 
(CH), 128.1 (CH), 127.9 (CH), 127.0 (CH), 125.1 (CH), 117.9 (Cq), 51.2 (CH), 46.0 (CH), 20.9 
(CH3), 20.7 (CH3), 20.6 (CH3), 20.1 (CH3).  
IR (ATR): ṽ = 2931, 2873, 1631, 1444, 1369, 1337, 1039, 786 cm–1.  








Br), 318 (38), 316 (37), 261 
(98), 259 (100), 152 (85).  
HR-MS (EI) m/z calcd for C19H22BrNO
+
 359.0885, found 359.0882.  
The spectral data were in accordance with those reported in the literature.
113a
 
Synthesis of 4-bromo-N,N-diisopropyl-4'-methyl-[1,1'-biphenyl]-3-carboxamide (220l) 
The general procedure H was followed using 
N,N-diisopropyl-4'-methyl-[1,1'-biphenyl]-3-carboxamide (219l) (148 mg, 
0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) 
yielded 220l (88 mg, 47%) as a white solid.  
M.p. = 193−194 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.57 (dd, J = 8.1, 0.5 Hz, 1H), 7.44 (dt, J = 8.1, 0.5 Hz, 2H), 
7.37 (dd, J = 8.2, 2.2 Hz, 1H), 7.34 (d, J = 2.0 Hz, 1H), 7.23 (d, J = 8.2 Hz, 2H), 3.67 (sept, J = 
6.7 Hz, 1H), 3.52 (sept, J = 6.7 Hz, 1H), 2.37 (s, 3H), 1.59 (d, J = 6.7 Hz, 3H), 1.57 (d, J = 6.7 Hz, 
3H), 1.24 (d, J = 6.7 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.1 (Cq), 140.7 (Cq), 140.4 (Cq), 137.8 (Cq), 136.5 (Cq), 133.1 
(CH), 129.6 (CH), 127.9 (CH), 126.8 (CH), 124.8 (CH), 117.5 (Cq), 51.2 (CH), 46.0 (CH), 21.1 
(CH3), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 20.1 (CH3).  
IR (ATR): ṽ = 2969, 2929, 1631, 1441, 1336, 1021, 763, 514 cm–1.  
MS (ESI) m/z (relative intensity): 396 (28) [(M+Na)
+
], 749 (100) [(2M+H)
+
].  
HR-MS (ESI) m/z calcd for [(C20H24BrNO)H]
+
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Synthesis of 4-bromo-4'-fluoro-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (220m) 
The general procedure H was followed using 
4'-fluoro-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (219m) (150 mg, 
0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) yielded 220m 
(102 mg, 54%) as a white solid.  
M.p. = 156−157 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.59 (d, J = 8.2 Hz, 1H), 7.49 (dd, J = 8.6, 8.6 Hz, 2H), 7.33 (dd, 
J = 8.2, 2.3 Hz, 1H), 7.30 (d, J = 2.3 Hz, 1H), 7.11 (dd, J = 8.6, 8.6 Hz, 2H), 3.66 (sept, J = 6.6 Hz, 
1H), 3.63 (sept, J = 6.6 Hz, 1H), 1.58 (d, J = 6.6 Hz, 3H), 1.56 (d, J = 6.6 Hz, 3H), 1.25 (d, J = 6.6 
Hz, 3H), 1.07 (d, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 167.9 (Cq), 162.7 (d, 
1
JC–F =  247 Hz, Cq), 140.5 (Cq), 139.9 
(Cq), 135.6 (d, 
4
JC–F = 3 Hz, Cq), 133.2 (CH), 128.7 (d, 
3
JC–F = 9 Hz, CH), 128.0 (CH), 124.9 (CH), 
117.9 (Cq), 111.9 (d, 
2
JC–F = 22 Hz, CH), 51.2 (CH), 46.1 (CH), 20.9 (CH3), 20.7 (CH3), 20.6 
(CH3), 20.1 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(114.3−114.6) (m).  
IR (ATR): ṽ = 2966, 2928, 1631, 1599, 1438, 1337, 1226, 849, 813 cm–1.  








Br), 336 (35), 334 (36), 279 
(99), 277 (100), 170 (75), 135 (60).  
HR-MS (EI) m/z calcd for C19H21FBrNO
+
 377.0791, found 377.0790. 
Synthesis of methyl 4'-bromo-3'-(diisopropylcarbamoyl)-[1,1'-biphenyl]-4-carboxylate 
(220n) 
The general procedure H was followed using methyl 
4'-bromo-3'-(diisopropylcarbamoyl)-[1,1'-biphenyl]-4-carboxylate 
(219n) (170 mg, 0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 
10/1→4/1) yielded 220n (120 mg, 57%) as a white solid.  
M.p. = 182−183 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.08 (dt, J = 8.4, 1.8 Hz, 2H), 7.62 (d, J = 8.2 Hz, 1H), 7.59 (dt, 
J = 8.4, 1.8 Hz, 2H), 7.41 (dd, J = 8.2, 2.2 Hz, 1H), 7.38 (d, J = 2.2 Hz, 1H), 3.94 (s, 3H), 3.65 
(sept, J = 6.7 Hz, 1H), 3.53 (sept, J = 6.7 Hz, 1H), 1.58 (d, J = 6.7 Hz, 3H), 1.57 (d, J = 6.7 Hz, 
3H), 1.25 (d, J = 6.7 Hz, 3H), 1.07 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 167.8 (Cq), 166.7 (Cq), 143.7 (Cq), 140.7 (Cq), 139.6 (Cq), 133.4 
(CH), 130.2 (CH), 129.5 (Cq), 128.2 (CH), 126.9 (CH), 125.1 (CH), 118.9 (Cq), 52.2 (CH3), 51.2 
(CH), 46.1 (CH), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2960, 1719, 1629, 1435, 1368, 1340, 1271, 1102, 769, 710 cm–1.  








Br), 376 (38), 374 (38), 
319 (98), 317 (100), 151 (19).  
HR-MS (EI) m/z calcd for C21H24BrNO3
+
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Synthesis of 4'-acetyl-4-bromo-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (220o) 
The general procedure H was followed using 
4'-acetyl-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (219o) (162 mg, 
0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 5/1→3/1) 
yielded 220o (70 mg, 34%) as a white solid.  
M.p. = 203−204 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.01 (d, J = 8.2 Hz, 2H), 7.66−7.58 (m, 3H), 7.38 (dd, J = 8.2, 
2.2 Hz, 1H), 7.38 (d, J = 2.2 Hz, 1H), 3.65 (sept, J = 6.7 Hz, 1H), 3.53 (sept, J = 6.7 Hz, 1H), 2.62 




C-NMR (75 MHz, CDCl3): δ = 197.5 (Cq), 167.8 (Cq), 143.8 (Cq), 140.7 (Cq), 139.5 (Cq), 136.3 
(Cq), 133.4 (CH), 129.0 (CH), 128.2 (CH), 127.1 (CH), 125.1 (CH), 119.0 (Cq), 51.3 (CH), 46.1 
(CH), 26.7 (CH3), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2989, 1681, 1637, 1603, 1441, 1337, 1257, 1016, 813, 604 cm–1.  








Br), 360 (43), 358 (43), 
303 (99), 301 (100), 151 (18), 43 (41).  
HR-MS (EI) m/z calcd for C21H24BrNO2
+
 401.0990, found 401.0990. 
Synthesis of 3'-acetyl-4-bromo-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (220p) 
The general procedure H was followed using 
3'-acetyl-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (219p) (162 mg, 
0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 10/1→4/1) 
yielded 220p (93 mg, 46%) as a white solid.  
M.p. = 159−160 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.11 (t, J = 1.6 Hz, 1H), 7.93 (dt, J = 7.8, 1.6 Hz, 1H), 7.72 (dq, 
J = 7.6, 1.1 Hz, 1H), 7.62 (d, J = 8.2 Hz, 1H), 7.52 (dd, J = 7.8, 7.6 Hz, 1H), 7.41 (dd, J = 8.2, 2.3 
Hz, 1H), 7.37 (d, J = 2.3 Hz, 1H), 3.65 (sept, J = 6.7 Hz, 1H), 3.53 (sept, J = 6.7 Hz, 1H), 2.63 (s, 




C-NMR (75 MHz, CDCl3): δ = 197.8 (Cq), 167.8 (Cq), 140.6 (Cq), 140.0 (Cq), 139.8 (Cq), 137.7 
(Cq), 133.4 (CH), 131.5 (CH), 129.2 (CH), 128.2 (CH), 127.8 (CH), 126.7 (CH), 125.1 (CH), 
118.7 (Cq), 51.2 (CH), 46.1 (CH), 26.8 (CH3), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2982, 2934, 1677, 1629, 1451, 1367, 1397, 1036, 767, 602 cm–1.  








Br), 360 (46), 358 (46), 
303 (98), 301 (100), 151 (15).  
HR-MS (EI) m/z calcd for C21H24BrNO2
+
 401.0990, found 401.0991. 
Synthesis of 5-(5'-acetylthiophen-2-yl)-2-bromo-N,N-diisopropylbenzamide (220q) 
The general procedure H was followed using 
3-(5'-acetylthiophen-2-yl)-N,N-diisopropylbenzamide (219q) (165 mg, 
0.5 mmol) and NBS (178 mg, 1.0 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 4/1→3/1) yielded 
220q (76 mg, 37%) as a white solid.  
Experimental Section 
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M.p. = 181−183 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.62 (d, J = 4.0 Hz, 1H), 7.58 (d, J = 8.2 Hz, 1H), 7.43 (dd, J = 
8.2, 2.2 Hz, 1H), 7.40 (d, J = 2.2 Hz, 1H), 7.29 (d, J = 4.0 Hz, 1H), 3.62 (sept, J = 6.7 Hz, 1H), 
3.53 (sept, J = 6.7 Hz, 1H), 2.54 (s, 3H), 1.59 (d, J = 6.7 Hz, 3H), 1.55 (d, J = 6.7 Hz, 3H), 1.24 (d, 
J = 6.7 Hz, 3H), 1.07 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 190.5 (Cq), 167.3 (Cq), 150.3 (Cq), 143.8 (Cq), 140.9 (Cq), 133.6 
(CH), 133.3 (CH), 133.0 (Cq), 127.0 (CH), 124.6 (CH), 124.0 (CH), 119.5 (Cq), 51.3 (CH), 46.1 
(CH), 26.5 (CH3), 20.9 (CH3), 20.6 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2977, 2936, 1653, 1621, 1435, 1340, 1281, 1021, 827, 796, 599 cm–1.  








Br), 366 (40), 364 (40), 
309 (100), 307 (100), 185 (14).  
HR-MS (ESI) m/z calcd for [(C19H22BrNO2S)H]
+
 408.0627, found 408.0620. 
Synthesis of 2-iodo-N,N-diisopropylbenzamide (221a) 
The general procedure H was followed using N,N-diisopropylbenzamide (219a) 
(103 mg, 0.5 mmol) and NIS (225 mg, 1.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 10/1→5/1) and normal phase HPLC 
(n-hexane/EtOAc: 19/1→9/1) yielded 221a (88 mg, 53%) as a white solid.  
M.p. = 188−189 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.76 (dd, J = 8.0, 1.0 Hz, 1H), 7.34 (ddd, J = 7.6, 7.5, 1.0 Hz, 
1H), 7.11 (dd, J = 7.6, 1.6 Hz, 1H), 7.00 (ddd, J = 8.0, 7.5, 1.6 Hz, 1H),  3.63−3.38 (m, 2H), 1.58 
(d, J = 6.8 Hz, 3H), 1.54 (d, J = 6.8 Hz, 3H), 1.25 (d, J = 6.8 Hz, 3H), 1.04 (d, J = 6.8 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.8 (Cq), 144.2 (Cq), 139.3 (CH), 129.4 (CH), 128.2 (CH), 
125.8 (CH), 92.2 (Cq), 51.2 (CH), 46.0 (CH), 20.7 (CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (neat): ṽ = 2967, 2929, 1618, 1581, 1435, 1339, 1012, 771 cm–1.  
MS (EI) m/z (relative intensity): 331 (7) [M
+
], 288 (27), 230 (100), 202 (21), 43 (23).  
HR-MS (EI) m/z calcd for C13H18INO
+
 331.0433, found 331.0414.  
The spectral data were in accordance with those reported in the literature.
113a
 
Synthesis of 2-iodo-N,N-diisopropyl-5-methylbenzamide (221h) 
The general procedure H was followed using 
N,N-diisopropyl-3-methylbenzamide (219h) (217 mg, 1.0 mmol) and NIS 
(450 mg, 2.0 mmol). After 22 h, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) and normal phase HPLC (n-hexane/EtOAc: 
19/1→9/1) yielded 221h (219 mg, 64%) as a white solid.  
M.p. = 161−162 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.63 (d, J = 8.0 Hz, 1H), 6.93 (d, J = 2.0 Hz, 1H), 6.82 (dt, J = 
8.0, 0.7 Hz, 1H), 3.58 (sept, J = 6.7 Hz, 1H), 3.49 (sept, J = 6.7 Hz, 1H), 2.27 (s, 3H), 1.57 (d, J = 
6.7 Hz, 3H), 1.54 (d, J = 6.7 Hz, 3H), 1.25 (d, J = 6.7 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.9 (Cq), 144.0 (Cq), 139.0 (CH), 138.4 (Cq), 130.4 (CH), 
126.5 (CH), 88.0 (Cq), 51.2 (CH), 45.9 (CH), 20.9 (CH3), 20.8 (CH3), 20.7 (CH3), 20.6 (CH3), 
20.0 (CH3).  
IR (ATR): ṽ = 2966, 2928, 1621, 1441, 1337, 1012, 834, 763, 621, 455 cm–1.  
MS (EI) m/z (relative intensity): 345 (11) [M
+
], 302 (23), 245 (100), 216 (16), 90 (22).  
HR-MS (ESI) m/z calcd for [(C14H20INO)H]
+
 346.0668, found 346.0662.  
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The spectral data were in accordance with those reported in the literature.
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Synthesis of 2-iodo-N,N-diisopropyl-4,5-dimethylbenzamide (219v) 
The general procedure H was followed using 
N,N-diisopropyl-3,4-dimethylbenzamide (219v) (233 mg, 1.0 mmol) and NIS  
(450 mg, 2.0 mmol). After 22 h, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 20/1→10/1) yielded 221v (187 mg, 52%) as a white solid.  
M.p. = 106−107 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.55 (s, 1H), 6.94 (s, 1H), 3.62 (sept, J = 6.7 Hz, 1H), 3.49 (sept, 
J = 6.7 Hz, 1H), 2.21 (s, 3H), 2.17 (s, 3H), 1.58 (d, J = 6.7 Hz, 3H), 1.56 (d, J = 6.7 Hz, 3H), 1.26 
(d, J = 6.7 Hz, 3H), 1.06 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 170.0 (Cq), 141.8 (Cq), 139.7 (CH), 138.4 (Cq), 137.0 (Cq), 126.8 
(CH), 88.3 (Cq), 51.1 (CH), 45.8 (CH), 20.8 (CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3), 19.3 
(CH3), 19.1 (CH3).  
IR (ATR): ṽ = 2970, 2929, 1623, 1435, 1359, 1322, 1043, 817, 609 cm–1.  
MS (EI) m/z (relative intensity): 359 (10) [M
+
], 316 (28), 259 (100), 232 (17), 104 (13).  
HR-MS (EI) m/z calcd for C15H22INO
+
 359.0746, found 359.0745. 
Synthesis of 3-fluoro-2-iodo-N,N-diisopropylbenzamide (219i) 
The general procedure H was followed using 3-fluoro-N,N-diisopropylbenzamide 
(219i) (219 mg, 1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification 
by column chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 221i 
(128 mg, 36%) as a white solid.  
M.p. = 124−125 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.32 (ddd, J = 8.0, 5.2, 0.7 Hz, 1H), 7.00 (ddd, J = 8.0, 7.6, 
1.5 Hz, 1H), 6.93 (dd, J = 7.6, 1.0 Hz, 1H), 3.62−3.43 (m, 2H), 1.60 (d, J = 6.6 Hz, 3H), 1.56 (d, 
J = 6.6 Hz, 3H), 1.26 (d, J = 6.6 Hz, 3H), 1.07 (d, J = 6.6 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 168.6 (d, 
4
JC–F = 2 Hz, Cq), 161.8 (d, 
1
JC–F = 246 Hz, Cq), 146.4 
(d, 
3
JC–F = 8 Hz, Cq), 130.3 (d, 
3
JC–F = 8 Hz, CH), 121.4 (d, 
4
JC–F = 3 Hz, CH), 114.8 (d, 
2
JC–F = 
24 Hz, CH), 76.5 (d, 
2
JC–F = 26 Hz, Cq), 51.3 (CH), 46.1 (CH), 20.8 (CH3), 20.7 (CH3), 20.6 (CH3), 
20.0 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = −(90.8−90.9) (m).  
IR (ATR): ṽ = 2967, 2930, 1620, 1435, 1340, 1203, 1041, 788, 604 cm–1.  
MS (EI) m/z (relative intensity): 349 (10) [M
+
], 306 (28), 249 (100), 218 (18), 43 (16).  
HR-MS (EI) m/z calcd for C13H17FINO
+
 349.0339, found 349.0339. 
Synthesis of 4-iodo-N,N-diisopropylbenzo[d][1,3]dioxole-5-carboxamide (221w) 
The general procedure H was followed using 
4-iodo-N,N-diisopropylbenzo[d][1,3]dioxole-5-carboxamide (219w) (249 mg, 
1.0 mmol) and NIS (450 mg, 2.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 221w (277 mg, 73%) 
as a white solid.  
M.p. = 149−150 °C.  
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1
H-NMR (300 MHz, CDCl3): δ = 6.73 (d, J = 7.8 Hz, 1H), 6.61 (d, J = 7.8 Hz, 1H), 6.02 (dd, J = 
7.0, 1.2 Hz, 2H), 3.62 (sept, J = 6.7 Hz, 1H), 3.47 (sept, J = 6.7 Hz, 1H), 1.55 (d, J = 6.7 Hz, 3H), 
1.52 (d, J = 6.7 Hz, 3H), 1.22 (d, J = 6.7 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.1 (Cq), 149.7 (Cq), 145.5 (Cq), 137.5 (Cq), 119.1 (CH), 108.3 
(CH), 100.7 (Cq), 70.0 (CH2), 51.2 (CH), 46.0 (CH), 20.8 (CH3), 20.7 (CH3), 20.6 (CH3), 20.2 
(CH3).  
IR (ATR): ṽ = 2961, 2927, 1621, 1445, 1339, 1238, 1033, 898, 763, 593 cm–1.  
MS (EI) m/z (relative intensity): 375 (13) [M
+
], 332 (20), 275 (100), 149 (12).  
HR-MS (EI) m/z calcd for C14H18INO3
+
 375.0331, found 375.0329.  
Synthesis of 4-iodo-N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (221k) 
The general procedure H was followed using 
N,N-diisopropyl-[1,1'-biphenyl]-3-carboxamide (219k) (141 mg, 0.5 mmol) and 
NIS (338 mg, 1.5 mmol). After 22 h, purification by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1→10/1) yielded 221k (130 mg, 64%) as a white 
solid.  
M.p. = 171−172 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.84 (d, J = 8.2 Hz, 1H), 7.53 (dt, J = 7.0, 2.0 Hz, 2H), 7.43 (dt, 
J = 7.0, 2.0 Hz, 2H), 7.36 (dt, J = 7.0, 1.3 Hz, 1H), 7.32 (d, J = 2.2 Hz, 1H), 7.23 (dd, J = 8.2, 
2.2 Hz, 1H), 3.65 (sept, J = 6.7 Hz, 1H), 3.52 (sept, J = 6.7 Hz, 1H), 1.60 (d, J = 6.7 Hz, 3H), 1.58 
(d, J = 6.7 Hz, 3H), 1.28 (d, J = 6.7 Hz, 3H), 1.06 (d, J = 6.7 Hz, 3H).
  
13
C-NMR (75 MHz, CDCl3): δ = 169.6 (Cq), 144.5 (Cq), 141.4 (Cq), 139.6 (CH), 139.4 (Cq), 128.9 
(CH), 128.1 (CH), 127.9 (CH), 126.9 (CH), 124.3 (CH), 90.8 (Cq), 51.2 (CH), 46.0 (CH), 20.8 
(CH3), 20.7 (CH3), 20.6 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2967, 2930, 1622, 1444, 1337, 1207, 785, 608 cm–1.  
MS (EI) m/z (relative intensity): 407 (15) [M
+
], 364 (35), 307 (100), 276 (25), 152 (45).  
HR-MS (EI) m/z calcd for C19H22INO
+
 407.0746, found 407.0727. 
Synthesis of 4-iodo-N,N-diisopropyl-4'-methyl-[1,1'-biphenyl]-3-carboxamide (221l) 
The general procedure H was followed using 
N,N-diisopropyl-4'-methyl-[1,1'-biphenyl]-3-carboxamide (219l) (148 mg, 
0.5 mmol) and NIS (225 mg, 1.0 mmol). After 22 h, purification by 
column chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) 
yielded 219l (145 mg, 68%) as a white solid.  
M.p. = 208−210 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.82 (d, J = 8.2 Hz, 1H), 7.43 (dt, J = 8.1, 1.8 Hz, 2H), 7.30 (d, 
J = 2.2 Hz, 1H), 7.26−7.19 (m, 3H), 3.65 (sept, J = 6.6 Hz, 1H), 3.52 (sept, J = 6.6 Hz, 1H), 2.37 




C-NMR (75 MHz, CDCl3): δ = 169.8 (Cq), 144.5 (Cq), 141.4 (Cq), 139.6 (CH), 137.8 (Cq), 136.6 
(Cq), 129.6 (CH), 128.0 (CH), 126.7 (CH), 124.1 (CH), 90.4 (Cq), 51.2 (CH), 46.0 (CH), 21.1 
(CH3), 20.8 (CH3), 20.7 (CH3), 20.7 (CH3), 20.0 (CH3).  
IR (ATR): ṽ = 2968, 2929, 1627, 1440, 1335, 1034, 762, 515 cm–1.  
MS (ESI) m/z (relative intensity): 382 (82) [(M+H)
+
], 444 (37) [(M+Na)
+
], 843 (100) [(2M+H)
+
].  
HR-MS (ESI) m/z calcd for [(C20H24INO)H]
+
 382.0975, found 382.0970. 
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Synthesis of 2-iodo-N,N-diisopropyl-5-(naphthalen-1-yl)benzamide (221x) 
The general procedure H was followed using 
N,N-diisopropyl-3-(naphthalen-1-yl)benzamide (219x) (166 mg, 0.5 mmol) 
and NIS (225 mg, 1.0 mmol). After 22 h, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 20/1→10/1) yielded 221x 
(134 mg, 59%) as a white solid.  
M.p. = 161−162 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.91 (d, J = 8.2 Hz, 1H), 7.89 (d, J = 8.2 Hz, 1H), 7.86 (d, J = 
8.6 Hz, 1H), 7.82 (d, J = 8.6 Hz, 1H), 7.50 (dd, J = 8.2, 7.0 Hz, 1H), 7.46 (ddd, J = 8.0, 7.0, 
1.5 Hz, 1H), 7.38 (ddd, J = 7.6, 7.5, 1.5 Hz, 1H), 7.37 (dd, J = 7.5, 1.1 Hz, 1H), 7.25 (dd, J = 2.2, 
2.1 Hz, 1H), 7.15 (dd, J = 8.2, 2.1 Hz, 1H), 3.77 (sept, J = 6.6 Hz, 1H), 3.51 (sept, J = 6.6 Hz, 1H), 




C-NMR (75 MHz, CDCl3): δ = 169.6 (Cq), 144.2 (Cq), 141.0 (Cq), 139.3 (CH), 138.3 (Cq), 133.7 
(Cq), 131.1 (CH), 128.4 (CH), 128.2 (CH), 127.4 (CH), 126.9 (CH), 126.3 (CH), 126.0 (CH), 
125.5 (CH), 125.3 (CH), 91.0 (Cq), 51.4 (CH), 46.0 (CH), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 
20.1 (CH3) (One Cq is invisible).  
IR (ATR): ṽ = 2968, 2933, 1624, 1439, 1368, 1331, 1119, 1038, 1011, 778 cm–1.  
MS (ESI) m/z (relative intensity): 458 [(M+H)
+
] (46), 915 [(2M+H)
+
] (100).  
HR-MS (ESI) m/z calcd for [(C25H18F3NO)H]
+ 
458.0975, found 458.0968. 
Studies with isotopically labelled [D]4-MeOH (Scheme 90a) 
 
A mixture of N,N-diisopropylbenzamide (219a) (103 mg, 0.5 mmol), Ru3(CO)12 (10.5 mg, 
3.3 mol %) and AgO2C(1-Ad) (28.7 mg, 20 mol %) in DCE (2.0 mL) and [D]4-MeOH (0.2 mL) 
was stirred at 100 °C under N2 for 16 h. The mixture was then allowed to cool to ambient 
temperature, diluted with EtOAc (5 mL), filtered through a short pad of silica gel and eluted with 
EtOAc (50 mL). After removing the solvent under reduced pressure, the product was purified by 
column chromatography on silica gel (n-hexane/EtOAc: 4/1) to yield a mixture 219a and 
[D]2-219a (93 mg, 90%) as a white solid. The deuterium incorporation was estimated to be 33% 
by 
1
H-NMR spectroscopy.  
Studies with isotopically labelled compound [D]1-250 (Scheme 90b) 
 
A mixture of N,N-diisopropylbenzamide (219a) (205 mg, 1.0 mmol), NBS (356 mg, 2.0 mmol), 
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Ru3(CO)12 (21.1 mg, 3.3 mol %), AgO2C(1-Ad) (57.4 mg, 20 mol %) and [D]1-250 (200 mg, 
2.0 mmol) in DCE (3.0 mL) was stirred at 120 °C under N2 for 16 h. The mixture was then 
allowed to cool down to ambient temperature, diluted with EtOAc (5 mL), filtered through a short 
pad of silica gel and eluted with EtOAc (50 mL). After removing the solvent under reduced 
pressure, the product was purified by column chromatography on silica gel (n-hexane/EtOAc: 
10/1→5/1) to give [D]1-220a (164 mg, 57%) as a white solid and [D]2-219a (79 mg, 38%) as a 
white solid. The deuterium incorporation was estimated by 
1
H-NMR spectroscopy. 
Kinetic isotope effect studies by parallel experiments (Scheme 91) 
 
A mixture of benzamide 219a or [D]5-219a (1.0 mmol), NBS (356 mg, 2.0 mmol), Ru3(CO)12 
(21.1 mg, 3.3 mol %), AgO2C(1-Ad) (57.4 mg, 20 mol %) and the internal standard 
1,3,5-tri-tert-butylbenzene (246 mg, 1.0 mmol) in DCE (8.0 mL) was stirred at 120 °C under N2. 
For three hours, an aliquot (0.2 mL) was collected every fifteen minutes and submitted to GC 
analysis to determine the conversion. 
 
Entry 1 2 3 4 5 6 7 8 9 10 11 12 
220a 2 9 20 25 31 35 39 38 44 46 48 49 
219a 98 91 76 75 69 65 61 58 56 54 52 51 
 
Entry 1 2 3 4 5 6 7 8 9 10 11 12 
[D]4-220a 2 9 19 25 31 35 39 41 43 44 46 46 
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9 List of Abbreviations  
Å Ångström ESI electronspray ionization  
Ac acetyl Et ethyl 
Ad adamantly FG functional group 
Alk alkyl  g gram 
AMLA ambiphilic metal-ligand activation GC gas chromatography 
aq. aqueous  h hour 
Ar aryl Het Hetero(aryl) 
APT attached proton test  Hept heptyl  
atm atmospheric pressure HPLC high performance liquid chromatography 
ATR attenuated total reflectance HR-MS high resolution mass spectrometry 
BHT 2,6-di-tert-butyl-4-methylphenol Hz Hertz  
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl  i iso 
Bn benzyl IES internal electrophilic substitution 
Boc tert-butyloxycarbonyl  IR infrared spectroscopy 
Bu Butyl J coupling constant  
Bz benzoyl KIE kinetic isotope effect 
calc. calculated  L ligand  
cat. catalyst  Leu leucine 
CMD concerted-metalation-deprotonation m meta 
cod 1,5-cyclooctadien m multiplet 
conv. conversion M molar  
Cp cyclopentadienyl [M+] molecular ion peak  
Cy cyclohexyl Me methyl  
δ  chemical shift  Mes mesityl  
d doublet mg milligram  
DCE 1,2-dichloroethane  MHz megahertz  
DCM dichloromethane min minute  
dd doublet of doublet mL milliliter  
DFT density functional theory mmol millimol  
DG directing group M. p. melting point 
DMA N,N-dimethylacetamide MPV membrane pump vacuum 
DME dimethoxyethane MS mass spectrometry 
DMF N,N-dimethylformamide m/z mass-to-charge ratio 
DMSO dimethyl sulfoxide n normal 
DoM directed ortho metalation NBS N-bromosuccinimide 
DPPH 2,2-diphenyl-1-picrylhydrazyl NHC N- heterocyclic carbene 
dt doublet of triplet NIS N-iodosuccinimide 
Ed. editor NMP N-methylpyrrolidinone 
EI electron ionization NMR nuclear magnetic resonance 
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o ortho SPS solvent purification system 
OPV oil pump vacuum t tert 
p para t triplet 
Ph phenyl  T temperature 
Piv pivaloyl TEMPO 2,2,6,6-tetramethylpiperidin-1-yloxy  
ppm parts per million  Tf trifluoromethanesulfonate 
Pr propyl TFA trifluoroacetic acid 
PTSA p-toluenesulfonic acid TFAA trifluoroacetic anhydride 
Py pyridyl THF tetrahydrofuran 
PyDipSi pyridyldiisopropylsilyl TLC thin layer chromatography 
pym pyrimidyl TM transition metal  
q  quartet  TMS trimethylsilyl 
R rest Ts para-toluenesulfonyl 
rac racemic TS transition state 
ref. reference ṽ absorption 
s singlet wt% weight by volume  
sat. saturated X (pseudo)halide 
sec secondary PyDipSi pyridyldiisopropylsilyl 
SE
Ar electrophilic aromatic substitution XPhos 2-dicyclohexylphosphino-2′,4′,6′-tri- 
SET single electron transfer   isopropylbiphenyl 
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